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Abstract
A panel of murine monoclonal antibodies was raised against human sperm plasma
membrane in order to identify and characterize molecules important in fertilization.
Twelve monoclonal antibodies were produced and of these nine belong to the IgM
subclass while the remaining three are of the IgG2a subclass. The antibodies were
purified from bulk culture supernatants using affinity chromatography— the IgG
antibodies on a protein A column and the IgMs on a column made using a commercially
available anti-mouse IgM antibody coupled to an inert support. These purified
antibodies were then used to characterize their respective antigens biochemically and
assessed for their biological activity using a variety of in vitro tests of sperm function.
All twelve antibodies recognized a molecule which was present on the entire
surface of human spermatozoa. Eight antibodies cross-reacted with both marmoset and
boar spermatozoa as well as with human leucocyte sublasses. The other four
immunoglobulins were highly specific for human sperm cells and did not cross-react
with any of the other cells tested. In Western blotting experiments, the monoclonals
recognized epitopes present on a variety of molecules. Only one antibody, spm 4/4,
failed to recognize any proteins when transferred to nitrocellulose.
When tested for their ability to interfere with the acrosome reaction, four
antibodies significantly inhibited the percentage of spermatozoa in a population
undergoing a spontaneous acrosome reaction. Subsequently, two of these antibodies,
spm 1/1 and spm 1/2, were shown to cause a significant decrease in the percentage of
sperm which were induced to undergo the acrosome reaction by the calcium ionophore
A23187. The interaction between spermatozoa and the zona pellucida was assessed
using salt-stored human zonae and two immunoglobulins, spm 1/2 and spm 4/6,
significantly reduced the mean number of spermatozoa bound to the zona pellucida.
These two antibodies also caused a marked inhibition of sperm-oolemmal fusion as
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assessed using the hamster egg penetration test. When this test was performed at
various sperm concentrations, both of these antibodies exhibited a dose dependent
decrease in the penetration rate. One further antibody, spm 4/7, was found to have
biological activity in that it stimulated the interaction between spermatozoa and the
oolemma.
The gene encoding the antigen recognized by one of the inhibitory antibodies,
spm 1/2, was isolated from a human testicular cDNA library cloned into the expression
vector Xgtl 1. The insertDNA was amplified using the polymerase chain reaction and
then subcloned into the phagemid pBluescript SK- for sequencing. The whole insert
was sequenced and found to be 1997 nucleotides in length. It contains an open reading
frame from nucleotide 1 to nucleotide 660 which encodes for the carboxy-terminal 219
amino acids of the antigen recognized by the antibody. It has a long 3' untranslated
region (1337 nucleotides) which contains a messenger RNA degradation signal, two
polyadenylation signals and a poly A tail. Homology searches of the Genebank and
Owl databases were made and no significant homology identified.
Thus from the initial panel of twelve monoclonal antibodies, three which
recognize molecules of particular interest were identified. Two have inhibitory effects
on fertilization and may be of use in producing a contraceptive vaccine. The other
immunoglobulin has a stimulatory effect on fertilization and may prove to have an
clinical application in the treatment of subfertile men.
(approximately 40 000 words in main text)
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1 Introduction
Global population growth has started to slow and is now less than 2% a year but this
f )
still means that there will be approximately 90 million more births than deaths this year
(Potts, 1990). Over 90% of these births will be in developing countries and clearly for
the survival of the human race on Earth with its limited resources, this 'population
explosion' must be controlled and curtailed.
In order to achieve this aim new methods of contraception have to be
developed. Among the novel ideas is the concept of a contraceptive vaccine which
would provide a safe and reliable method of birth control. There are three main target
areas for a possible contraceptive vaccine— (1) endocrine signals, (2) products of
the conceptus and (3) gamete specific antigens. The production of a vaccine based on
gamete specific antigens, in particular spermatozoal antigens, is the long term aim of the
work described in this thesis and therefore the other areas will not be considered
further.
Spermatogenesis is not initiated until puberty, long after immunological
tolerance to self antigens is established and therefore antigens unique to spermatozoa
are not included in this recognition process (Haas & Beer, 1986). The process of
spermatogenesis is therefore sequestered from the immune system. Tight junctions
between Sertoli cells form the protective 'blood-testis' barrier which isolates
spermatozoa within the seminiferous tubules from blood components such as
lymphocytes and immunoglobulins (Johnson, 1973). Throughout the rest of the male
reproductive tract, spermatozoa are sequestered behind tight junctions between
epithelial cells. Disruption of this blood-testis barrier can lead to the triggering of an
immune response (Dondero et al, 1990). Such conditions include vas obstruction
(Hendry et al, 1982), biopsy study (Hjort et al, 1974), malignancy (Guazziero et al,
1985) and vasectomy (Alexander & Anderson, 1979). The most common cause of
1
Chapter 1 Introduction 2
antigen leakage from the protected reproductive tract is vasectomy (Haas & Beer, 1986)
and approximately 50% ofmen develop antibodies to their spermatozoa after vasectomy
(Talwar, 1980). Evidence for the feasibility of a contraceptive vaccine is provided by a
group of people who suffer from idiopathic autoimmunity against gamete-specific
antigens (Bronson et al, 1984). Such immunological problems are a well recognized
cause of human infertility and this affects approximately 10% of men who are
spontaneously infertile (Dondero et al, 1990).
Further advances in the development of new contraceptive regimes occur
hand-in-hand with advances in the understanding of basic processes involved in
reproduction (Mastroianni et al, 1990). Not all antibodies that react with the sperm
surface may affect fertility (Jager et al, 1987) therefore a detailed understanding of the
events of the fertilization process is imperative both for contraceptive vaccine
development and for the diagnosis and treatment of patients with putative
immune-mediated infertility (Alexander, 1989). The structural and functional
characteristics of the human sperm surface are still poorly understood and monoclonal
antibody technology provides important probes for these studies (Anderson &
Alexander, 1983). As monoclonal antibodies recognize a specific epitope on a
particular molecule, they are valuable tools for dissecting the process of fertilization.
They can be used for the identification and characterization of the important molecules
and subsequently for the identification of clones of the gene encoding the antigen of
interest, ultimately permitting the production of the antigen by recombinant DNA
technology in sufficient quantities for trials in vivo.
In the work described in this thesis, monoclonal antibodies were produced
against a sperm plasma membrane preparation (Chapter 4), purified and biochemically
characterized (Chapter 5), assessed for their cell- and species-specificity (Chapter 6)
and biologically characterized (Chapter 7). On the basis of the results obtained in the
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proceeding experiments, one of the monoclonal antibodies was chosen for further
investigation and used in molecular studies which are described in Chapter 8.
Each experimental chapter has a specific introductory section which aims to
discuss briefly literature relevant to the work described in that chapter. Thus the
overview provided in Chapter 2 does not set out to review the whole literature pertinent
to all the material contained in this thesis. It does however aim to provide a foundation
for the understanding and appreciation of the studies described in the rest of the thesis.
Methods common to more than one chapter which are integral to the whole thesis are
described in Chapter 3 but those relevant to the work described within only one chapter
are detailed in the materials and methods section of that particular chapter. Each chapter
also contains a discussion of the results obtained in the context of those reported by
other investigators and the limitations of the methods used, and concludes with a short
summary of the results reported in that chapter. The final chapter, Chapter 9,
comprises a general discussion of the experiments and results described in the thesis
and highlights areas which hold particular promise for the future.
2 Background
2.1 Historical Aspects
A Sanscrit treatise on ancient Indian embryology thought to have been written in
1416BC refers to the process of fertilization saying "From the conjugation of blood and
semen, the embryo comes into existence" (Moore, 1989). Thus as early as 1416BC it
was recognized that for fertilization to occur semen from a male was required and that
once fertilization had happened menses ceased although it was wrongly believed that
blood and semen combined to produce the embryo. However it was not until the
middle of the 17th century when early microscopes were developed, that much
progress was made in understanding the process of fertilization. In 1673, Malpighi
studied what he believed to be unfertilized hens' eggs which had in fact been fertilized
(Gwatkin, 1977). He thus observed early chick embryos and concluded that a hen's
egg contained a miniature chick which enlarged when stimulated by a spermatozoon.
Four years later in 1677, Hamm and Leeuwenhoek were the first people to observe
human spermatozoa (Moore, 1989). However they misconstrued the role of
spermatozoa in fertilization and concluded that the human spermatozoon contained a
miniature human being which enlarged when it entered an egg. These studies led to the
formulation of the 'Theory of Preformation' although the proponents of this theory
were divided. Some believed that the spermatozoon contained the homunculus (the
name given to the preformed organism) and were thus called 'spermatists' while others,
the 'ovists', believed that the egg contained the homunculus (Gwatkin, 1977). A copy
of a drawing by Hartsoeker, a spermatist, showing the homunculus as it was believed
to be positioned inside the sperm head is shown in Figure 2.1. It was not until
approximately 200 years later when Schleiden and Schwann proposed the 'Cell Theory
of Tissue Organization' that these ideas were really questioned. In 1840, strongly
4
Figure 2.1 Drawing by Hartsoeker showing how 17th century spermatists believed
the homunculus to be positioned within the sperm head.
Chapter 2 Background 6
influenced by this new theory, van Koelliker looked for the cellular origin of
spermatozoa in the testis (Roosen-Runge, 1977; Bremner, 1981). He concluded that
spermatozoa developed in the testicular tubules by processes analagous to the
development of cells. Thus spermatozoa did not contain young developing animals as
held by the advocates of the preformation theory, but were the results of a variation on
ordinary cell production. The Swiss embryologist, Fol, was the first person to observe
the process of fertilization as it took place by watching a starfish spermatozoon attach to
and fertilize a starfish egg in 1877 (Epel, 1977) and the following year Flemming
observed chromosomes and suggested a probable role for them in fertilization (Moore,
1989). By the end of the 19th century, van Beneden had shown that the chromosomes
of the first cleavage were derived equally from spermatozoon and egg (Gwatkin,
1977). Mendel's laws of heredity were rediscovered by Correns in 1900 and their
significance realized soon afterwards (Moore, 1989; Stent & Callendar, 1987). Thus
by the turn of the century, the haploid/diploid status of the gametes and zygote were
finally appreciated and the process of fertilization realized.
During the first half of this century, much progress was made in the study of
fertilization mechanisms occurring in organisms which practise external fertilization
such as marine animals (Wassarman, 1987a). Studies on mammalian fertilization
lagged behind and to a large extent this can be attributed to the difficulties encountered
when studying animals which practise internal fertilization. This situation changed in
1954 when Dauzier et al were the first people to successfully fertilize a mammalian egg
in vitro by incubating rabbit eggs with spermatozoa recovered from the uterus and
observing cleavage of the resulting zygotes (Dauzier et al, 1954; Gwatkin 1977).
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2.2 Fertilization
At the time of ejaculation some 200-500 million spermatozoa are released into the upper
fornix of the vagina. Spermatozoa travel from here, through the female reproductive
tract, to the ampulla of the fallopian tube which is the site of fertilization. The
interaction between spermatozoon and egg is dynamic, as spermatozoa must recognize
the egg, bind to and penetrate through the egg investments and fuse with the oolemma.
Once penetrated by a spermatozoon, the egg must respond by modifying its
investments so that no further spermatozoa can fertilize the egg in order to prevent a
polyspermic fertilization from occurring. An overview of the processes involved in
fertilization is provided in Figure 2.2.
2.2.1 Sperm Transit Through the Female Reproductive Tract
Sperm transit from the vagina to the upper female genital tract is complex and poorly
understood (Stone, 1989). The vaginal environment is highly acidic (pH3-4), despite
partial neutralization by semen which is alkaline, and thus is highly deleterious to
spermatozoa (Chretien, 1989). After ejaculation, spermatozoa rapidly move from the
hostile acidic vaginal environment into the cervix. The lumen of the cervical canal is
filled with a complex cervical secretion, cervical mucus, which is a hydrogel composed
of macromolecular glycoprotein filaments arranged in a meshlike three-dimensional
network containing more than 90% water (Pommerenke, 1964; Odeblad, 1968). This
viscous gel which fills the lumen of the cervix, acts as a filter which allows sperm
penetration (under certain conditions) while maintaining an effective barrier against the
infiltration ofmicroorganisms into the uterine cavity (Haas & Beer, 1986). During the
luteal phase of the menstrual cycle and throughout pregnancy spermatozoa are trapped
within this glycoprotein network, as under progesterone dominance the mucus
framework shrinks and forms an impervious clot of gelatinous material (Chretien &













Figure 2.2 Diagrammatic overview of fertilization. See text for details.
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David, 1980). However at ovulation, under oestrogen dominance, the meshwork
widens progressively and midcycle mucus is readily penetrated by spermatozoa
(Chretien, 1989). Under such conditions, many spermatozoa move rapidly from the
hostile vaginal environment to the protective cervical mucus, although sperm loss in the
vagina is thought to be high (Barratt & Cooke, 1991). Settlage et al (1973) suggested
that only one in every two thousand ejaculated spermatozoa will enter the cervical
mucus. There is a constant flow of cervical mucus down the canal to the vagina and
thus only spermatozoa with sufficient dynamic properties to overcome its resistance
successfully penetrate the mucus (Chretien, 1989). Many morphologically abnormal
spermatozoa are excluded from cervical penetration (Hanson & Overstreet, 1981; Katz
et al, 1990) or become trapped in the meshwork and are rapidly expelled by the mucus
flow (Chretien, 1989). Thus a very reduced population of spermatozoa successfully
pass through the cervix and enter the uterine cavity (Chretien, 1989; Stone, 1989; Zhu
et al, 1992). The arrival of spermatozoa in the uterus induces a leucocytic response and
an increase in phagocytosis (Austin, 1957; Hafez, 1976; Stone, 1989) and many
spermatozoa are lost in the numerous folds and crypts which cover the uterine
endometrium (Hafez, 1976; Chretien, 1989). Several workers have recovered only a
few hundred spermatozoa from flushings of human fallopian tubes (Settlage et al,
1973; Croxatto et al, 1975; Zhu et al, 1992) and Ahlgren (1975) calculated that the
number of spermatozoa reaching the site of fertilization in the oviduct did not exceed
200, a figure which is regularly quoted (Harper,1982; Wassarman, 1987a; Chretien,
1989; Rait et al, 1991). Thus of the millions of spermatozoa released upon ejaculation,
only a few hundred reach the fertilization site in the fallopian tube and this may
contibute to the prevention of polyspermy (Stone, 1989).
There is some evidence that passive transport aids the movement of
spermatozoa through the female genital tract (Settlage et al 1973; Stone, 1989). Brown
(1944) found that the time taken for spermatozoa to reach the fallopian tubes after
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insemination indicated that the velocity of sperm movement in vivo was greater than
that measured in vitro thus suggesting that the female reproductive tract offered some
assistance to the movement of spermatozoa. Although passage of inert particles from
the vagina to the oviduct has been described (Egli & Newton, 1961), dead spermatozoa
are unable to ascend the tract (Stone, 1989) indicating that active sperm movement is
also required.
It has been suggested that spermatozoa found the egg by rheotaxis where they
swam against the current in a moving body of fluid. As the flow of fluid in the female
genital tract is outward towards the vagina, spermatozoa move upstream to the fallopian
tubes. However, it has been demonstrated in many animal species, including
mammals, that the process of fertilization is preceeded by a chemical signal from the
oocyte to the male sperm cells (Garbers et al, 1989) and some evidence suggests that
sperm passage to the site of fertilization is synchronized with ovulation to ensure
successful gamete interaction occurs (Cooper et al, 1979; Smith et al, 1987; Suarez,
1987). In many species, spermatozoa have been shown to accumulate in various
regions of the female reproductive tract after insemination and these sites may serve as
regions of sperm storage or reservoirs (Overstreet, 1983). The cervix (Overstreet et al,
1988; Zinaman et al, 1989) and the intramural segment of the fallopian tubes (Hunter,
1987) have both been implicated as sperm reservoir sites in humans. Human follicular
fluid has also been shown to contain a chemoattractant (Herriot et al, 1986; Bryant et
al, 1988). Villaneuva-Diaz et al (1990) and Rait et al (1991) showed that spermatozoa
were attracted to human follicular fluid but that this response was quite variable. Rait et
al (1991) also demonstrated that there was a strong correlation between the ability of
follicular fluid from a particular follicle to attract spermatozoa and the ability of the egg
obtained from the same follicle to be fertilized in vitro. Cell surface receptors for
progesterone have been identified on the head of human spermatozoa (Blackmore &
Lattanzio, 1991) and this coupled with the evidence that progesterone can induce the
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acrosome reaction in human spermatozoa (Osman et al, 1989) made progesterone a
strong contender for the chemoattractant. However Rait et al (1991) showed that the
chemoattractant ability of follicular fluid was not correlated with levels of progesterone
or oestrogen. Recently Parmentier et al (1992) have demonstrated the presence of
transcripts belonging to a putative olfactory receptor gene family in mammalian germ
cells and although it does not follow that the corresponding proteins are produced, it is
tempting to speculate that these transcripts might encode the receptors implicated in the
chemotaxis of sperm cells during fertilization.
2.2.2 Capacitation
Freshly ejaculated spermatozoa are not able to directly fertilize an egg but first require a
period of maturation in the female reproductive tract. These prefertilization changes in
spermatozoa were first reported independently by Austin (1951) and Chang (1951) and
subsequently termed 'capacitation' (Austin, 1952). The original definition of
capacitation included all maturational changes which occurred in spermatozoa after they
left the male reproductive tract which rendered them capable of penetrating zona-intact
eggs (Austin, 1952; Chang, 1984). As spermatozoa recovered from the fertilization
site often had modified acrosomes or lacked them entirely (Austin & Bishop, 1958a), it
was initially thought that the capacitation process included the loss of the acrosome
during the acrosome reaction (Section 2.2.3). However, it was discovered that
capacitated spermatozoa could be 'decapacitated' by treatment with seminal plasma and
that decapacitated spermatozoa could be 'recapacitated' in the oviducts (Chang, 1957)
indicating that capacitation is a reversible phenomenon (Bedford & Chang, 1962;
Zaneveld et al, 1991). In contrast, the acrosome reaction is an irreversible event and
thus capacitation was redefined to include all the prefertilization changes occurring in
spermatozoa which prepare them for the acrosome reaction but excluding the acrosome
reaction itself (Bedford, 1970). Capacitation is therefore a general term which includes
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many physiological and morphological changes that occur in spermatozoa during transit
through the female reproductive tract but which is still poorly understood (Chang,
1984; Sidhu & Guraya, 1989).
The majority of changes in capacitating spermatozoa occur in an asynchronous
manner (Perreault & Rogers, 1982; Fraser & Ahuja, 1988) and as the physiological
synchronization of capacitation in large numbers of spermatozoa is difficult to achieve,
biochemical analysis of these changes is also difficult (Fraser & Ahuja, 1988). Many
alterations to the plasma membrane occur during capacitation (O'Rand, 1979) including
the loss of decapacitation factors (Chang, 1957; Eng & Oliphant, 1978), loss or
movement of antigenic sites (Koehler, 1976; Oliphant & Brackett, 1973; Myles &
Primakoff, 1984) and lectin binding changes (Schwarz & Koehler, 1979; Talbot &
Franklin, 1978; Gordon et al, 1975). Some changes in lipid composition have also
been reported (Schwarz & Koehler, 1979; Davis et al, 1980; Evans et al, 1980) which
can result in restricted movement of some antigens (O'Rand, 1977, 1979).
Spermatozoa also exhibit a progressive increase in oxygen uptake and glycolytic
activity during capacitation (Hamner & Williams, 1963; Mounib & Chang, 1964;
Murdoch &White, 1967; Black et al, 1968; Iritani et al, 1969). These changes in the
metabolic activity of spermatozoa during capacitation are manifested in altered
movement characteristics of spermatozoa during the latter stages of capacitation
(Robertson et al, 1988). This different motility pattern of spermatozoa before and after
capacitation was first noticed in hamster spermatozoa and described by Yanagimachi as
'activation* (Yanagimachi, 1969, 1970) but subsequently renamed 'hyperactivation' to
distinguish this type ofmovement from the initiation of spermmotility which occurs at
ejaculation in many species (Yanagimachi, 1981). Hyperactivated motility has since
been shown to occur in many other species (Yanigimachi, 1988b; Burkman, 1991)
including guinea pig (Yanagimachi, 1972a), mouse (Fraser, 1977), rabbit (Brackett &
Oliphant, 1975) and humans (Gould et al, 1983; Burkman, 1984; Mortimer et al,
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1984). Prior to capacitation, spermatozoa swim in linear trajectories (Yeung &
Wooley, 1984) but spermatozoa exhibiting hyperactivated motility move in a
non-progressive circular manner (Suarez et al, 1983) and the sperm heads trace erratic
trajectories (Katz & Yanagimachi, 1980; Robertson et al, 1988). The biological
importance and significance of hyperactivated motility is still a subject of debate (Katz
et al, 1989b; Mortimer & Mortimer, 1990; Barratt & Cooke, 1991) although it is
generally agreed to be a necessary part of capacitation (Bedford, 1983; Chang, 1984;
Yanagimachi, 1988b). Burkman (1984) showed that subfertile human specimens
exhibited significantly less hyperactivation when compared to samples proven fertile
during IVF and subsequently demonstrated that sperm populations with low
hyperactivation show decreased binding to hemi-zonae pellucidae and have significantly
lower IVF success rates (Burkman et al, 1990; Coddington et al, 1991).
It has been proposed that capacitation may facilitate the migration of
spermatozoa by avoiding entrapment in the female tract and thus increasing the
possibility of contact with the egg (Katz et al, 1989a) and/or that hyperactivated
movement is required for penetration of oocyte investments in particular the cumulus
oophorus and the zona pellucida (Fleming & Yanagimachi, 1982; Fraser, 1981). The
alterations to the sperm membrane, together with the increase in sperm metabolism and
consequent development of hyperactivated motility, that occur during capacitation and
enable spermatozoa to undergo the acrosome reaction, are thus thought to be
mechanisms which ensure that the spermatozoon's ability to fertilize an egg occurs at
the correct time and place (O'Rand, 1979; Wassarman, 1987a; Sidhu & Guraya,
1989; Kopf&Wilde, 1990).
2.2.3 Acrosome Reaction
The acrosome is a membrane bound organelle which occupies the anterior region of the
sperm head, just above the nucleus and beneath the plasma membrane (Wassarman,
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1987a) and its name derives from the Greek for 'sharp body' (Epel, 1977). The
acrosome reaction is a specialized calcium-dependent exocytosis event which occurs
during the fertilization process and involves fusion of the outer acrosomal membrane
with the overlying plasma membrane and the concomitant release of the acrosomal
contents (Russell et al, 1979; Yanagimachi, 1981). One of the first reports of an
acrosome reaction was made by Popa in 1927 who noticed that a droplet of 'sticky
substance' was extruded from the tip of sea urchin spermatozoa when they were treated
with 'egg water' (Popa, 1927 cited in Austin, 1968) but it was not until the 1950's that
the acrosome reaction of sea urchin spermatozoa which occurs following contact with
the jelly coat of the egg was fully described (Dan, 1952, 1956). The role of the
acrosome reaction in mammalian spermatozoa was originally studied in rodents by
Austin & Bishop (1958a&b) who concluded that "the acrosome becomes modified in
sperm passing through the female genital tract and is detached before the sperm
penetrates the zona pellucida".
The importance of the acrosome in human fertilization is highlighted by the
impaired fertility ofmen whose spermatozoa have acrosomal defects (Liu et al, 1989a;
Schill, 1991) such as globozoospermia (Jeyendran et al, 1985; Aitken et al, 1990),
crater defect syndrome (Baccetti et al, 1989) and decapacitated spermatozoa syndrome
(Perotti et al, 1981; Baccetti et al, 1984). Globozoospermic spermatozoa possess no
acrosomal vesicle and are not able to bind to the zona pellucida (Aitken et al, 1990) nor
to fuse with the oocyte (Weissenberg et al, 1983; Syms et al, 1984; Lalonde et al,
1988). The lack of an acrosome is incompatible with the participation of spermatozoa
in the whole process of fertilization because a normal acrosome reaction is a
prerequisite for sperm penetration of the egg investments (Moore & Bedford, 1983;
von Bernnarcii et al, 1990) particularly the zona pellucida (Tesarik et al, 1988; Tesarik,
1989) and the oolemma (Yanagimachi, 1988a; Tesarik & Testart, 1989).
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The human sperm acrosome reaction is thought to proceed in a slightly different
manner to that observed for spermatozoa from other species although the end result is
the same (Nagae et al, 1986). In the typical acrosome reaction, multiple fusions occur
between the plasma and outer acrosomal membranes and the acrosomal contents are
dispersed through the fenestrated membranes (Piko & Tyler, 1964a&b; Barros et al,
1967; Sidhu & Guraya, 1989; Saling, 1991). Several investigators have shown that
human spermatozoa follow a slightly different path (Roomans & Afzelius, 1967; Jamil
& White, 1981; Nagae et al, 1986; Zaneveld et al, 1991). Initially the acrosomal
matrix partially decondenses and the outer acrosomal membrane alone, or in
combination with the plasma membrane, invaginates to form many vesicles in the
acrosomal cap. After this the plasma and outer acrosomal membranes fuse. Membrane
fusion always occurs at the anterior end of the equatorial segment and seldom occurs in
the acrosomal cap region. These membranes then detach from the main body of the
spermatozoon leaving numerous vesicles near the inner acrosomal membrane. Finally
these vesicles disperse leaving the inner acrosomal membrane completely exposed
(Nagae et al, 1986). The acrosome contains several hydrolytic enzymes including
proacrosin/acrosin, neuramidase and hyaluronidase (Allison & Hartree, 1970;
McRorrie & Williams, 1974; Morton, 1977; Stambaugh, 1978; Meizel, 1984) which
are released during the acrosome reaction and thought to aid zona penetration (Meizel,
1978; Chang, 1984; Talbot, 1985; Zaneveld et al, 1991).
There is some controversy over the location of spermatozoa when they undergo
the acrosome reaction. The main area of dispute is over whether it occurs before or
after zona binding. Initially it was thought that only spermatozoa which had undergone
the acrosome reaction could penetrate the cumulus oophorus (a layer of follicle cells
embedded in a hyaluronic acid polymer matrix which surrounds ovulated eggs in most
mammalian species), as spermatozoa observed in the cumulus matrix and associated
with the zona pellucida of fertilized and unfertilized eggs in vitro had undergone the
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acrosome reaction (Talbot & Di Carlantonio, 1984a&b; Wassarman, 1987a). Also
hyaluronidase, one of the enzymes which is released from the acrosome during the
acrosome reaction, was thought to degrade the hyaluronic acid in the cumulus matrix
thus aiding sperm penetration of the cumulus layer (Austin & Bishop, 1958b; Bedford,
1972; Talbot & Franklin, 1974a&b; Perreault et al, 1979; Huang et al, 1981a).
Furthermore many substances have been shown to induce spermatozoa to undergo the
acrosome reaction (Wassarman, 1987a; Meizel, 1985) including oviductal fluid,
follicular fluid and cumulus cells (Gwatkin, 1977; Green, 1978; Meizel, 1978,1984;
Yanagimachi, 1981; Boatman & Robbins, 1991) although other reports have refuted
these claims (Suarez et al, 1983; Jacobs et al, 1984) and the physiological relevance of
some of this data has recently been contested (Mortimer & Camenzind, 1989; White et
al, 1990; Zaneveld et al, 1991).
It is difficult to identify unambiguously whether acrosome reacted spermatozoa
found in the cumulus matrix in vivo are capable of fertilizing the egg or whether
spermatozoa associated with the zona pellucida in vivo underwent the acrosome
reaction before or after zona binding (Wassarman, 1987a). Several investigators have
now suggested that spermatozoa which spontaneously acrosome react in vitro are
inferior sperm cells and thus are unable to fertilize an egg (Schill et al, 1988; White et
al, 1990; Fenichel et al, 1991). Human spermatozoa can initiate binding to the zona
pellucida after the acrosome reaction (Morales et al, 1989) but only those that undergo
the acrosome reaction at the zona pellucida seem capable of penetration (Tesarik et al,
1988; Tesarik, 1989). Furthermore Topfer-Petersen et al (1985) reported that infertile
men with polyzoospermia (ie with an increased number of spermatozoa in their
ejaculate, usually >350 x 106/ml), have an abnormal rate of spontaneously occurring
acrosome reactions. These data suggest that spermatozoa which spuriously acrosome
react before interaction with the egg are not capable of completing the fertilization
process. This indicates that the timing and location of the acrosome reaction are
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important factors in determining the fertilizing ability of spermatozoa (Schill et al, 1988;
Tesarik, 1989; Wolf, 1989; Tesarik et al, 1990). There have also been some reports
that acrosome intact spermatozoa can penetrate the cumulus and bind to the zona
pellucida (Anderson et al, 1975; Storey et al, 1984; Cherr etal, 1986; Menkveld et al,
1991) and that both uncapacitiated and acrosome reacted spermatozoa are incapable of
entering the matrix (Cherr et al, 1986; Cummins & Yanagimachi, 1986). Talbot et al
(1985) showed that sea urchin and frog spermatozoa which lack hyaluronidase can
penetrate the cumulus matrix in vitro and reach the zona pellucida although they are
unable to bind to or penetrate it. There have also been some reports which identified
hyaluronidase associated with the plasma membrane of acrosome intact spermatozoa. It
has therefore been questioned whether it is necessary for spermatozoa to undergo the
acrosome reaction in order to penetrate the cumulus matrix (Talbot & Franklin,
1974a&b; Talbot, 1985; Zao et al, 1985). Although it must be remembered that these
experiments were carried out in vitro and that under such conditions the state of the
cumulus may differ from that found in vivo, these data suggest that the cumulus matrix
is not a significant barrier to spermatozoa trying to reach the egg.
major to fertilization
Thej[block^appears to be at the level of the zona pellucida as spontaneously
acrosome reacted spermatozoa are still able to fertilize an egg and lead to normal
development and subsequent birth of normal young, but only if the zona pellucida is
first removed from the oocyte (Naito et al, 1992). Experiments with 'denuded' eggs
(which have had the cumulus cells removed) indicate that only acrosome intact
spermatozoa bind to the zona pellucida (Wolf & Inoue, 1976; Saling et al, 1978;
Saling & Storey, 1979; Phillips & Shalgi, 1980a; Bleil & Wassarman, 1983) and after
binding they are induced to undergo the acrosome reaction (Saling et al, 1979; Florman
& Storey, 1982; Bieil 8c Wassarman, 1983; Cherr et al, 1986). These observations
are consistent with the results of further experiments which showed that acid- or
heat-solubilized zona pellucida can induce the acrosome reaction (Florman & Storey,
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1982; Bleil & Wassarman, 1983, Cherr et al, 1986). When the zona pellucida is
dissociated into its component glycoproteins, one of these, ZP3, binds preferentially to
acrosome intact spermatozoa (Bleil & Wassarman, 1986) and can stimulate the
acrosome reaction (Bleil & Wassarman, 1983; Wassarman et al, 1985). Treatment of
ZP3 with pronase destroys its acrosome reaction-inducing ability thus indicating that
the protein component is important for this function (Florman et al, 1984) although
Wassarman (1987b&c) subsequently demonstrated that both the polypeptide chain and
the oligosaccharides are required. More recently, Leyton & Saling (1989)
demonstrated that the cross-linking of receptors in spermatozoa by ZP3 is responsible
for its acrosome reaction-inducing capability. Binding of ZP3 is thought to induce a
fusogenic cascade involving guanine nucleotide binding proteins (Endo et al, 1987;
Florman et al, 1989; Lee et al, 1992; Wilde et al, 1992). It is therefore now thought
that acrosome intact spermatozoa penetrate through the cumulus oophorus matrix and
bind to the zona pellucida where cross-linking of sperm receptors by ZP3 induces the
spermatozoon to acrosome react
Although much of this work has been carried out in the mouse, the same
mechanisms are believed to occur in humans. Human spermatozoa can traverse the
cumulus oophorus in an acrosome intact state and the human cumulus does not rapidly
induce the acrosome reaction in these spermatozoa (White et al, 1990). Both acrosome
intact and acrosome reacted spermatozoa can bind to the human zona pellucida (Morales
et al, 1989) although Chen & Sathananthan (1986) demonstrated that only a small
proportion of the spermatozoa which reach the zona of intact oocytes one hour post
insemination had acrosome reacted. However after a further 1-2 hours, many
spermatozoa were observed undergoing the acrosome reaction within the cumulus and
on the zona surface (Sathananthan et al, 1982; Dvorak et al, 1984; Chen &
Sathananthan, 1986). The zona pellucida has also been shown to play a significant role
in the induction of the acrosome reaction in human spermatozoa (Cross et al, 1988;
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Aitken, 1989b; Liu & Baker, 1990). Tesarik (1989) demonstrated that the number of
spermatozoa within the zona pellucida corresponded with the number of acrosin
deposits on the zona surface. This indicated that the timing of the acrosome reaction was
synchronized to maximize the spermatozoon's potential to penetrate through the egg
investments by releasing acrosin at the surface of the zona pellucida. These results have
lead to the suggestion that the first human spermatozoa to penetrate the cumulus, react
at the zona surface and that only later do a significant number begin to react within the
cumulus matrix before reaching the zona pellucida (White et al, 1990). The action of
the hydrolytic enzymes released by the acrosome reaction will be maximized if the
timing of the acrosome reaction is coordinated to coincide with the binding of the
spermatozoon to the layer which the enzymes aid penetration through (Zaneveld et al,
1991). Thus if the enzymes are involved in zona penetration (Section 2.2.4), it would
be physiologically more advantageous if they were released after the spermatozoon had
bound to the zona so that they exert their action specifically at the site where sperm
binding takes place. Thus the induction of the acrosome reaction in 'later' spermatozoa
while in the cumulus layer will result in a less efficient acrosome reaction and may be
another protective mechanism by which the egg decreases the probability of a
polyspermic fertilization occurring.
2.2.4 Sperm-Zona Pellucida Interaction
The zona pellucida is an extracellular matrix of glycoproteins which surround the
oocyte (Bleil & Wassarman, 1980a; Dunbar etal, 1980; Dunbar & Wolgemuth, 1984;
Wassarman et al, 1985). Mammalian zonae are typically composed of three major
glycoprotein families which are named ZP1, ZP2 and ZP3 in order of decreasing
molecular weight (Bleil & Wassarman, 1980a; Sacco et al, 1981). The members of
each individual family are all related by the same polypeptide backbone but exhibit
molecular weight and charge heterogeneity due to differential glycosylation which is
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both N- and O-linked to the peptide core (Hendrick & Wardrip, 1981; Wassarman et
al, 1985). The zona pellucida proteins are synthesized by the growing oocyte and
secreted to form a filamentous zona matrix (Bleil & Wassarman, 1980b; Phillips &
Shalgi, 1980b; Shimizu et al, 1983). This matrix is composed of ZP2 and ZP3
copolymers crosslinked by ZP1 (Greve & Wassarman, 1985; Wassarman, 1988b).
Initially spermatozoa become loosely associated with the zona pellucida and this is
referred to as 'attachment' (Hartmann et al, 1972; Hartmann, 1983). Subsequently,
spermatozoa adhere more strongly and this is known as 'binding' (Hartmann et al,
1972; Hartmann, 1983). It is thought that the orientation of both gametes with respect
to each other during the attachment phase, influences whether or not this progresses to
the binding phase (Wassarman, 1987a).
As discussed in the previous section, it is currently thought that acrosome intact
spermatozoa bind to the zona pellucida (via ZP3) and are induced to undergo the
acrosome reaction. Spermatozoa bind to O-linked oligosaccharide chains of ZP3 (Bleil
& Wassarman, 1980c; Florman et al, 1984; Florman & Wassarman, 1985; Bleil &
Wassarman, 1988) and cross-linking of zona-receptors in spermatozoa by ZP3 results
in the acrosome reaction (Leyton & Saling, 1989). The enzymes released from the
acrosome as a consequence, are thought to aid zona penetration (Gaddum & Blandau,
1970; McRorie & Williams, 1974; Gwatkin, 1977; Hartree, 1977; Stambaugh,
1978). The zona protein ZP1, has been identified as the primary substrate for acrosin
(Brown & Cheng, 1985; Dunbar etal, 1985; Urch et al, 1985). The digestion of ZP1
by acrosin destroys cross-linking between the ZP2 and ZP3 copolymers and this
coupled with the propulsive force of sperm movement allows the spermatozoa to
penetrate the zona pellucida (Bedford & Roger, 1983). ZP2 exhibits preferential
binding for acrosome reacted sperm (Bleil & Wassarman, 1986; Mortillo &
Wassarman, 1991) and is thought to act as a secondary sperm receptor for bound
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spermatozoa after the induced acrosome reaction (Bleil & Wassarman, 1986; Bleil et
al, 1988).
The zona pellucida conveys some species specificity to the fertilization process
(Section 2.2.7), is involved in the block to polyspermy (Section 2.2.6) and is also
thought to act as a filter which ensures that morphologically normal spermatozoa
participate in the fertilization process (Krzanowska & Lorenc, 1983; Kot & Handel,
1987; Menkveld et al, 1991). Whether this is due to a rejection of abnormal
spermatozoa by the zona pellucida or due to an inherent disability of the abnormal
sperm cells to bind to the zona pellucida is unclear.
2.2.5 Sperm-Oolemma Interaction
Spermatozoa which penetrate the zona pellucida reach the perivitelline space where they
interact with microvilli from the oocyte which attach to the sperm head at anterior and
posterior positions (Koehler et al, 1982). Fusion of the spermatozoon with the egg is
initiated by the plasma membrane overlying the equatorial segment (Bedford & Cooper,
1978; Bedford et al, 1979). This region of the plasma membrane acquires the ability to
fuse with the oolemma only after the spermatozoon has undergone the acrosome
reaction, as acrosome intact spermatozoa cannot fuse with the egg even if the zona
pellucida is first removed (Yanagimachi & Noda, 1970). It is not thought that any of
the contents of the acrosomal vesicle which are released during the acrosome reaction,
alter the plasma membrane over the equatorial segment because acrosome intact
spermatozoa cannot be induced to fuse with the oolemma after treatment with crude
acrosomal extracts (Yanagimachi, 1988a). It has been suggested that an influx of Ca2+
into acrosome reacting or reacted spermatozoamay be one of the factors responsible for
this modification of the sperm membrane (Monroy, 1985).
As soon as the spermatozoon contacts the egg plasma membrane, the sperm tail
abruptly ceases to move (Yanagimachi, 1966; Sato & Blandau, 1979; Gaddum-Rosse,
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1985) and unlike sperm-zona pellucida penetration, sperm movement is not required for
sperm-oolemma fusion to occur in humans (Yanagimachi, 1981). This is demonstrated
by spermatozoa from men who have Kartagener's syndrome, a condition where
spermatozoa are completely normal except they lack dynein arms and therefore are
completely motionless (Afzelius et al, 1975). If such spermatozoa are capacitated,
acrosome reacted and micromanipulated so that they lie adjacent to the oolemma, they
fuse with and fertilize the egg (Aitken et al, 1983).
The cortex of the egg, an area of cytoplasm just beneath the oolemma, contains
the contractile proteins actin and myosin, which extend from the cortex into the
microvilli. The microvilli interdigitate over the sperm head and the actin and myosin
filaments contract upon fertilization, drawing the spermatozoon into the egg
(Wassarman, 1987c). The sperm head decondenses within the egg and subsequently
becomes the male pronucleus (Bedford & Roger, 1983). Fusion of the spermatozoon
with the oolemma activates the egg which completes meiosis and extrudes the second
polar body (Bedford & Roger, 1983). It also triggers the cortical reaction which
contributes to the block to polyspermy (Section 2.2.6).
The amino acid sequence Arg-Gly-Asp (RGD) has been shown to be involved
in a variety of cell-cell adhesion recognition systems (Ruoslahti & Piershbacher, 1986;
Hynes, 1987) and the receptors that recognize RGD in their ligands are members of a
supergene family known as the integrins (Edelman, 1987; Hynes, 1987). Fibronectin
is an extracellular matrix protein which contains the RGD sequence in its cell binding
domain (Yamada & Kennedy, 1985; Plow et al, 1985) and which has been detected on
the surface of fixed human spermatozoa (Vuento et al, 1984; Glander et al, 1987).
Fusi & Bronson (1992) confirmed the presence of fibronectin on the surface of unfixed
living spermatozoa and demonstrated that its expression was increased on capacitated
spermatozoa probably due to the unmasking of a cellular form of fibronectin on the
sperm surface during the capacitation process. Preliminary experiments showed that
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peptides containing the RGD adhesion peptide sequence are able to cause a
concentration-dependent decrease in the adhesion of human spermatozoa to the
oolemma of zona-free hamster eggs and their subsequent penetration whereas similar
peptides which do not contain RGD cannot (Bronson & Fusi, 1990a&b). The use of
immunobeads coupled to an RGD-containing peptide indicated that the integrin receptor
is localized on the egg surface (Bronson & Fusi, 1990b). Recentiy Fusi et al (1992)
provided further evidence that the human oolemma contains an integrin cell adhesion
receptor by demonstrating that a specific RGD-binding moiety was present on the egg
plasma membrane and that fibronectin was also able to bind to the oolemma.
Furthermore anti-fibronectin antibodies interfere with the sperm-oolemma interaction as
assessed using human sperm and the zona-free hamster eggs (Fusi & Bronson, 1992).
Recently Blobel et al (1992) have isolated the gene for a guinea pig sperm protein,
PH30, which is involved in guinea pig sperm-egg fusion and identified an integrin
binding domain (disintegrin) within the sequence (see Section 2.3.3). No human
homologue of this protein has yet been identified. Taken together these data strongly
suggest that a fibronectin-integrin receptor system is involved in the human
sperm-oolemma interaction.
2.2.6 Block to Polyspermy
The fertilization of the egg by more than one spermatozoon (polyspermy) is lethal for
the embryo (Bedford & Roger, 1983). This is mainly prevented by the cortical reaction
which leads to the zona reaction (Soupart & Strong, 1974; Bedford & Roger, 1983;
Wassarman, 1987c; Ducibella, 1991). Corticle granules are membrane-bound,
lysosome-like organelles which are located in the egg cortex. The cortical reaction is
triggered by fertilization and involves fusion of the cortical granules with the plasma
membrane of the egg (Nicosia et al, 1977; Schuel, 1978; Gulyas, 1980; Wassarman,
1987a). Membrane fusion initially occurs at the point of sperm-egg fusion and is
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propagated as a wave over the entire surface of the egg (Wassarman, 1987a). The
contents of the granules, including various hydrolytic enzymes, are released into the
perivitelline space (Gwatkin, 1977; Whitaker & Steinhart, 1985) and permeate the zona
pellucida which is highly porous (Gwatkin, 1977). The zona pellucida is then
modified— the extracellular layer hardens and sperm receptors are inactivated (Barros
& Yanagimachi, 1971; Bleil & Wassarman, 1980a; Wassarman, 1987a). ZP3 is
modified to become ZP3f which no longer binds to spermatozoa nor induces the
acrosome reaction and ZP2 is modified to become ZP2f which is also unable to bind
spermatozoa (Bleil & Wassarman, 1980c; Bleil et al, 1981; Wassarman et al, 1986;
Moller & Wassarman, 1989; Kopf & Wilde, 1990). This prevents further
spermatozoa from interacting with the egg and provides some protection for the
developing embryo.
2.2.7 Species Specificity
Several investigations into mammalian heterologous fertilization have been reported
with varying results (Dickmann, 1962; Yanagimachi, 1972b; Hanada & Chang, 1972,
1976, 1978; Fukuda et al, 1979). In general, sperm penetration through the zona
pellucida and sperm-egg fusion may occur between closely related species (Maddock &
Dawson, 1974; Lambert, 1984; Roldan et al, 1985) but spermatozoa usually fail to
attach to or penetrate into the zonae pellucidae of eggs from distant species or from
different genera (Yanagimachi, 1977). Often fertilization does not occur if zona-intact
eggs are used but spermatozoa can readily fuse with the oolemma if the zona pellucida
is removed, indicating that much of the block to species specificity resides in the zona
pellucida (Hanada & Chang, 1972; Yanagimachi, 1972b, 1977; Pavlok, 1979).
Zona-free hamster eggs can be penetrated by spermatozoa from a wide variety of
mammals including humans and this is used as the basis of an in vitro test of the
fertilizing capacity of spermatozoa, the hamster egg penetration test (Yanagimachi et al,
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1976; Binor et al, 1980; Pavlok et al, 1983; Hoffman & Curtis, 1984; Yanagimachi,
1984; Rechon & Pavlok, 1986; Warikoo et al, 1986; Lambert et al, 1991). However
the plasma membrane does not totally lack species specificity. When zona-free hamster
eggs are incubated with equal numbers of hamster, human and guinea pig spermatozoa,
a greater number of homologous than heterologous spermatozoa penetrate the eggs
(Yanagimachi, 1981) and the plasma membrane of mouse eggs will only fuse with
mouse spermatozoa (Yanagimachi, 1984, 1988a). It is thus thought that the affinity of
the egg plasma membrane is greatest for homologous spermatozoa although the
mechanism of action of this species specificity is not known. Even in those few cases
when interspecies fertilization does occur (Bedford, 1977; Lambert, 1984; Roldan et
al, 1985), the heterologous combination of spermatozoa and oocytes results in fewer
fertilized oocytes than the homologous combination, both in vitro and in vivo (O'Rand,
1988). Embryo abnormality in the heterologous situation is high and development is
often arrested at the two-cell stage. Although a few mammalian hybrids do exist (eg
horse and donkey cross to give mule or hinny and horse and zebra cross to give
horsebras or zebrorses), these are the exception rather than the rule (Wassarman,
1987a; O'Rand, 1988). The fact that interspecies fertilization does occur shows that
some of the mechanisms involved are similar between species and that the
incompatability demonstrated by the abnormality of the resulting embryo or its arrested
development is largely due to the incompatability of the genomes (O'Rand, 1988).
This implies that if a molecule is shown to be important for fertilization in one species,
a homologue may be found in other species (see Section 2.3).
2.3 Sperm Antigens
Numerous sperm antigens have now been identified and some have been well
characterized. Of the many that have been reported, only a few have been identified as
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playing a role in fertilization (Anderson et al, 1987). A selection of monoclonal
antibodies which have identified molecules of particular interest, is discussed in the
following sections and they have been categorized according to the event in the
fertilization process at which they exert their effect. Special attention has been paid to
antigens found on human spermatozoa and to those which are particularly relevant to
the development of contraceptive vaccines.
2.3.1 Capacitation and the Acrosome Reaction
MA24 is a monoclonal antibody which was raised against human spermatozoa and is
germ cell- but not species-specific (Naz et al, 1984). Its corresponding antigen, FA-1
has been isolated from both human and murine testis (Naz et al, 1984) and is
homologous when purified from either source (Naz et al, 1986; Naz, 1987b). FA-1
exists as a monomer of 23kD that frequently dimerizes to a 47kD form (Naz et al, 1984;
Naz & Bhargava, 1990). This glycoprotein contains 18.8% carbohydrate by mass
(Naz et al, 1986) and localizes to the postacrosomal region of the sperm head and the
mid and principle piece of the tail (Naz et al, 1984). MA24 inhibits murine and rabbit
in vitro fertilization and the hamster egg penetration test performed using human
spermatozoa (Naz et al, 1984; Naz, 1988). The antibody reduces the number of
spermatozoa binding to the zona pellucida and abolishes sperm penetration through the
zona. In the murine system, fertilization is inhibited by MA24 only in the presence of
the zona pellucida as no block is seen when it is removed (Naz et al, 1984; Naz, 1988)
suggesting that the block occurs at or before the level of the zona. As the antibody also
completely inhibits the pentration of zona-free hamster oocytes by human spermatozoa,
it is thought that FA-1 may be vital for capacitation or the acrosome reaction (Gould et
al, 1983; Naz et al, 1984; Naz, 1988). Fertilization was blocked in female rabbits
when they were artificially inseminated with MA24-treated spermatozoa (Naz et al,
1984). Active immunization studies using purified FA-1 in female rabbits have been
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performed and resulted in a complete block of fertility in the majority of animals (Naz,
1987b). Antisera from these rabbits recognized the specific monomeric (23kD) and
dimeric (47kD) forms of FA-1 in Western blots and were tissue specific. This indicates
that the polyclonal immune response produced upon active immunization with FA-1,
was tissue specific which is a major requirement in the development of a contraceptive
vaccine in order to minimize side-effects. Sera from immunoinfertile men and women
and from vasectomized men reacts strongly with FA-1 whereas sera from fertile men
and women does not and there is a good correlation between the presence of these
anti-FA-1 antibodies and the failure of in vitro fertilization in humans (Naz, 1987b;
Naz et al, 1989; Bronson et al, 1989). Naz et al (1987b) demonstrated that it was
possible to specifically neutralize the adverse effect of sera from these patients on the
hamster egg penetration test by absorption with FA-1. These data suggest that FA-1 is
involved in involuntary infertility in humans and that the antigen is tissue specific in
man as no adverse side effects are apparent
M42 is a monoclonal antibody raised against murine spermatozoa which
recognizes an antigen located in a restricted region of the plasma membrane overlying
the acrosome, called the acrosomal crest (Saling & Lakoski, 1985). It specifically
inhibits the induction of the acrosome reaction (Saling, 1986) but discriminates between
physiologically- and pharmacologically-induced acrosome reactions, inhibiting only the
former (Leyton et al, 1989). The antigen is involved in an early step in the acrosome
reaction as once initial events have occurred, M42 antibody can not inhibit completion
of the acrosome reaction (Leyton et al, 1989). This initial step must be bypassed when
the acrosome reaction is artificially induced, for example by using the calcium
ionophore A23187. In Western blotting experiments, M42 recognizes a doublet at
220/240kL> in caput epididymal mouse spermatozoa and at 200/220kD in cauda
epididymal mouse spermatozoa suggesting that the M42 antigen is post-translationally
modified during epididymal maturation (Lakoski et al, 1988). Cross-reactivity is seen
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with hamster but not human or rabbit spermatozoa (Saling & Lakoski, 1985) although
it must be remembered that monoclonal antibodies only recognize a single epitope on a
molecule and this does therefore not preclude a homologue in other species. Passive
immunization of female mice with purified M42 inhibits fertilization in a
concentration-dependent manner (Sating et al, 1986; Saling, 1990) demonstrating that
passive transfer of antibodies to affect fertility is a feasible proposition. Using this
approach, Saling et al (1886) also found that the simultaneous use of two monoclonal
antibodies increased the degree of inhibition suggesting that antibodies can work
additively and a multivalent vaccine might be the best approach.
HS-63 is a monoclonal antibody raised against human sperm which reacts
specifically with a highly conserved sperm antigen (Lee et al, 1984). Although it
cross-reacts with spermatozoa from different mammalian species where the antigen is
localized to the acrosome, no cross-reactivity with an extensive panel of somatic tissues
has been identified (Anderson et al, 1987). HS-63 inhibits both the zona- and
ionophore-induced acrosome reactions of human and mouse spermatozoa thus blocking
fertilization (Liu et al, 1989b). HS-63 was used in passive immunization studies in
male and female mice (Lee et al, 1987) and an antifertility effect was seen although this
was weaker in the in vivo situation than that obtained in the in vitro experiments. The
antifertility effect was also sex related in that it was lower in passively immunized males
than females probably due to the presence of the blood-testis barrier which sequesters
much of the male reproductive tract from the immune system. The corresponding
mouse sperm antigen, MSA-63, has been purified from mouse testis and elicits a strong
isoimmune response in female mice following active immunizations (Liu et al, 1989c).
This isoimmune serum was shown to have a strong inhibitory effect on the in vitro
fertilization of mouse oocytes (Liu et al, 1989c). The gene encoding MSA-63 was
isolated from a mouse testicular cDNA library (Liu et al, 1990). This gene was shown
to be conserved among different mammalian species and gene expression identified as
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tissue specific (Liu et al, 1990). Recombinant MSA-63 was produced and specific
antisera raised in mice and rabbits. The titre of the antisera raised against the fusion
protein was considerably lower than that obtained with the native protein and
consequently the antifertility effect of the anti-fusion protein antiserum was also weaker
(Liu et al, 1990). However an antifertility effect was observed using the recombinant
protein, indicating that it is possible to produce suitable immunocontraceptive vaccines
using recombinant DNA technology.
2.3.2 Sperm-Zona Pellucida Interaction
Monoclonal antibody 1A1 has recently been reported and was produced using in vitro
capacitated spermatozoa as the immunogen (Dubova-Mihailova et al, 1991). It
recognizes a family of proteins of molecular weight 20-34kD in Western blots. The
corresponding antigen is located in the acrosome of human spermatozoa and is widely
distributed among different mammalian species. The antibody blocks murine, porcine
and human in vitro fertilization by blocking sperm attachment to and penetration
through the zona pellucida. Further studies on this antibody and its corresponding
antigen are required to identify their potential for contraceptive vaccine development
PH20 is an integral membrane protein of 64kD found in guinea pig spermatozoa
(Primakoff & Myles, 1983; Myles & Primakoff, 1984; Primakoff et al, 1988a). In
acrosome intact spermatozoa, PH20 is located exclusively in the posterior head region
but after the acrosome reaction, its localization is altered (Myles & Primakoff, 1984).
In acrosome reacted spermatozoa, it is found on the inner acrosomal membrane and the
number of antigenic sites increases three fold (Cowan et al, 1986). PH20 is thought to
play a role in the interaction between spermatozoa and the zona pellucida as antibodies
raised against PH20 inhibit guinea pig in vitro fertilization and the binding of guinea pig
spermatozoa to the zona pellucida (Primakoff et al, 1985; Myles et al, 1987). Active
immunization of male and female guinea pigs with PH20 completely blocked fertility
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(Primakoff et al, 1988b). This effect was long lasting and reversible as fertility was
regained within 6-15 months, thus indicating that this approach to the development of a
contaceptive vaccine is possible and suitable for use in both males and females.
Although a monoclonal antibody raised against PH20 recognizes only guinea pig
spermatozoa, polyclonal antibodies cross-react with human spermatozoa (Isojima,
1990) indicating that a human homologue of PH20 may exist
2.3.3 Sperm-Oolemma Interaction
MHS-10 is a monoclonal antibody produced against human spermatozoa (Herr et al,
1985). In Western blotting experiments, MHS-10 recognizes a family of proteins of
relative molecular mass 18-34kD (Herr et al, 1990a). It is testis- but not species-
specific (Anderson et al, 1987; Herr et al, 1990b) cross-reacting with spermatozoa
from baboons, macaques and pigs but not with rabbit, bull, rat, guinea pig and cat
spermatozoa (Herr et al, 1990b). The corresponding antigen, SP-10, is not found on
the surface of acrosome intact spermatozoa but is located within the acrosome. After
the acrosome reaction, it remains associated with the inner acrosomal membrane and
equatorial segment (Herr et al, 1990a). The MHS-10 monoclonal antibody inhibits the
sperm-oolemma interaction as assessed using zona-free hamster oocytes (Anderson et
al, 1987). The gene encoding SP-10 has been isolated from a human testicular cDNA
expression library (Wright et al, 1990) and no significant homology with other
sequences contained in the three sequence databanks searched was identified. The
sequence contains a 795bp open reading frame which translates to a 265 amino acid
(28.3kD) protein. The deduced amino acid sequence contains several O- and N-linked
glycosylation sites and has a very hydrophobic amino terminus which is thought to
constitute a signal peptide, required to localize SP-10 to the acrosome. Recombinant
fusion protein was produced and polyclonal antisera raised against it. The polyclonal
antisera behaved in a similar fashion to the monoclonal antibody when tested in both
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Western blots and immunocytochemistry suggesting that the SP-10 fusion protein can
act as an effective immunogen. Further experiments using recombinant SP-10 are
required to fully evaluate its potential as a candidate for a contraceptive vaccine.
Shaha et al (1988) raised a polyclonal antiserum against human spermatozoa
which identified a protein band at 40kD in Western blots of human sperm proteins and
at 24kD in rat testicular cytosol. These proteins were shown to share immunoreactive
epitopes (Shaha et al, 1988). The antiserum recognized the acrosome of human, rat,
mouse, hamster, rabbit and monkey spermatozoa and blocked attachment of mouse
spermatozoa to mouse oocytes in vitro (Shaha et al, 1988). When it was passively
administered to mice, a reduction in fertility resulted (Shaha et al, 1988). Monoclonal
antibodies were raised against purified 24kD proteins from rat testicular cytosol (Shaha
et al, 1989). One of these antibodies, HS-D5, was shown to agglutinate human
spermatozoa and prevented binding of hamster spermatozoa to zona-free hamster eggs.
The 24kD proteins from rat testicular cytosol were then used in active immunization
studies in female rats (Shaha et al, 1990). High antibody titres were produced and the
majority of the animals (83%) became infertile and remained infertile during the three
months of the study. Those animals which fell pregnant had the lowest titres indicating
that a high titre must be attained in all animals for the contraceptive efficacy to reach
100%.
M29 is a monoclonal antibody of the IgM subclass which was raised against
mouse spermatozoa (Saling et al, 1983; 1985). It is germ cell-specific but species-
cross-reactive recognizing spermatozoa from all of the other three species tested
(human, hamster and rabbit; Saling et al, 1985). The antibody recognizes a 60kD
protein which is extremely sensitive to proteolysis, rapidly breaking down to a 40kD
form in the absence of protease inhibitors (Saling, 1990) and is localized to the
equatorial segment of the mouse sperm head (Saling et al, 1985). M29 inhibits in vitro
fertilization of mouse eggs in a concentration-dependent manner. The block appears to
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be at the level of the oolemma as the inhibition of fertilization by M29 is unaffected by
the presence or absence of the cumulus layer or the zona pellucida (Saling et al, 1985).
Passive immunization studies using M29 in female mice, resulted in a concentration-
dependent inhibition of fertilization in vivo (Saling & Waibel, 1985). Although
fertilization was not completely inhibited at the highest antibody concentration used,
further studies have demonstrated that passive administration of two anti-sperm
antibodies which interfere at different points in fertilization, has a synergistic effect
leading to a complete block to fertilization (Saling et al, 1986). Thus if passive
immunization was to be used as the method of choice for administering a contraceptive
vaccine, an antibody cocktail would be most effective.
PH-30 is an integral membrane protein located on the surface of guinea pig
sperm (Primakoff & Myles, 1983; Primakoff et al, 1987). It is composed of two
tightly associated but immunologically distinct subunits, a and (3 which have molecular
weights of 44 and 60kD respectively and are both synthesized as larger precursor
molecules (Primakoff et al, 1987; Blobel et al, 1990). A monoclonal antibody raised
against PH-30 localizes the antigen to the postacrosomal region of the sperm head
(Primakoff et al, 1987). PH-30 has been implicated in the fusion of the spermatozoon
with the oolemma as the anti-PH-30 monoclonal antibody blocks the penetration of
zona-free guinea pig eggs by guinea pig spermatozoa but not the binding of the
spermatozoa to the oolemma (Primakoff et al, 1987). The genes encoding the PH-30 a
and P subunits have been cloned and sequenced (Blobel et al, 1992). The a subunit
nucleotide sequence contains an open reading frame which translates to a 289 amino
acid protein which is thought to contain a large extracellular domain, a single membrane
spanning domain and a short cytoplasmic tail. It also contains a putative fusion peptide
which is similar to viral fusion peptides. The deduced amino acid sequence for the p
subunit is 353 amino acids long and it has a similar structure to the a subunit except it
lacks the putative fusion peptide in its extracellular domain. Instead the P subunit
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contains an integrin binding domain (disintegrin) in this region which is thought to
interact with an integrin-like receptor on the oolemma (see Section 2.2.5). Thus PH-30
is thought to mediate sperm-oolemma binding, via the {3 subunit and integrin receptor,
and sperm-oolemma fusion, via the fusion peptide of the a subunit. No human
homologue of this protein has yet been identified.
2.4 Summary
Although a great deal of research has been carried out on fertilization, the sequence of
events is still poorly understood. With the advent of hybridoma technology, these
processes and the molecules involved are now beginning to be elucidated. Monoclonal
antibodies raised against spermatozoa from different species are able to identify some of
the molecules important for fertilization thus allowing a more detailed insight in the
interaction between spermatozoa and the egg.
3. General Materials and Methods
The materials and methods described in the following chapter are common to more than
one individual experiment. Those pertaining to a particular experiment are described in
the materials and methods section of the relevant chapter.
3.1 Semen Donation
The donors for the experiments described in this thesis were normal healthy males all of
whom had undergone a complete physical examination and had been screened for
hepatitis and sexually transmitted diseases including HTV. Human spermatozoa were
collected by masturbation into sterile plastic containers (Sterilin, Hounslow, Middlesex,
UK), from donors exhibiting normal semen profiles (>20 x 106 spermatozoa/ml,
>40% progressive motility and >40% normal morphology; World Health
Organization, 1987). At least 30 minutes were allowed for liquefaction to occur before
the spermatozoa were separated from the seminal plasma as detailed below. A
conventional semen profile was constructed for each sample using the procedures laid
down by the World Health Organization (WHO; World Health Organization, 1987).
3.2 Sperm Preparation
Two different methods of sperm preparation were used. One involved separating the
spermatozoa on Percoll gradients and the other used several cycles of washing. These
are detailed in Sections 3.2.1 and 3.2.2 respectively. Regardless of the method used to
prepare the spermatozoa, the final sperm pellet was resuspended in an appropriate
known volume (usually 1ml) of Biggers, Whitten and Whittingham medium (BWW;
Biggers et al, 1971), analysed to determine the concentration of spermatozoa, using an
34
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improved Neubauer haemocytometer, and finally diluted to a concentration of 20 x 106
sperm cells/ml.
3.2.1 Percoll Separation
A slightly modified version of the protocol for the fractionation of semen on Percoll
gradients described by Aitken and Clarkson (1988) was used. Liquefied semen was
layered on top of a two step discontinuous Percoll gradient containing 3mls 100%
Percoll overlayed with 3mls 50% Percoll in a 15 ml conical based sterile centrifuge
tube (Falcon; Becton Dickinson Labware, Cowley, Oxford, UK). Isotonic Percoll
was created by supplementing lOmls of 10 x concentrated medium 199 (Flow
Laboratories, Irvine, Scotland, UK) with 300mg bovine serum albumin (BSA), 3mg
sodium pyruvate and 0.37ml sodium lactate syrup (1.3g/ml; final concentration
4.8mg/ml; Sigma, Poole, Dorset, UK) and diluted with 90mls Percoll (Pharmacia
LKB, Milton Keynes, UK). This solution was designated 100% isotonic Percoll
(Lessley & Garner, 1983) and was subsequently diluted to 50% with BWW medium.
The gradients were centrifuged at 500 x g for 20 minutes after which the seminal
plasma was discarded and three cellular fractions were collected from the top of the
gradient (0% fraction), the 50%/100% interface (50% fraction) and the base of the
100% fraction (100% fraction). The cells from each fraction were then resuspended in
lOmls of BWW medium, centrifuged at 500 x g for 5 minutes to remove any residual
traces of Percoll and finally resuspended in BWW medium at a concentration of
20 x 106 cells/ml.
3.2.2 Washing Preparation
Some semen samples were prepared by a conventional 3 x centrifugation and
resuspension technique (Mann, 1945; Aitken et al, 1982a&b). Spermatozoa were
separated from seminal plasma by 3 cycles of centrifugation (500 x g for 5 minutes)
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and resuspension in lOmls BWW medium. Spermatozoa were finally diluted to a
concentration of 20 x 106 cells/ml.
3.3 Isolation of Sperm Plasma Membrane
Isolation of the plasma membrane fraction from human spermatozoa was achieved by
following a protocol previously described by Gillis et al (1978) as modified by Aitken
et al (1987a). Sperm samples were prepared by either method detailed in Section 3.2
and resuspended in ImM EDTA (pH5.0) containing a protease inhibitor, ImM
phenylmethyl sulphonyl fluoride (PMSF; Sigma). The sperm membranes were
detached using an ultrasonicator (Soniprep; MSE, Crawley, Sussex, UK) using
3 x 10 second bursts with a probe amplitude of 30pm. The tubes were kept on ice
between bursts to minimize the heating effects. The ultrasonicated suspension was
centrifuged at 500 x g to pellet the intact spermatozoa and the supernatant was
centrifuged again at 3 000 x g to remove any residual cells. This supernatant was
centrifuged at 100 000 x g for 1 hour on an ultracentrifuge (Sorvall OTD-50; Du
Pont Instruments, Stevenage, Herts, UK). The crude membrane pellet was
resuspended in 0.25M sucrose and layered onto a discontinuous sucrose gradient
(1.57M, 1.3M, 1.0M sucrose) and centrifuged at 100 000 x g for 2 hours. The
membrane fraction was collected as a discrete layer at the 1.0M/1.3M sucrose
interface, diluted in Dulbecco's phosphate buffered saline (PBS; Row Laboratories)
and centrifuged at 100 000 x g to pellet the membranes. The membrane preparations
(tout)
were resuspended in a small known volume of PBS (typically 100pi) and an aliquot^
taken for protein estimation (Section 3.4). The plasma membrane preparations were
stored frozen at -20°C until required.
Chapter 3 General methods 37
3.4 Protein Estimation
An estimation of the protein content of samples was determined using a bicinchoninic
acid (BCA) kit method (Pierce, Chester, Cheshire, UK) which was used according to
the manufacturer's instructions. The working solution was prepared by mixing 25mls
of BCA reagent with 0.5mls copper sulphate solution. 50pl of the standard or
(1/100 dilution)
unknown solution^was added to 1ml of the working solution and mixed well. Bovine
serum albumin diluted in PBS was used as the standard (0.2mg/ml, 0.4mg/ml,
0.6mg/ml, 0.8mg/ml, l.Omg/ml and 1.2mg/ml) and PBS was used as the blank. The
reaction was developed at room temperature for 1 hour and the absorbance at 562nm
measured (Pye Unicam, Cambridge, UK). An assay calculation program written by Dr
Phil Taylor for the Apple Macintosh Computer (AssayZap; Elsevier Biosoft,
Cambridge, UK) was used to calculate the protein concentration of each unknown
sample using a plot of the absorbance value at 562nm against the known protein
concentrations.
3.5 Animals and Management
All the animals used in the experiments described in this thesis were housed in the
Reproductive Biology Unit Animal House in the Centre for Reproductive Biology,
Edinburgh. All experiments involving animals were approved by the Home Office
under the terms of the Animal (Scientific Procedures) Act 1986; Project Licence
PPL 60/00697; Personal Licence PIL 60/02179.
4. Production of Anti-Sperm
Monoclonal Antibodies
4.1 Introduction
Since the production of monoclonal antibodies of predefined specificity was first
described by Kohler and Milstein in 1975, they have been used for a wide variety of
purposes in a host of disciplines. They have been used in areas as diverse as
radioimmune assay of hormones and drugs, histocompatability testing,
immunotherapy, purification of molecules by affinity chromatography, neurochemistry
and microbial and parasitic disease (Goding, 1980). The basic production technique
which is summarized in Figure 4.1 and described below, has remained virtually
unaltered except for the addition of a few refinements.
A monoclonal antibody is one which is produced by a single clone of cells and
structurally it is no different from other antibodies produced under natural conditions.
Their production requires that antibody producing B lymphocytes are made immortal in
the laboratory and are allowed to continue synthesizing antibody. This is achieved by
the fusion of two cells— a B lymphocyte and a myeloma cell. The myeloma cell used
is a malignancy of B lymphocyte which has the ability to reproduce itself indefinitely in
culture but also has genetic deficiencies which do not allow it to grow under certain
conditions. The two cell types are usually fused using polyethylene glycol (PEG;
Davison and Gerald, 1976; Kohler and Milstein, 1976; Gefter et al, 1977) to promote
membrane fusion although Sendai virus or lysolecithin can also be used (Goding,
1980). After the fusion process, the resulting cell is called a hybrid-myeloma or
hybridoma but is commonly referred to as a hybrid. Hybrids are immortal antibody
producing cell lines and are selected using HAT medium (so called because it contains
Hypoxanthine, Aminopterin and Thymidine; Littlefield, 1964). Aminopterin is a
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Figure 4.1 Summary of the basic technique of monoclonal antibody production.
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powerful toxin which blocks the main pathway for endogenous synthesis of purine and
pyrimidine nucleotides which are required for DNA synthesis. This block can be
bypassed using the salvage pathway which recycles preformed nucleotides only if the
cells are provided with hypoxanthine and thymidine and possess the enzymes
hypoxanthine guanine phosphoribosyl transferase (HGPRT) and thymidine kinase
(TK). The B lymphocytes used for the fusion have these enzymes and are therefore
HAT resistant. The myeloma cell line however lack HGPRT and are therefore HAT
sensitive. As a result of the fusion, the only cell type which can survive under HAT
selection conditions is the hybrid which obtains HAT resistance (and antibody
production capability) from the parental B lymphocyte and immortality from the
parental myeloma cell. The other cell types die as a B lymphocyte-B lymphocyte fusion
and unfused B lymphocytes are mortal and succumb after 1-2 weeks in culture. Any
myeloma-myeloma cell fusions and unfused myeloma cells are sensitive to HAT
selection and also die.
In order to increase the chances of obtaining a hybrid which is secreting the
antibody of choice, the animal used for the the fusion is primed with antigen. Animals
are normally given a primary injection and two boosters to elicit an immune response
and a final boost 3-4 days prior to fusion. The immunization of the spleen donor has
two main purposes— i) expanding the desired clones and therefore increasing the
chances of obtaining a relevant hybrid; and ii) causing the B cells to divide and
differentiate into cells which will fuse and form useful hybrids (Goding, 1980). There
is evidence that recently activated B cells fuse preferentially and experiments have
shown that the best time for fusion is 3-4 days after boosting when antigen induced
proliferation is strong (Goding, 1980; French et al, 1986).
In order to assign defined biological roles to specific membrane components of
the human spermatozoon, monoclonal antibodies have to be produced. Polyclonal
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antisera are unsuitable for this task as they contain a complex mixture of antibodies
which all have differing biological activities. Monoclonal antibodies are (by definition)
specific to one particular epitope and are therefore crucial if this task is to be
accomplished. Work using polyclonal antisera has shown that antibodies against the
sperm head are responsible for blocking sperm-zona pellucida interaction in vitro
(Aitken et al, 1981). Many workers have used whole spermatozoa as an immunogen
when producing monoclonal antibodies and this often results in the production of
monoclonal antibodies which localize to cytoskeletal elements of the spermatozoon
particularly in the tail (Moore & Hartmann, 1984). This is probably due to the
relatively long tail of spermatozoa which provides more antigen and hence provokes a
greater immune response. If these antibodies block fertilization, it must be by an
indirect method by interfering with sperm transport through the female reproductive
tract thus preventing spermatozoa from reaching the site of fertilization (Aitken, 1982;
Bronson et al, 1984). In order to assign specific biological functions to membrane
components, the antibody must be able to interact directly with antigens expressed on
the surface of the human spermatozoon. In order to increase the probability of
producing a monoclonal antibody directed against a sperm surface antigen involved in
fertilization, purified sperm plasma membrane has been prepared and used to
preimmunize the mice.
4.2 Materials and Methods
4.2.1 Immunization Protocol
Female Balb/c mice were immunized intraperitoneally (ip) with purifed sperm plasma
membrane. Each mouse was given lOOpl of immunization mixture at each injection.
The primary injection was given when the mice were 12 weeks old and consisted of
Chapter 4 Production 42
antigen emulsified in complete Freund's adjuvant (FCA; Sigma, Poole, Dorset, UK).
The ratio of aqueous phase to FCA used was 2:3. Usually two booster injections of
antigen adsorbed onto aluminium hydroxide gel (alum; Superfos, Vedbaek, Denmark)
at a ratio of 1:1, were given. A final booster injection which contained no alum, was
given 3 days prior to fusion. The details of the immunization schedule are shown in
Table 4.1.
4.2.2 Bleeding of Mice
Mice were bled periodically to monitor the production of antibodies. They were
anaesthetized using ether and a small volume of blood was collected from the tail vein
by making a small nick using a sterile scalpel blade. The blood was then allowed to
coagulate at room temperature for 30 minutes before centrifuging at 1 250 x g for 10
minutes to obtain serum. The antibody level was determined by ELISA.
4.2.3 Media
RPMI 1640 medium containing 20mM HEPES (Gibco, Paisley, Scotland, UK) was
supplemented with 2mM L-glutamine, lOmM sodium pyruvate and 125 000 Units/1
penicillin/streptomycin (all Gibco) was used throughout the tissue culture programme.
As serum lots differ widely on their ability to support growth of hybrids (Oi &
Herzenberg, 1980; Kennett, 1980; Galfre & Milstein, 1981), batches of foetal calf
serum (FCS; Gibco) were tested using the parental NS-0 cells to ensure that they
could support the growth of hybrids. This was kindly carried out by Dr Margaret
Paterson. The FCS batch which had optimal cloning efficiency was purchased in
sufficient quantities to be used for all the hybridoma work. The concentration of FCS
used varied between 5% and 15% (v/v) depending upon the procedure being used and
the cell line being cultured. HAT selection media contained 15% (v/v) FCS, O.lmM
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hypoxanthine, 4(iM aminopterin and 16[lM thymidine in supplemented RPMI media.
HT media had the same composition as HAT medium except that no aminopterin was
added. Cells were harvested using 0.02% (v/v) EDTA (BDH, Poole, Dorset, UK) in
Dulbecco's formula A phosphate buffered saline (PBS; Row Laboratories, Irvine,
Scotland, UK). Mixed thymocyte conditioned medium (MTM) was prepared as
described by Micklem et al (1987). Briefly the thymus was aseptically removed from
two 5-6 week old female rats of different strains (Wistar and Sprague Dawley). A cell
suspension was made by pressing the thymus tissue between ground glass slides. The
cells were counted and cultured at 5 x 106 cells/ml in 15% (v/v) FCS in supplemented
RPMI 1640 medium for 48 hours. The culture medium was centrifuged at 1 250 x g
for 10 minutes and the supernatant stored at -20°C until required.
4.2.4 Fusion Protocol
A diagram summarizing the fusion procedure is shown in Figure 4.1. Cells were
incubated at 90% humidity and 37°C in 5% CCVair. A total of four fusions were
carried out. The first fusion was kindly performed by Dr Margaret Paterson and her
assistance with the other three fusions is also gratefully acknowledged.
Spleen cells The spleen was aseptically removed from the preimmunized mouse and
transferred to a petri dish containing lOmls PBS. The spleen was gently teased apart
using forceps then homogenized to obtain a cell suspension. The cells were then
washed three times in PBS by centrifugation at 200 x g for 10 minutes. The pellet was
finally resuspended in lOmls PBS and counted using the fluorescent stain acridine
orange/ethidium bromide (each 1 part permillion; Parks et al, 1962; Lee et al, 1975).
Approximately 1 x 108 cells were typically obtained.
Plasmacytoma Cell Line The Balb/c plasmacytoma cell line, NS-0 (Galfre &
Milstein, 1981) was used to produce the monoclonal antibodies. This was a generous
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gift from Dr Liesel Micklem. NS-0 cells in the log phase of growth were harvested
using 0.02% (v/v) EDTA in PBS and washed twice in PBS. The cells were counted
using an acridine orange/ethidium bromide vital stain.
Fusion Procedure 5 x 107 spleen cells and an equivalent number of NS-0 cells
were mixed together and centrifuged at 200 x g for 5 minutes. The supernatant was
removed and 1ml 50% (w/v) polyethylene glycol 4000 (PEG; Fisons, Loughborough,
Leicestershire, UK) in supplemented RPMI 1640, pH8.5 was slowly added down the
side of the tube. The cells were swirled gently for 2 minutes and then centrifuged at
70 x g for 5 minutes. 5mls of supplemented RPMI medium was slowly overlaid over
1-2 minutes without disturbing the pellet The tube was gently swirled for 3-4 minutes
to gradually resuspend the cells. After centrifuging at 150 x g for 5 minutes, the
supernatant was discarded and 5mis HAT medium slowly added without disturbing the
pellet. This was allowed to stand for 7 minutes before being gently swirled to
resuspend the fusion mixture. Finally HAT medium and MTM were added to adjust
the cell concentration to 2 x 105 cells/0.2ml in 15% (v/v) MTM/HAT medium. The
cells were then plated out (0.2ml/well) into the central 60 wells of a 96 well culture
plate (Costar; Northumbria Biologicals, Cramlington, Northumberland, UK). The
wells were checked for growth after 7 days and fed with 0.1ml HAT medium. Any
well containing bacterial contamination and the 9 wells immediately surrounding it,
were treated with sterile 1M NaOH. After a further 7 days and every subsequent 3
days, hybrids were examined. When the hybrid was large enough, the supernatant was
screened for antibody production by ELISA. Each hybrid was tested at least twice and
those hybrids which had two consecutive positive tests for anti-sperm antibody
production were cloned immediately by limiting dilution (Section 4.2.6). Aliquots of
each positive hybrid were stored in liquid nitrogen (Section 4.2.8).
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4.2.5 Detection of Anti-Sperm Antibodies
Sperm coated plates 96 well microtitre plates were coated with spermatozoa for use
in an enzyme linked immunoabsorbant assay (ELISA) to monitor the amount of anti-
sperm antibody present. Spermatozoa were isolated by centrifugation through isotonic
Percoll (Section 3.2.1) and adjusted to 10 x 106 cells/ml in PBS prewarmed to 37°C.
50pl of this solution was added to each well of a microtitre plate (5 x 105 cells/well)
and the plate spun at 1 000 rpm (Coolspin; MSE, Crawley, Sussex, UK) at 25°C for
5 minutes. After aspirating the supernatant, lOOp.1 of 1% (v/v) para-formaldehyde in
PBS was added to each well and the plates incubated at room temperature for 30
Sigma) to reduce non-specific binding.
minutes. The plates were spun again and washed 3 times in PBS-tween (0.05% v/yX
The plates were dried in an aspirator containing phosphorus pentoxide under vacuum at
4°C. The sperm-coated plates were stored at -20°C prior to use.
ELISA 50pl of antibody solution was added to each well of a sperm-coated plate and
incubated either for 1-2 hours at room temperature or overnight at 4°C. Culture
supernatants were used neat and solutions to be titrated were added in doubling
dilutions from 1/10. The supernatant was aspirated and the wells washed 3 times with
PBS-tween (0.05% v/v). A 1/1 000 dilution (in PBS) of second antibody, sheep anti-
mouse Ig-alkaline phosphatase conjugate (Sigma) was added and incubated for 1-2
hours at room temperature. The plates were washed again and 50p.l of lmg/ml
p-nitrophenylphosphate substrate (Sigma) made up in 10% (v/v) diethanolamine
(Sigma), pH9.8 was added to each well. The reaction was allowed to develop for
30-60 minutes at room temperature before the reaction was stopped by adding 50pl 3M
NaOH to each well. The absorbance at 405nm was read using a 96 well plate reader
(Titertek; How Laboratories) using air as the blank. A positive (mouse anti-sperm
plasma membrane polyclonal antiserum) and negative (RPMI medium) control were
included on each plate. A positive value was defined as any reading which was at least
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twice the negative value. The titre was taken as the highest dilution which still gave a
positive ELISA result (Voller et al, 1976). The assistance of Mr Martin Hulme in
screening the hybridomas obtained from fusion number spm 1 is gratefully
acknowledged.
4.2.6 Cloning By Limiting Dilution
Positive hybrids were detached from the plate by gentle pipetting with a sterile pasteur
pipette. The number of viable cells was calculated using a vital stain (acridine
orange/ethidium bromide, lppm each). The cells were diluted in HT medium
containing 10% (v/v) MTM and plated (O.lml/well) into the central 60 wells of a 96
well plate at three different cell densities so that 2 rows theoretically contained an
average of 5 cells/well, 2 rows an average of 1 cell/well and the last 2 rows an average
of 0.5 cells/well. One of these plating concentrations usually yielded wells with
monoclonal growth. The plate was incubated undisturbed at 37°C with 5% CO2. After
one week, the wells were examined with an inverted microscope and the wells
containing cells noted. It was possible to estimate the actual number of cells originally
plated in each well as the cells grow in discrete clusters if the plate is incubated
undisturbed. Each well was fed with 0.1ml HT medium containing 10% (v/v) MTM
and incubated for a further week. Antibody production was monitored by testing the
supernatants by ELISA. Hybrids which had high antibody production and originated
from a single progenitor cell (ie showed monoclonal growth) were then chosen to be
processed further. Positive hybrids were cloned twice to ensure that a stable cell line
had been produced and that a pure clone was obtained. At each stage in the cloning
procedure, aliquots of cells were frozen in liquid nitrogen as described in Section
4.2.8.
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4.2.7 Bulk Culture
Once a pure cell line had been produced, large quantities (approximately 700mls) of
culture supernatant were produced from which the monoclonal antibody was to be
purified (Chapter 5). The cells were sequentially grown up in 25cm2, 75cm2 and
175cm2 flasks (Costar; Northumbria Biologicals) in supplemented RPMI medium
containing 10% or 5% (v/v) FCS and allowed to overgrow beyond the time taken for
the culture to die to allow for the release of all the antibody produced.
4.2.8 Storage of Cell Lines in Liquid Nitrogen
At every point in the production process, several aliqots of hybrid cells were frozen in
liquid nitrogen. Cells were grown in 25cm2 culture flasks until they were confluent
and harvested using 0.02% (v/v) EDTA in PBS. They were centrifuged and gently
resuspended in 0.5ml 90% (v/v) FCS, 10% (v/v) dimethylsulphoxide (DMSO; Sigma)
before transferring to cryotubes (Nunc; Gibco, Paisley, Scotland, UK). The tubes
were stored in the vapour phase of liquid nitrogen for 24 hours before being moved to
the main liquid nitrogen cryostat storage.
4.3 Results
A total of four fusions were carried out. The immunization schedules of the mice are
detailed in Table 4.1. The mice used for fusions spm 1, spm 2 and spm 3 belonged
to a separate group of mice (group 1) to the mouse that was used for fusion number
spm 4 (group 2). Group 1 mice received a total of 4 injections each containing 100|ig
of purified sperm plasma membrane. Mice belonging to group 2 were only given 3
injections as no second booster was administered and varying amounts of antigen were
received at each injection. Mice were bled at several stages during the immunization
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Fusion spm 1 spm 2 spm 3 spm 4
number
Primary lOO^ig lOO^ig lOOp-g 40(lg
injection day 0 day 0 day 0 day 0
First lOO^tg 100(lg lOOiig 50(ig
Boost day 44 day 44 day 44 day 79
Second lOO^ig 100|lg lOOp-g none
Boost day 130 day 130 day 130
Final lOO^tg lOOng lOO^ig 100p.g
Boost day 491 day 749 day 798 day 153
Fusion day 494 day 752 day 801 day 156
Table 4.1 Immunization schedule for the four fusions numbered spm 1-4. The
date of the primary injection was designated as day 0.
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procedure and the antibody titre for each mouse determined. Figure 4.2 shows the
pooled data for the mice in group 1 and indicates that antibody titre level increases with
each immunization although the response of each animal is variable. The data for group
2 are similar although higher levels of antibody titre were achieved. The mean titre for
group 2 mice after the first booster injection was 1/11 170 (± 6 702) as compared to
1/272 (± 77) for group 1. This further highlights the individuality of response as these
mice received fewer injections containing less antigen. Results of the fusions are
summarized in Table 4.2. A total of 388 hybridomas were produced and 12 of these
were identified as secreting anti-human sperm antibodies by ELISA. Each positive
hybrid was cloned twice before being bulk cultured for antibody purification (Chapter
5). The hybrids were checked at each stage of the cloning procedure to ensure that a
stable antibody-secreting cell line was produced and the pooled results are shown in
Figure 4.3.
4.4 Discussion
Immunization of the mice to be used for the fusions is crucial to the production of
monoclonal antibodies. In an immunological sense, mice will not have seen human
spermatozoa before and if the animal does not contain cells expressing the desired
antibody then it is not possible to immortalize these cells (Milstein, 1982).
Immunization schedules vary from laboratory to laboratory but the most commonly
used method consisting of a primary injection followed by two boosters and a final
booster three days prior to the fusion, was followed here. The exception to this was
the group 2 mouse used for fusion number spm 4 which did not receive a second
booster injection. This was not detrimental to the successful production ofmonoclonal
antibodies as this fusion resulted in over half of the monoclonals reported here. Indeed
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Figure 4.2 Mean antibody titre (± standard deviation) for group 1 mice (n=8)
during the immunization procedure. Times of injections are indicated by the arrows—
P, primary injection given on day 0; 1st B, first booster injection on day 44; 2nd B,
secondbooster injection on day 130.
Fusion spm 1 spm 2 spm 3 spm 4
number
Ratio 1:1 4:1 5:1 2:1
spleen:NS 0
Number of 88 123 none 177
hybrids
Number of 2 2 none 8
+ve hybrids
Table 4.2 Summary of the results of the four fusions spm 1-4.



















1st test 2nd test 1st clone 2nd clone Bulk Culture
Stage of Cloning Procedure
Figure 4.3 Pooled data for the twelve monoclonal antibodies produced showing
the ELISA readings (A205) obtained at five different stages during the cloning
procedure. Values are expressed as a percentage of the positive control ± standard
deviation. EH, negative control medium; □, hybrid supernatant
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it is possible to do 'blind' fusions where the fusion is carried out 4 days after a single
injection of antibody and still produce monoclonals (Trucco et al, 1978; Galfre &
Milstein, 1981). Kennett et al (1978) found that a primary intraperitoneal injection
followed by an intravenous injection was sufficient to obtain as many hybrids as could
be conveniently screened and processed further and that no significant increase in the
number of hybrids produced was seen when several injections over a period of several
months were given. On the other hand, French et al (1986) reported that the maximum
number of hybridomas were obtained if the animals were rested until there was little
circulating antibody and then boosted for the fusion.
Monoclonal antibodies directed against biologically active molecules have been
produced by using whole washed spermatozoa as the immunogen. For example
Hinrichsen-Kohane et al (1985) and Kallajoki et al (1986a) have both produced anti-
acrosin antibodies in this way. However, the immunogen does not have to be
particularly pure as the animal will make antibodies against each component of the
mixture and the ones directed against the antigen of choice can be selected for. This
depends on the ability of the chosen screening procedure to detect only antibodies
directed against the antigen of interest. The main drawback of this strategy is that
numerous hybrids may have to be screened to find one which is positive. This is not a
major problem if the screening method is specific and simple to perform but it can be
time consuming and is therefore inefficient. The primary interest of this research is to
identify monoclonal antibodies directed against biologically functional molecules on the
sperm surface. However the initial screening assay is based on a purely non-functional
recognition event so the probability of obtaining monoclonals against biologically active
molecules was increased by using purified sperm plasma membrane as the immunogen.
This strategy was also followed by Peterson and colleagues who found that several
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monoclonal antibodies raised against purified boar sperm plasma membranes were
biologically active (Peterson etal, 1980a&b, 1981a&b).
The lack of a second booster injection is not the only difference between the
immunization schedules of the two groups of mice. Group 1 mice received more
antigen over a longer time scale and consequently were older at the time of fusion. The
level of antibody titre reached varied a great deal both between the two groups of mice
and within each group. It is interesting to note that the mean titre after the first booster
injection is greater in the second group of mice (1/11 170 as compared to 1/272) even
though they had received less antigen and the immunizations were further apart. The
reasons for this are not clear although it is indicative of the variability of the immune
response of individual animals which involves suppression as well as induction (Galfre
& Milstein, 1981). Herbert (1978) also found that peak antibody titres which were
measured following a simple immunization schedule, varied as much as 500 times
among individual animals. The immune response is a complex system which is still not
fully understood. It is the body's defence system against foreign substances and is
thought to have evolved as a protective mechanism against invasion by pathogens such
as viruses, bacteria and fungi (Darnell et al, 1990). The system works in two ways—
by humoral immunity and by cellular immunity. The introduction of a foreign
substance into an animal elicits the formation of antibodies (humoral immunity) and
immune cells (cellular immunity) both of which can bind to that substance and lead to
its elimination from the body. Antibodies are produced by B lymphocytes which are
produced with immunoglobulin on their surface in the bone marrow. Binding of
antigen to these surface bound antibodies activates the so-called virgin B lymphocyte.
This leads to their proliferation and maturation into plasma B cells which are highly
specialized for immediate antibody production and secretion, and memory B cells
which live for a long time and respond rapidly to further encounters with the antigen.
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There are three major types of T cells which are also involved in the immune response
— cytotoxic T lymphocytes which directly kill target cells that they recognise; helper T
lymphocytes which assist B cells in their reaction to antigen; and suppressor T
lymphocytes which dampen the responses of B cells. The response of an individual
animal to any foreign substance is therefore variable as it depends on the interaction
between these various cell types.
The precise details of fusion procedures vary from laboratory to laboratory
(Goding, 1980). The procedure used here was based on the method of Kennett et al
(1978) using MTM instead of feeder cells (Micklem et al, 1987). Ultimately, for the
production of monoclonal antibodies, only one hybrid should be produced per culture
well when the fusion is plated out. However more than one hybrid is frequently
produced in each well and only one of them may be secreting the antibody of interest.
The other hybrid may be secreting another irrelevant antibody or not secreting antibody
at all. Problems arise when the other hybrid is not secreting any antibody as non-
producers tend to overgrow producers and the culture quickly becomes dominated by
non-producing variants (Goding, 1980). This is the main reason why positive hybrids
should be cloned as soon as possible after their detection. Approaches to this problem
have included culturing the cells in a large number of small wells and seeding the
culture wells with fewer fused cells (Kennett et al, 1978; Oi & Herzenberg, 1980).
However de Bias et al (1981) reported that the probability of hybridoma survival
decreased with post-fusion cell dilution, so feeder cells are widely used to improve
culture conditions and increase the ability of cultured cells to grow at very low densities
(Galfre & Milstein, 1981). However feeder cells have several disadvantages. The
main ones are the increased risk of bacterial contamination and the additional time taken
for any procedure. Thus, alternatives to feeder cells in the form of conditioned
medium, have been investigated (Micklem et al, 1987; Orlik & Altaner, 1988; Bazin &
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Lemieux, 1989) and one of these, mixed thymocyte conditioned medium (MTM;
Micklem et al, 1987), was used in this protocol.
The ratio of spleen cells to NS-0 myeloma cells used for each fusion also
varied. Ratios of between 1:1 and 5:1 were used but the precise ratio of spleen to
myeloma cells has been shown to be non-critical and good results have been achieved
using ratios between 1:1 and 10:1 (Goding, 1980). Other variations to the basic fusion
protocol have been described by several authors. These include the addition of
dimethyl sulphoxide (DMSO) to the PEG (Norwood et al, 1976) and changes in the
concentration and molecular weight of PEG used (Davidson et al, 1976; Gefter et al,
1977). However no protocol seems to work better than any other. They have all been
used successfully and no one method consistently gives better results (Yelton et al,
1980; Galffe & Milstein, 1981; Melamed & Bradley, 1989).
The antibodies produced by the permanently established hybrids from a fusion
are generally a representative cross-section of the antibodies produced by the
immunized animal which was used for the fusion although there is an enrichment for
the antibody secreting phenotype (Milstein, 1982) and routinely more positive hybrids
than would be expected are obtained (Yelton et al, 1980). Approximately 5% of spleen
cells actively secrete immunoglobulin whereas after a fusion as many as 45% of the
hybrids from a mouse NS-0 myeloma-mouse spleen fusion may secrete antibody
(Clark & Milstein, 1981). Thus of the 388 hybrids produced in the fusions reported
here, 175 would be expected to be secreting antibody of any description (although this
was not determined) and 10% of these (17-18 hybrids) would be expected to secrete
specific antibody (Milstein, 1982). This compares well with the twelve hybrids which
were actually found to be producing anti-sperm antibodies.
There are two commonly used methods of large scale production ofmonoclonal
antibodies— i) bulk culture of cells in vitro; and ii) growing cells as tumours in vivo
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(Goding, 1980; Galfre & Milstein, 1981). The former method was used and it
involves allowing the cultures to overgrow until the cells die, releasing all the antibody
into the spent medium. The concentration of antibody produced in this way is typically
10-100jJ.g/ml although the actual concentration attained here was not measured. The
alternative method involves reintroducing the cells into an animal inducing the
formation of tumours. This results in the production of the antibody in the serum and
body fluids of the animal and achieves high concentrations of antibody (3-15mg/ml;
Goding, 1980). Usually hybrids are injected into the peritoneum which serves as a
growth chamber for the cells. A peritoneal tumour forms and antibody is secreted into
the intraperitoneal fluid. This is known as ascitic fluid and is a more concentrated
source of antibody than bulk culture supernantant but it also contains more
contamination (Galfre & Milstein, 1981). The impurities present in the spent medium
can be largely controlled as most are introduced as components of the medium. More
importantly the only murine antibody present in the spent medium is the monoclonal of
interest unlike the ascitic fluid which is contaminated with naturally occurring
immunoglobulin. The monoclonal normally comprises a maximum of 90% of the
immunoglobulin component of ascites (Galfre & Milstein, 1981). Thus to obtain pure
monoclonal antibody (which is important for the assignation of specific biological
properties to the antibody and antigen; de Almeida et al, 1991) bulk cultures of the
hybrids were prepared. The purification of the monoclonals from this medium and
their biochemical characterization are detailed in Chapter 5.
4.5 Summary
A conventional immunization procedure comprising a primary injection, 1 or 2 booster
injections and a final booster 3 days prior to fusion, was followed. In order to increase
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the probability of obtaining monoclonal antibodies directed against molecules direcdy
involved in biological functions, purified sperm plasma membrane was used as the
immunogen. A total of four fusions were performed resulting in the production of 388
hybrids. Twelve of these hybrids were identified as secreting anti-sperm monoclonal
antibodies by ELISA and these were cloned twice before being bulk cultured for
monoclonal antibody purification.





As discussed in the previous chapter, purified monoclonal antibodies are required to
specifically identify those molecules on the sperm surface that are directly involved in
biological events. Bulk culture supernatants contain impurities which may interfere
with tests of biological function and thus the monoclonals require to be purified from
this medium (de Almeida et al, 1991). The usual method of choice is by affinity
chromatography in a protein-A column (Goding, 1978). Protein-A is a cell wall protein
isolated from the bacterium Staphlococcus aureus, which binds to the Fc region of
antibodies (Forsgren & Sjoquist, 1966). However not all antibodies bind to protein-A
as this is dependent on the species and subclass of antibody (Ey et al, 1978; Goding,
1978; Goudswaard et al, 1978). Murine IgG2a, IgG2b and IgG3 bind strongly to
protein A but IgGi and IgM antibodies bind poorly, if at all (Ey et al, 1978; Mackenzie
et al, 1978). Binding is highly pH dependent (Ey et al, 1978) and elution is easily
achieved by lowering the pH. For antibodies which do not bind to protein-A, affinity
chromatography on anti-immunoglobulin coupled to a support matrix (usually
cyanogen bromide-activated sepharose 4B) is the method of choice (Goding, 1980).
Ion exchange on DEAE columns is another method which can be used to purify
monoclonal antibodies but this is usually used to purify from ascites or serum as it does
not generally provide complete purification from culture fluid (Goding, 1980).
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5.1.2 Biochemical Characterization
In 1975, Southern developed a technique for analysing DNA fragments separated on
agarose gels by transferring these fragments to a nitrocellulose membrane where they
were probed by RNA or cDNA. The method of transfer became known as 'blotting'
because the pattern of bands on the nitrocellulose membrane is an exact copy of the
pattern on the original gel and thus this technique for the analysis of DNA became
known as 'Southern blotting'. A similar technique for the analysis of RNA was
developed and this came to be known as 'Northern blotting'. Therefore when another
similar method based on proteins was described by Towbin et al (1979) and Renart et al
(1979), this became commonly known as Western blotting'. However the scientific
community has yet to identify a fourth analogous technique which could be called
"Eastern blotting'.
Western blotting is also known as immunoblotting and has become a widely
used technique for the identification of antigens recognized by antibodies (Stott, 1989;
Poxton, 1990). Since it was first described, the method has been extensively
developed and modified and it has been applied in an enormous variety of studies
(Stott, 1989). Although some of the steps in the process are still not fully understood,
there is no doubt that it is an extremely powerful technique which has revolutionized the
detection of antigens and antibodies (Poxton, 1990).
Prior to its inception, the methods available were severely limited. Although a
variety of methods were available for the separation of complex mixtures into their
component parts (usually by electrophoresis in an agarose or polyacrylamide gel), some
means of identifying the protein of interest was required. Until immunoblotting was
developed, the only methods for identification were based on mobility, molecular
weight and isoelectric point or some innate activity (eg enzymatic) of the protein in
question (Stott, 1989). A technique called immunofixation which involved the direct
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overlay of the gel with antibody was developed to identify the antigen of interest.
However this method was limited to use with agarose gels which have a large pore size
through which an antibody can penetrate. The small pore size of polyacrylamide gels
restricts the movement of protein molecules and thus they are not readily penetrated by
immunoglobulin molecules. Also the long incubation times involved in
immunofixation allow the bands to diffuse resulting in a loss of resolution.
Immunoblotting involves the separation of proteins by electrophoresis (usually
on polyacrylamide gels) and their subsequent transfer to a nitrocellulose membrane.
The blots are then probed with antibodies and any bound antibody detected. Transfer
can be achieved by simple diffusion (Bowen et al, 1980), capillary transfer (Renart et
al, 1979) or electrophoresis (Towbin et al, 1979). Diffusion is the simplest method but
takes 36-48 hours although transfer can be speeded up by inducing a flow of solvent
from the gel through the membrane by capillary action. However transfer from
polyacrylamide gels using either the diffusion or capillary action method is very
inefficient due to the small pore size of the gel which hinders the movement of large
molecules. Thus for transfer from polyacrylamide gels, the electrophoretic method is
generally preferred. Thus since Western blotting was first described, it has been
extensively used as it permits relatively quick reproducible identification of specific
proteins.
5.2 Materials and Methods
5.2.1 Isotyping
Two methods were used to determine the isotype of the monoclonal antibodies, namely
Ouchterlony immunodiffusion and red blood cell agglutination.
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Ouchterlonv Immunodiffusion A kit for determining the isotype of monoclonal
antibodies from mouse tissue culture supernatants (The Binding Site, Birmingham,
UK) based on the gel double diffusion method of Ouchterlony (1958), was used
according to the manufacturer's instructions. Approximately 75|il of the tissue culture
supernatant to be tested was pipetted into the central well of one of the rossettes cut in
an agarose gel. In a documented fashion, 10|il of each of the six antisera against
mouse immunoglobulins (anti-IgGi, anti-IgG2a> anti-IgG2b, anti-IgG3, anti-IgA and
anti-IgM) was pipetted into the outer six wells of the same rossette. The plate was then
covered and incubated at room temperature for 24-48 hours. The result was easily
readable as an immunoprecipitate arc formed between the central well and one of the
outer wells containing antisera against the appropriate isotype.
Red Cell Agglutination An alternative method used to determine the class of the
monoclonal antibodies was a kit (Serotec, Oxford, UK) based on the agglutination of
red blood cells coated with anti-mouse immunoglobulin subclass antibodies. The assay
was carried out in 96 well round bottomed plates and dilutions of 1/10 and 1/100 in
PBS of the supernatant to be tested were used. A 30pl aliquot of the diluted
supernatant was pipetted into each of 7 wells across a microtitre plate and then 30pl of
each specific isotyping reagent was added. The solutions were mixed and the plate left
on a flat surface undisturbed for 1 hour for the results to develop. A part or full carpet
of agglutination was taken as a positive result and a small red circle or button of red
blood cells in the bottom of the well as a negative result.
5.2.2 Affinity Chromatography
Protein-A Column Protein-A immobilized on a Trisacryl GF-2 000 support (Pierce,
Chester, Cheshire, UK) was washed with 0.1M phosphate buffer and left to settle.
The supernatant was removed and the resulting slurry poured into a 1 x 10 cm
Chapter 5 Purification and Biochemical Characterization 62
column (Amicon, Stonehouse, Gloucestershire, UK). The column was equilibrated
with 0.1M phosphate buffer, pH8.1 at a flow rate of 20ml/hour for a least 1 hour prior
to use. The pH of the antibody containing supernatant was adjusted to 8.1 with 2M
Tris before it was loaded overnight onto the column. After washing the column with
0.1M phosphate buffer, pH8.1, the antibody was eluted using 0.1M citrate buffer,
pH3.5. The pH of the eluted antibody solution was immediately raised to 7.4 using
2M Tris to prevent denaturation of the antibody. The column was washed thoroughly
with 0.1M phosphate buffer, pH8.1 and stored at 4°C in the same buffer containing
IjjJVf azide. All affinity chromatography columns were run at 4°C.
Anti-mouse IgM Column An affinity column was made by coupling a commercially
available anti-mouse IgM antibody (Sigma, Poole, Dorset, UK) to cyanogen bromide-
activated (CNBr) Sepharose 4B (Pharmacia LKB, Milton Keynes, UK). The CNBr-
activated Sepharose 4B was swollen for 2 hours in ImM HC1 and then washed on a
sintered glass filter (porosity G 3) with the same solution. Anti-mouse IgM antibody
was dissolved in coupling buffer (0.1M NaHCC>3, pH 8.3 containing 0.5M NaCl).
After washing the gel suspension in coupling buffer, it was immediately mixed with the
antibody solution and gently rocked overnight at 4°C. Any remaining active groups
were blocked by transferring the gel to buffer with blocking agent (0.2M glycine) and
incubating for 4 hours at room temperature. The gel was washed twice to remove any
unbound protein using alternating coupling and acetate (0.1M, pH4, containing 0.5M
NaCl) buffer, finishing with coupling buffer. The column was then poured and
equilibrated with 0.1M phosphate buffer, pH8.1. After adjusting the pH of the
antibody containing supernatant to 8.1 with 2M Tris, it was loaded onto the column.
The column was washed with 0.1M phosphate buffer, pH8.1 and the monoclonal
antibody eluted using glycine/HCl buffer (0.1M adjusted to pH2.5 with 0.2M HC1).
The pH of the eluted protein was immediately raised to 7.4 by the addition of 2M Tris.
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Finally the column was washed thoroughly with 0.1M phosphate buffer, pH8.1 and
then stored at 4°C in the same buffer containing 0.1 |iM azide.
5.2.3 Concentration
Purified antibody solutions were dialysed against two changes of PBS and then
concentrated using a minicon-B125 concentrator (Amicon). After filter sterilization
(0.2pm filter; Ministart NML; Sartorius, Belmont, Surrey, UK), aliquots were stored
frozen at -70°C until required. The protein content of the concentrated antibody
solution was estimated using a BCA protein assay (Pierce) as described in Section 3.4.
5.2.4 Titration
Sperm coated plates Microtitre plates (96 well) were coated with spermatozoa for use
in an enzyme linked immunoabsorbant assay (ELISA) to determine the amount of anti-
sperm antibody present in the purified solutions. Sperm cells (100% fraction) were
prepared (see section 3.2.1) and adjusted to 10 x 106 cells/ml in PBS prewarmed to
37°C. A 50pl aliquot of this solution was added to each well of a microtitre plate and
the plate spun at 1 000 rpm (Coolspin; MSE, Crawley, Sussex, UK) at 25°C for 5
minutes. After aspirating the supernatant, lOOpl of 1% para-formaldehyde in PBS was
added to each well and the plates incubated at room temperature for 30 minutes. The
plates were spun again and washed 3 times in PBS-tween (0.05%). The plates were
dried in an aspirator containing phosphorus pentoxide under vacuum at 4°C then stored
at -20°C until required.
ELISA 50[il of sample was added to each well of a sperm-coated plate. Purified
monoclonal antibody solutions were added in doubling dilutions from 1/10 to 1/20 480
and incubated for either 1-2 hours at room temperature or overnight at 4°C. The
supernatant was aspirated and the wells washed 3 times with PBS-tween (0.05%;
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250}il/well). A 1/1 000 dilution (in PBS; 50(il/well) of second antibody, sheep anti-
mouse Ig-alkaline phosphatase conjugate (Sigma), was added and incubated for 1-2
hours at room temperature. The plates were washed again and 50|il of lmg/ml p-
nitrophenylphosphate substrate (Sigma) made up in 10% (v/v) diethanolamine (Sigma),
pH9.8 was added to each well. The reaction was allowed to develop for 30-60
minutes, protected from the light, at room temperature before it was stopped with 50|il
3M NaOH per well. The absorbance at 405nm was read using a 96 well plate reader
(Titertek; Row Laboratories, Irvine, Scotland, UK) using air as the blank. A positive
(mouse anti-sperm plasma membrane polyclonal antiserum) and negative (PBS or
medium) control were included on each plate. A positive value was defined as any
reading which was at least twice the negative value. The titre was taken as the dilution
at which the ELISA reading changed from positive to negative (Voller et al, 1976).
5.2.5 Electrophoresis
One dimensional sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS
PAGE) was performed according to the method of Laemmli (1970) using a Protean
electrophoresis cell (BioRad, Hemel Hempstead, Hertfordshire, UK). The stacking gel
was composed of 3.6% acrylamide, pH6.8 and the resolving gel contained 10%
acrylamide, pH8.8. Samples of purified sperm plasma membrane (80|ig protein/track)
and seminal plasma (approximately 80|lg protein/track) were run under reducing and
non-reducing conditions. 2-mercaptoethanol (1%, v/v) was used as the reducing agent
and bromophenol blue as the indicator. Molecular weight standards (high range -
myosin, 205kD; (3-galactosidase, 116kD; phosphorylase b, 97.4kD; bovine albumin,
66kD; egg albumin, 45kD; carbonic anhydrase, 29kD; low range - bovine albumin,
66kD; egg albumin, 45kD, glyceraldehyde-3-phosphate dehydrogenase, 36kD;
carbonic anhydrase, 29kD; PMSF treated trypsin, 24kD; soyabean trypsin inhibitor,
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20.1kD; a-lactalbumin, 14.2kD; Sigma) were also run. If the gel was to be blotted,
prestained molecular weight standards (phosphorylase b, 106kD; bovine serum
albumin, 80kD; ovalbumin, 49.5kD; carbonic anhydrase, 32.5kD; soyabean trypsin
inhibitor, 27.5kD; lysozyme, 18.5kD; BioRad) were used. Electrophoresis was
performed at a constant current of 40mA through the stacking gel, then at 25mA for 2-3
hours through the resolving gel using Tris, glycine, 0.1% SDS as electrode buffer.
Some gels were silver stained as described in Section 5.2.6 whereas others were
blotted as described in Section 5.2.7.
5.2.6 Silver Staining
Silver staining was performed using a kit (BioRad) used according to the
manufacturer's instructions. All solutions were made up using deionized water and the
incubations were performed at room temperature on a rocking table. Gels were fixed in
40% methanol/10% acetic acid (v/v) for 1 hour then twice in 10% ethanol/5% acetic
acid (v/v) for 30 minutes each. After a 10 minute incubation with oxidizer, the gels
were washed three times in deionized water (10 minutes each). After a 30 minute
incubation with silver reagent, the gels were washed briefly in deionized water (2
minutes). Developer was added for approximately 30 seconds until the solution turned
yellow or a smoky brown precipitate appeared when it was poured off and fresh
developer added. Development was stopped when the bands reached the desired
intensity in relation to the background, by adding 5% acetic acid (v/v).
5.2.7 Immunoblotting
Dot Blotting Preliminary dot blotting experiments were carried out by spotting
approximately 12|ig of purified sperm plasma membrane and seminal plasma under
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both reducing and non-reducing conditions onto nitrocellulose and then developed as
described below.
Western Blotting The Western blotting experiments were carried out using a
modified version of the method of Towbin et al (1979). A dry blotting procedure using
an LKB Multiphor II electrophoresis system (Pharmacia LKB) was followed. A
continuous buffer system (39mM glycine, 48mM Tris, 0.0375% SDS, 20% methanol)
was used and the nitrocellulose paper was placed anodal to the gels. The transfers were
typically carried out at 250mA constant current for 1 hour.
Development of Blots The blots were blocked in 5% dried milk (Marvel, Premier
Brands, Knighton, Adbaston, Stafford, UK) in TBS-tween (0.05%) for 1-2 hours and
incubated with the first antibody diluted 1/200 in the same solution overnight at 4°C.
The blots were washed 3 times in TBS-tween and incubated with the second antibody,
sheep anti-mouse Ig-horseradish peroxidase (HRP) conjugate (Amersham, Aylesbury,
Bucks, UK), diluted 1/2000 in TBS-tween-milk for 2-3 hours at room temperature.
The blots were washed again and developed using either the classical colour
development method using 4-chloro-l-naphthol as the substrate (BioRad) or enhanced
chemiluminescence (ECL; Amersham).
Nitrocellulose Two different types of nitrocellulose were used for the
immunoblotting experiments. If the blots were to be colour developed, Immobilon
PVDF (Millipore, Watford, Hertfordshire, UK) was used. However if they were to be
developed using the ECL system, Hybond C-Super (Amersham) was used.
5.3 Results
The twelve monoclonal antibodies were named according to the fusion from which they
were produced. Thus the two monoclonals from fusion spm 1 were named spm 1/1
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and spm 1/2, the two from fusion spm 2 were named spm 2/1 and spm 2/2 and the
eight from fusion spm 4 were named spm 4/1 to spm 4/8.
In order to determine the chosen method for purification, the antibodies were
isotyped to indicate what immunoglobulin subclass they belonged to. Two methods of
isotyping were used — Ouchterlony immunodiffusion and red cell agglutination. A
photograph of a representative Ouchterlony gel is shown in Figure 5.1 and details of
the isotyping results are shown in Table 5.1. These experiments indicated that nine of
the antibodies belonged to the IgM subclass while the remaining three were IgG2a
antibodies.
The antibodies were purified from bulk cultured supernatants (Chapter 4).
They were purified by affinity chromatography on either a protein-A column (those
belonging to IgG2a subclass) or an anti-IgM column (those belonging to IgM subclass).
A representative trace showing the absorbance at 280nm (A280) of the fluid eluting
from a protein-A column during a run is shown in Figure 5.2. The column eluates
were dialysed against two changes of PBS and concentrated before being filter
sterilized. The titre and protein concentration of each antibody solution were
determined and the results are summarized in Table 5.1.
The ability of the monoclonals to recognize sperm plasma membrane proteins
under reducing and non-reducing conditions, was checked using a dot blot technique.
As seminal plasma proteins are known to coat the entire sperm surface (Russell et al,
1983), the antibodies were also blotted against seminal plasma proteins to identify any
directed against accessory gland products that coat spermatozoa. The dot blotting
results are summarized in Table 5.2. Eleven of the twelve antibodies recognized the
sperm proteins and of this eleven, four recognized seminal plasma proteins with the
same intensity, six had a reduced intensity and one did not recognize any seminal
plasma proteins. One monoclonal did not dot blot norWestern blot
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Figure 5.1 A representative Ouchterlony immunodiffusion isotyping gel. The
large central wells contained culture supernatant— well 1, spm 4/1 supernatant; well
2, spm 4/2; well 5, spm 4/5; well 7, spm 4/7; well 8, spm 4/8; and well 9, polyclonal
positive control serum. Six antisera against mouse immunoglobulin were pipetted into
the outer six wells of each rosette as shown on rosette 3 — A, anti-IgGl; B,
anti-IgG2a; C, anti-IgG2b; D, anti-IgG3; E, anti-IgA; and F, anti-IgM. As the
antibodies diffused through the agarose, an immunoprecipitate arc formed between the
central well containing the antibody to be isotyped and one of the outer wells of the
rosette containing antisera against the appropriate isotype. Thus spm 4/1 (well 1), spm
4/2 (well 2), spm 4/7 (well 7) and spm 4/8 (well 8) were all identified as IgM
antibodies and spm 4/5 (well 5) as an IgG2a antibody.
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Antibody Isotype 1/Titre Protein
Concentration
spm 1/1 IgM 2 560 2.16
spm 1/2 IgM 320 1.01
spm 2/1 IgM 320 0.79
spm 2/2 IgM 320 0.73
spm 4/1 IgM 20 480 0.9
spm 4/2 IgM 20 480 0.5
spm 4/3 IgG2a 10 0.25
spm 4/4 IgM 40 0.2
spm 4/5 IgG2a 20 480 3.1
spm 4/6 IgG2a 1 280 1.77
spm 4/7 IgM 10 240 1.36
spm 4/8 IgM 10 240 1.67
Table 5.1 Details of the isotypes, titres and protein concentrations of the twelve
purified monoclonal antibody solutions. Protein concentrations are given in mg/ml.
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Figure 5.2 A28O profile of eluate from a protein-A affinity chromatography column
during purification of spm 4/5 from bulk culture supernatant, a, last of antibody
solution passing through column; b, washing of column; c, elution of monoclonal
antibody from the column.
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Antibody spm R spm NR sem pi R sem pi NR
spm 1/1 ++ ++ + +
spm 1/2 + + + +
spm 2/1 + + (+) (+)
spm 2/2 + + + +
spm 4/1 + + + +
spm 4/2 + + + +
spm 4/3 ++ ++ - -
spm 4/4 _ - - -
spm 4/5 ++ ++ + +
spm 4/6 ++ ++ + +
spm 4/7 + + (+) (+)
spm 4/8 + + (+) (+)
Table 5.2 Summary of dot blot results against sperm plasma membrane (spm) and
seminal plasma proteins (sem pi) under reducing (R) and non-reducing (NR)
conditions. ++, strong positive reaction; +, positive reaction; (+), weak positive
reaction; negative reaction.
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In order to characterize the antigens recognized by the antibodies in more detail,
purified sperm plasma membrane and seminal plasma proteins were electrophoresed
under reducing and non-reducing conditions on one dimensional SDS polyacrylamide
gels. After transferring to nitrocellulose, these blots were then probed with the
monoclonals. Figure 5.3 shows silver stained gels before and after blotting indicating
that little residual protein is left in the gel after blotting. More residual protein is visible
in the high molecular weight region of the gel and this is not unexpected as high weight
bands transfer less efficiently than low weight bands due to the small pore size of
acrylamide gels which restricts the movement of large molecules (Stott, 1989).
Positive control blots probed with polyclonal anti-sperm plasma membrane antibodies
were developed using enhanced chemiluminescence (ECL) and a colour development
system using 4-chloro-l-naphthol as substrate. Photographs of representative blots
developed using these methods are shown in Figure 5.4. It can be seen that the ECL
system (Figure 5.4a) is more sensitive than the colour development system (Figure
5.4b). This can particularly be seen in the seminal plasma protein lanes (lanes 3 and 4
in Figure 5.4a and b) where more minor bands are visualized. Thus the ECL system
was used as the method of choice for the development of blots probed with these
monoclonals.
Preimmune mouse serum recognized two proteins (28kD and 12kD) in spermatozoa
and at least seven proteins in seminal plasma (115kD, 81kD, 20kD, 18kD, 16kD, llkD
and lOkD) in addition to a high molecular weight band in each lane which did not enter
the gel. However as all the monoclonals were tested as purified antibody solutions,
othermonoclonal antibodies were used as controls to identify the level of non-specific
binding. Thus a monoclonal raised against human growth hormone (Sigma) was used
(Figure 5.5). It recognized a high molecular weight band which did not enter the gel,
in sperm preparations particularly under reducing conditions and four
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Figure 5.3 Silver stained gels before (lanes 6-10) and after (lanes 1-5) blotting.
Lanes 1 & 10 contain molecular weight standards, lanes 2 & 8 and 3 & 9 contain
purified sperm plasma membrane under reducing and non-reducing conditions
respectively and lanes 4 & 6 and 5 & 7 contain seminal plasma under reducing and
non-reducing conditions respectively. Approximately 80|ig protein was loaded into
each sperm plasma membrane and seminal plasma lane. Molecular weight markers as
indicated on right hand side of the gels.
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Figure 5.4 Blots of sperm plasma membrane (lanes 1 and 2) and seminal plasma
proteins (lanes 3 and 4) under reducing and non-reducing conditions respectively,
probed with polyclonal anti-sperm plasma membrane serum. Blot (a) developed using
the ECL system, blot (b) using colour development.
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Figure 5.5 Blot of sperm plasma membrane (lanes 1 & 2) and seminal plasma
proteins (lanes 3 & 4) under reducing and non-reducing conditions respectively, probed
with a monoclonal antibody raised against human growth hormone. A high molecular
weight band was identified in sperm plasma membrane under reducing conditions in
addition to four other bands of relative molecular mass 20kD, 18kD, 1 lkD and lOkD in
the seminal plasma lanes.
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further proteins present only in seminal plasma with relative molecular masses of 20kD,
18kD, llkD and lOkD. Another control antibody raised against leucocyte common
antigen (Scottish Antibody Production Unit, Carluke, Scotland, UK) was also used
(Figure 5.6). In addition to the high molecular weight proteins and the four proteins in
the seminal plasma lanes recognized by anti-human growth hormone, anti-leucocyte
common antigen antibody also recognized proteins with relative molecular masses of
127kD and 63kD in sperm plasma membrane preparations. This may give an indication
of the level of leucocyte contamination in the sperm plasma membrane preparations.
Photographs of representative blots probed with each of the monoclonals are shown in
Figures 5.7 to 5.17 and details of the major protein bands recognized are detailed in the
legend of the corresponding figure. The antibodies bound to a number of proteins of
varying molecular weight. Several antibodies recognized more than one sperm protein
thus indicating that these molecules contain shared epitopes. Omission of the primary
or secondary antibody or use of the development reagents alone, produced no
immunostaining on the blot. The majority of non-specific binding appears to be
restricted to four proteins present in seminal plasma which have relative molecular
masses of 20kD, 18kD, llkD and lOkD. Also a high molecular weight band is often
present which is thought to consist of aggregated proteins and thus it does not enter the
gel.
5.4 Discussion
When an animal encounters a foreign substance, the body mounts an immune response
to eliminate it. Part of the response is to produce antibodies against the foreign
substance. This is called the humoral response and is composed of four distinct
phases - i) a lag phase where no antibody is detected; ii) a log phase in which the
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Figure 5.6 Blot of sperm plasma membrane (lanes 1 & 2) and seminal plasma
proteins (lanes 3 & 4) under reducing and non-reducing conditions respectively, probed
with a monoclonal antibody raised against leucocyte common antigen. In addition to a
high molecular weight band which did not enter the gel, the other major bands
recognized had molecular masses of 127kD and 63kD in sperm plasma membrane
preparations and 20kD, 18kD, 1 lkD and lOkD in seminal plasma.
m
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Figure 5.7 Blot of sperm plasma membrane (lanes 1 & 2) and seminal plasma
proteins (lanes 3 & 4) under reducing and non-reducing conditions respectively, probed
with monoclonal antibody spm 1/1. Three proteins of 82kD, 72kD and 56kD were
recognized in all four lanes. Two proteins of 94kD and 63kD and a broad band centred
around 30kD were identified in sperm plasma membrane only and one of 36kD in
seminal plasma only.








Figure 5.8 Blot of sperm plasma membrane (lanes 1 & 2) and seminal plasma
proteins (lanes 3 & 4) under reducing and non-reducing conditions respectively, probed
with monoclonal antibody spm 1/2. In addition to a high molecular weight band
visualized in all four lanes, spm 1/2 recognized a protein of 36kD in sperm plasma
membrane and one of 86kD in seminal plasma.
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Figure 5.9 Blot of sperm plasma membrane (lanes 1 & 2) and seminal plasma
proteins (lanes 3 & 4) under reducing and non-reducing conditions respectively, probed
with monoclonal antibody spm 2/1. A band at 77kD was identified in sperm plasma
membrane under both reducing and non-reducing conditions and one at 40kD was
identified in sperm plasma membrane and seminal plasma under reducing conditions.
Further bands at 88kD and 60kD were seen in sperm plasma membrane under reducing
conditions and at 120kD and 16kD in seminal plasma also under reducing conditions.
The two bands at 40kD and 16kD seen in seminal plasma under reducing conditions
were also present under non-reducing conditions although they were faint.









Figure 5.10 Blot of sperm plasma membrane (lanes 1 & 2) and seminal plasma
proteins (lanes 3 & 4) under reducing and non-reducing conditions respectively, probed
with monoclonal antibody spm 2/2. The antibody recognized a high molecular weight
band in sperm plasma membrane under reducing conditions, a protein smear of 21kD to
17kD in both lanes containing sperm plasma membrane and five proteins of 44kD,
20kD, 18kD, llkD and lOkD in seminal plasma.
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Figure 5.11 Blot of sperm plasma membrane (lanes 1 & 2) and seminal plasma
proteins (lanes 3 & 4) under reducing and non-reducing conditions respectively, probed
with monoclonal antibody spm 4/1. Two bands of relative molecular mass 82kD and
72kD were recognized in both sperm plasma membrane and seminal plasma but only
under reducing conditions. Under non-reducing conditions only a very high molecular
weight band which did not enter the gel, was visualized.
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Figure 5.12 Blot of sperm plasma membrane (lanes 1 & 2) and seminal plasma
proteins (lanes 3 & 4) under reducing and non-reducing conditions respectively, probed
with monoclonal antibody spm 4/2. Under reducing conditions one protein of 89kD
was identified in sperm plasma membrane and was also seen in seminal plasma. Two
weakly staining bands of 58kD and 38kD and a heavily staining doublet of 16kD and
15kD were also visible in seminal plasma under reducing conditions. Under
non-reducing conditions, a faint band at 97kD was seen in sperm plasma membrane
and another at 86kD was seen in seminal plasma.










Figure 5.13 Blot of sperm plasma membrane (lanes 1 & 2) and seminal plasma
proteins (lanes 3 & 4) under reducing and non-reducing conditions respectively, probed
with monoclonal antibody spm 4/3. A protein smear from 22kD to 17kD was
recognized in both lanes containing sperm plasma membrane although the reaction was
stronger under reducing conditions. No reactivity with seminal plasma proteins was
detected.
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Figure 5.14 Blot of sperm plasma membrane (lanes 1 & 2) and seminal plasma
proteins (lanes 3 & 4) under reducing and non-reducing conditions respectively, probed
with monoclonal antibody spm 4/5. A high molecular weight band which did not enter
the gel is seen in all four lanes. A protein of 71kD was heavily stained in both sperm
plasma membrane and seminal plasma under reducing conditions and was also present
under non-reducing conditions although it was not so heavily stained. Another heavily
staining protein of 55kD was seen in sperm plasma membrane under reducing
conditions but was not present in any other lane and a protein of 58kD which stained
heavily in sperm plasma membrane under non-reducing conditions was also present in
seminal plasma under non-reducing conditions.
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Figure 5.15 Blot of sperm plasma membrane (lanes 1 & 2) and seminal plasma
proteins (lanes 3 & 4) under reducing and non-reducing conditions respectively, probed
with monoclonal antibody spm 4/6. A large protein smear from 90kD to 16kD was
visualized in sperm plasma membrane under both reducing and non-reducing
conditions. In seminal plasma, spm 4/6 recognized a smaller smear which was
composed of at least six protein bands of 26kD, 25kD, 23kD, 21kD, 19kD and 18kD
under reducing and non-reducing conditions.












Figure 5.16 Blot of sperm plasma membrane (lanes 1 & 2) and seminal plasma
proteins (lanes 3 & 4) under reducing and non-reducing conditions respectively, probed
with monoclonal antibody spm 4/7. Two proteins of 87kD and 74kD and a distorted
band which migrated behind the ion front were recognized in all four lanes. In addition
a protein of 65kD was identified only in sperm plasma membrane under reducing
conditions. In seminal plasma, two further bands of 119kD and 1 lOkD were observed
in both lanes and an additional band of 123kD was present under non-reducing
conditions.
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Figure 5.17 Blot of sperm plasma membrane (lanes 1 & 2) and seminal plasma
proteins (lanes 3 & 4) under reducing and non-reducing conditions respectively, probed
with monoclonal antibody spm 4/8. A high molecular weight band which did not enter
the gel was visualized in all four lanes. Two proteins of lOOkD and 37kD were
recognized in both lanes containing sperm plasma membrane and three proteins of
84kD, 20kD and 17kD were identified in both seminal plasma lanes.
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antibody titre rises logarithmically; iii) a plateau phase in which the antibody titre
stabilizes; and iv) a decline phase during which the antibody is cleared or catabolized
(Roitt et al, 1985). The first encounter produces a primary antibody response which is
initially dominated by IgM and subsequently by IgG. A second encounter with the
same antigen leads to a secondary response which comprises a prompt and massive
IgG response with a smaller IgM component (Darnell et al, 1990). As all the fusions
were carried out after an immunization schedule which included a primary injection and
at least one booster injection before the final boost, each animal would contain a large
number of cells producing antibodies of the IgG class due to the production of
secondary immune responses. It is therefore surprising that such a large proportion of
the monoclonals produced were of the IgM class. Seventy five percent of the
antibodies belonged to this class and this may be compared with the average of 33%
reported at two workshops on anti-sperm antibodies organized by the World Health
Organization (Anderson et al, 1987). One possible reason for the production of such a
high number of IgM antibodies could be related to the immunogen. The sperm plasma
membrane preparations used for the immunizations are particulate and particulate
antigens have been found to stimulate good antibody responses that have a large IgM
component (Herbert, 1978).
Large scale production of monoclonal antibodies by bulk culture in vitro
typically produces antibody concentrations of 10-100(1g/ml (Goding, 1980). As
approximately 700mls of bulk culture supernatant were produced for each antibody, the
solution would be expected to contain between 7 and 70mgs of antibody. After
purification and concentration, the antibodies were finally resuspended in 5mls PBS
and aliquotted for storage. The protein content of each of these concentrated antibody
solutions was determined and found to range from 0.2 to 3.1mg/ml (Table 5.1). Thus
the final amount of antibody purified from the culture supernatants varied between 1
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and 15.5mg. This is less than would be predicted but can probably be accounted for by
loss of antibody during the purification and concentration procedure, for example by
non-specific binding to dialysis membranes.
Antisera can be compared semi-quantitatively by determining the end point of
their titration curves (Hudson & Hay, 1980). The method usually involves making
doubling dilutions of the antibody solution and testing these for the presence of
antibody (Dausset & Colombani, 1964). The highest dilution still showing a positive
reaction in the test for antibody is taken as the end point and termed the titre (Humphrey
& White, 1963). It is a relative measure of the antigen binding capacity of a solution
and thus gives an indication of the avidity of antibodies in the original solution for the
antigen of interest (Humphrey & White, 1963; Hudson & Hay, 1980). Affinity is a
measure of the strength of binding between an antigenic determinant (epitope) and an
antibody combining site (paratope; Roitt et al, 1985). When multivalent antigens and
antibodies are involved, the interaction is more complex and the term avidity is used
(Hudson & Hay, 1980). The avidity is therefore a measure of the functional combining
strength of an antibody with its antigen and is related to both the affinity of the reaction
between the epitopes and paratopes and the valencies of the antibody and antigen (Roitt
et al, 1985). The titre of an antibody solution therefore gives an indication of the
avidity of the antibody for the antigen of interest. It does not give an accurate
measurement of the antibody concentration (Dausset & Colombani, 1964) as can be
seen by comparing the titres and protein concentrations given in Table 5.1. Antibody
solutions with similar protein concentrations can have vastly different titres and vice
versa (eg spm 1/2 and spm 4/7 which have protein concentrations of l.Olmg/ml and
1.36mg/ml and titres of 1/320 and 1/10 240 respectively). It gives a relative measure
of the antigen binding capacity of a solution and is therefore only sufficient to allow a
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comparison to be made between different antibody solutions when they are tested in
parallel with the same antigen (Hudson & Hay, 1980).
The level of contamination of the purified antibody solutions with other
immunoglobulin molecules has been minimized. The use of FCS in the culture medium
means that a small amount of bovine antibodies will be present in the culture
supernatant. However these should not be copurified with the monoclonals as the
anti-IgM column used to purify the IgM antibodies, was made with antibodies targetted
specifically against mouse IgM molecules and the monoclonals are the only murine
antibodies present in the culture supernatants. Little bovine IgG is bound by protein A
and thus the purity of the IgG monoclonals purified in this manner is high (Oi et al,
1978; Goding et al, 1979). The level of contamination of the purified antibody
solutions with other immunoglobulin molecules is therefore negligible if any are present
at all.
Semen is a heterogeneous mixture composed of various fluid secretions,
somatic cells, cellular fragments, and particulate matter in addition to spermatozoa
(Lessley & Gamer, 1983). Sperm populations are also very heterogeneous. There is a
large degree of variability of spermatozoa both within one man (in one ejaculate and
between different ejaculates) and between different men (Katz et al, 1989a; Mallidis et
al, 1991) and thus sperm samples prepared in different ways can have differing protein
compositions. For example, Gupta et al (1990) found that different extraction
procedures from the same pooled sample can have different gel electrophoresis profiles
and that different three times washed pools varied in their protein pattern. However
they also showed that swim-up sperm extracts had yet another protein pattern but this
was more consistent than those of the thrice washed spermatozoa. Naaby-Hansen
(1990) also prepared spermatozoa using a three times washing protocol and found that
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the overall protein profile was highly reproducible although minor variations between
different protein preparations were observed even though the method of sperm
preparation had been standardized. This can be explained by the fact that a significant
number of leucocytes are present in the ejaculates of normal men although the actual
number present varies (Olsen & Shields, 1984; Wolff & Anderson, 1988; Aitken &
West, 1990). The swim-up method of sperm preparation is a selective method in that
only motile spermatozoa are isolated. Spermatozoa prepared by the three times
washing protocol, a non-selective method, will thus comprise a more heterogeneous
mixture ofmotile and non-motile spermatozoa, and round cells including germ cells and
leucocytes. It is interesting to note that the SDS PAGE profiles of each sperm plasma
membrane preparation made here were very similar even though they were prepared
from a mixture of Percoll prepared spermatozoa and three times washed spermatozoa.
The separation of spermatozoa on Percoll gradients is a selective method of preparation
and spermatozoa prepared in this way have been shown to be functionally eqivalent to
those prepared using the swim-up technique (Morales et al, 1991). Spermatozoa
prepared on Percoll gradients have been shown to contain very little leucocyte
contamination (Lessley & Garner, 1983; Aitken & West, 1990) and as the bulk of the
starting material for each sperm plasma membrane preparation was prepared on Percoll
gradients, the contribution of leucocyte contamination will be minor. Peterson et al
(1983) used a similar method of sperm plasma membrane preparation to the one used
here, also based on the method of Gillis et al (1978) although they used boar
spermatozoa. They also found that the protein pattern, albeit on two dimensional gels,
was consistent
A large number of bands are visible in the silver stained gels before blotting
(Figure 5.3b). This is indicative of the vast array of proteins present in spermatozoa
and confirms the findings of other research workers. Studies on boar spermatozoa by
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Peterson et al (1983) have shown the presence ofmore than 100 different polypeptides
in the plasma membrane. Russell et al (1983) identified an even greater number (more
than 250) also on boar spermatozoa. Using two dimensional electrophoresis,
Naaby-Hansen (1990) has shown the presence of more than 260 proteins in human
spermatozoa! extracts and at least 60 of these have been identified as intrinsic membrane
proteins.
Polyclonal murine anti-human sperm plasma membrane antibodies were used as
a positive control for the blotting procedure (Figure 5.4a) and a large number of the
bands were stained. This confirms the findings of Lee et al (1982a) who showed that
anti-human sperm antisera raised in the mouse or rabbit reacted with almost all the
protein bands of blots of human sperm proteins. Preimmune mouse serum reacted with
several proteins in human seminal plasma and spermatozoa. This is a reflection of the
xenogeneic status of human spermatozoa in mice and thus the proteins detected are
likely to be primarily 'human' antigens rather than sperm-specific antigens. This is
further supported by the work of Lee et al (1982a) who found that in a homologous
situation, preimmune rabbit serum did not detect any protein bands on blots of rabbit
sperm proteins. Alternatively some of the proteins recognized by the preimmune serum
in the heterologous situation may represent cross-reacting anti-microbial antibodies
which are present in the immunoglobulin repertoire of the mice (World Health
Organization Reference Bank, 1977; Naaby-Hansen & Bjerrum, 1985).
However as all the monoclonals were tested as purified antibody solutions from
culture supernatants, other monoclonal antibodies were used as controls to identify the
level of non-specific binding. The majority of non-specific binding was confined to
four protein bands of 20kD, 18kD, llkD and lOkD in seminal plasma and to high
molecular weight bands which did not enter the gels. These latter bands are thought to
comprise aggregates of proteins and their presence is sporadic depending on whether
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this part of the gel was removed with the stacking gel before blotting or not. This high
molecular weight material has been reported previously by Young & Goodman (1980)
and Naaby-Hansen & Bjerrum (1985). They also found that the bands were more
frequently present under non-reducing conditions which is consistent with the
hypothesis that they comprise aggregates of proteins which precipitate at the origin of
the gel.
Several studies have investigated the surface labelling of human spermatozoa in
order to identify proteins which are externally orientated (Young & Goodman, 1980;
Naaby-Hansen & Bjerrum, 1985; Aitken et al, 1987a). Naaby-Hansen & Bjerrum
(1985) identified several major bands of 112kD, 64kD, 41kD and 32kD and a lesser
band of 78kD, although under non-reducing conditions the 64kD and 32kD bands were
not seen. The protein of 64kD is similar to the one of 66kD identified by Aitken et al
(1987a) although they do not report on its behaviour under non-reducing conditions.
This protein may correspond to the antigen recognized by monoclonal antibody spm 4/7
which identified a protein of 65kD only present under reducing conditions. Other
proteins which may correspond include the 41kD and 78kD proteins (Naaby-Hansen &
Bjerrum, 1985) with the 40kD and 77kD antigens recognized by spm 2/1.
There is now a substantial body of evidence implicating antibodies present in
the sera of some infertile people as the cause of their infertility (Jones, 1980; Bronson,
1988; Alexander, 1989). Several studies have been carried out using human sera from
patients exhibiting idiopathic autoimmunity to identify the major antigens involved
(Poulsen & Hjort, 1981; Lee etal, 1983; Naaby-Hansen & Bjerrum, 1985; Aitken et
al, 1987a). The most heavily staining band in two of these studies (Lee et al, 1983;
Aitken et al, 1987a) had a molecular weight of 90kD and could correspond to the
antigens recognized by several of the monoclonals namely spm 1/1 (94kD), spm 2/1
(88kD), spm 4/2 (89kD) and spm 4/7 (87kD). A further protein of 35kD identified by
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Aitken et al (1987a) may correspond to the 36kD antigen recognized by spm 1/2 or the
37kD antigen recognized by spm 4/8. Interestingly the 64/66kD protein identified as a
surface protein, which may correspond to the 65kD antigen recognized by spm 4/7
discussed earlier, was also recognized by autoimmune sera (Naaby-Hansen & Bjerrum,
1985; Aitken et al, 1987a) as were the 40/41kD and 77/78kD antigens recognized by
spm 2/1.
Several monoclonals exhibited binding to bands which were present in both
spermatozoa and seminal plasma and are thus thought to recognize epitopes on sperm
coating proteins (Weil et al, 1956; Weil, 1965; Mancini et al, 1971). Examples
include spm 1/1 which recognized three antigens of 82kD, 72kD and 55kD and spm 4/7
which recognized two proteins of 87kD and 74kD. Other monoclonals recognized
epitopes on putative sperm coating proteins but only under reducing conditions (eg spm
4/1 which identified two proteins of 82kD and 72kD and spm 4/2 which bound to a
protein of 89kD) or non-reducing conditions (eg spm 4/5 which recognized a protein of
58kD). Alternatively such antibodies may recognize epitopes which are shared
antigenic determinants between spermatozoa and seminal plasma proteins. It is
interesting to note that Young & Goodman (1980) identified by lactoperoxidase
catalysed Na125I radiolabelling, three major components of the human sperm surface
which were proteins adsorbed from seminal secretions. One of these had a molecular
weight of approximately 72-74kD and may correspond to the 72-74kD antigen
recognized by spm 1/1, spm 4/1 and spm 4/7. They also identified two other major
proteins present in seminal plasma which were not found to be labelled on
spermatozoa. One of these proteins, HP-3, had a molecular weight of 44kD and may
correspond to the 44kD antigen recognized in seminal plasma by spm 2/2.
Carbohydrates have been shown to be important in many cell-cell recognition
events and fertilization is no exception (Shur, 1989; Wassarman, 1989; Miller & Ax,
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1990). Many of the proteins on the surface of spermatozoa have been identified as
glycoproteins (Koehler, 1981; Kumar et al, 1990) and the carbohydrate is thought to
play a fundamental role in the species specificity of fertilization (Wassarman, 1989). It
is therefore not surprising that at least one of the antibodies may recognize an epitope on
the carbohydrate component of the sperm proteins. Antibody spm 4/6 recognized a
large protein smear from 90 to 16kD in spermatozoa and a smaller smear of low
molecular weight in seminal plasma. This antibody is thought to recognize a frequently
occurring carbohydrate epitope which is common to many sperm proteins. Two other
monoclonals, spm 2/2 and spm 4/3, also recognized protein smears. These were most
heavily stained at 17kD and had a tapering tail of staining to 21kD. This is indicative of
molecular weight heterogeneity which is characteristic of differential glycosylation of a
protein (Hamilton, 1981).
The monoclonal spm 4/7 recognized a distorted band which migrated just
behind the ion front. This was also visible as a large heavily staining component of the
purified sperm plasma membrane in silver stained gels (lanes 8 and 9, Figure 5.3b) and
is thought to have a lipid-like composition as Aitken et al (1987a) found that it was
readily removed by organic solvents.
Many of the antibodies recognize more than one sperm protein band. This is
concordant with the work of Peterson et al (1981b) and Lee et al (1984) who also
found that some antibodies exhibited binding to more than one protein band indicating
that the same antigenic determinants are frequently shared by more than one sperm
protein. Alternatively protein degradation could be occurring but as the protease
inhibitor PMSF was present during the plasma membrane purification procedure, this is
unlikely.
Some antibodies do notWestern blot and this is particularly true formonoclonal
antibodies which recognize only one epitope (Stott, 1989). The monoclonal spm 4/4
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described here is one example. This is usually due to denaturation of the antigen with
subsequent loss of the epitope during the blotting procedure which involves such harsh
treatment as heating the protein to 100°C in an SDS solubilization buffer (Poxton,
1990). Thus conformationally dependent epitopes are lost. Howevermany antibodies
still recognize their corresponding antigen after blotting from denaturing gels as the
SDS is stripped off the proteins during transfer thus permitting renaturation to occur
(Lee etal, 1982b; Stott, 1989).
5.5 Summary
The twelve monoclonal antibodies were isotyped and nine were identified as belonging
to the IgM class and the remaining three belonged to the IgG2a subclass. They were
purified from bulk culture supernatants by affinity chromatography on either a
protein-A column (IgG2a antibodies) or an anti-IgM column (IgM antibodies). The titre
and protein concentration of each purified antibody solution were determined and found
to range from 1/10 to 1/20 480 and from 0.2mg/ml to 3.1mg/ml respectively.
The ability of the monoclonals to recognize sperm plasma membrane proteins
and seminal plasma proteins under reducing and non-reducing conditions was
investigated using a dot blotting technique. Eleven of the twelve antibodies were found
to recognize purified sperm proteins and ten also recognized seminal plasma proteins.
One antibody did not blot at all. The antigens recognized by the antibodies were further
characterized by blotting against one-dimensional SDS-polyacrylamide gels of seminal
plasma and purifed sperm plasma membrane proteins. Non-specific binding was found
to be directed against a high molecular weight band composed of aggregated proteins
which did not enter the gels, and four seminal plasma proteins of relative molecular
masses 20kD, 18kD, 1 lkD and lOkD. The antibodies exhibited binding to a number of
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proteins of varying molecular weight. Several were tentatively identified as sperm
coating proteins due to their presence in both seminal plasma and spermatozoa. Some
antibodies recognized proteins which may correspond to antigens which have
previously been implicated as playing a role in autoimmune infertility. One antibody
recognized an epitope on the carbohydrate component of many of the sperm proteins
and two other antibodies identified a protein which may exhibit differential
glycosylation. Most of the monoclonals recognized more than one protein band
indicating that the same antigenic determinant is present on several sperm proteins.
6 Immunocytochemical Localization
of Sperm Surface Antigens
6.1 Introduction
Despite the fact that spermatozoa are covered by a continuous plasma membrane, it
exhibits a mosaic structure within which there are boundaries limiting the lateral
diffusion of particles to discrete domains on the sperm surface, delineating such regions
as the acrosome, post-acrosomal region, midpiece and tail (Cardullo & Wolf, 1990).
Using antibodies or lectins as probes, the localization of molecular entities to specific
regions of the sperm surface has been repeatedly demonstrated (Koehler, 1975;
O'Rand & Romrell, 1981; Feuchter et al, 1981). The sperm cell surface is therefore
highly differentiated (Primakoff & Myles, 1984) with the result that different
sperm-specific antibodies bind to different regions of the cell (Bellve & Moss, 1983;
Holt, 1984; Primakoff & Myles, 1983). These regions may have differing functions,
their structural composition reflecting the presence of functional domains involved in
the fertilization process (Jones et al, 1983; Mortillo & Wassarman, 1991). Indeed
several molecules, the function of which have been putatively identified with
fertilization and the acrosome reaction, have been localized to the anterior region of the
head where the acrosome reaction occurs (Moore & Hartman, 1984; Cardullo & Wolf,
1990). In addition anti-sperm antibodies directed against antigens associated with the
sperm head have been shown to alter the ability of spermatozoa to penetrate zona-ffee
hamster eggs (Bronson et al, 1981, 1983; Alexander, 1984; Haas et al, 1985).
Components of the zona pellucida have also been shown to bind preferentially to
different sperm membrane compartments, ZP3 binding to acrosome intact spermatozoa
and ZP2 to acrosome reacted spermatozoa (Mortillo & Wassarman, 1991).
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It is unlikely that antibodies against intracellular antigens (with the possible
exception of acrosomal antigens) will affect the process of fertilization (Haas et al,
1988; Cross & Moore, 1990) and therefore a variety of techniques have been
developed to reveal whether anti-sperm antibodies are directed against surface antigens
and to which region of the sperm surface they bind (Bronson et al, 1986; Smithwick &
Young, 1990). These methods include agglutination (Hargreave & Hjort, 1983),
immunobead binding (Bronson et al, 1981; Clarke et al, 1985; Shulman et al, 1985;
Adeghe et al, 1986; Clarke, 1987), immunofluorescence (Isahakia & Alexander, 1984;
Cross & Moore, 1990) and immunoenzymatic methods (Paul et al, 1982; Cordell et al,
1984; Holcberg etal, 1986). Immunobead assays have poor spatial resolution because
the beads are relatively large in comparison to spermatozoa and much higher resolution
can be achieved using indirect immunofluorescence (Cross & Moore, 1990). However
immunofluorescent staining of surface antigens is often of low intensity (Jones et al,
1983; Cross & Moore, 1990) and therefore an enzymatic method which permits
amplification of the signal was used in these studies (Cordell et al, 1984). This
procedure which is depicted diagrammatically in Figure 6.1, utilizes an unlabelled
'bridge' antibody (rabbit anti-mouse immunoglobulins; RAM) which links the primary
antibody with the labelled antibody complex and an alkaline phosphatase anti-alkaline
phosphatase complex (APAAP). Simple repetition of these two incubation steps
substantially increases the intensity of staining allowing this enhanced APAAP
procedure to reveal antigens at concentrations below the threshold of sensitivity of other
immunohistologic labelling procedures (Cordell et al, 1984).
One prerequisite for a contraceptive vaccine based on sperm surface antigens is
that the molecule should be gamete specific (Shaha et al, 1991; Talwar et al, 1989) in
order that intervention can be made specifically on reproductive processes without









Figure 6.1 A schematic representation of RAM APAAP staining.
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generalized effects on other tissues or functions of the body (Talwar, 1980). Sperm
antigens share many antigens with somatic cells (Freund et al, 1955; Kerek, 1974;
Mathur et al, 1981; Chaffee & Schachner, 1978). In light of this requirement, the
same technique used to identify the regional binding specificity of the antibodies, was
also used to determine the extent of cross-reactivity of the monoclonal antibodies with a
variety of antigens.
Antigenic similarities between mammalian spermatozoa were first described by
von Moxter, 1900
von Moxter as early as 1900^(Isahakia & Alexander, 1984) and although cell specificity
is a prerequisite for a contraceptive vaccine candidate, species specificity is not. Indeed
cross-reactivity with spermatozoa from other species may be advantageous permitting
the use of animal models for further investigation and testing of promising candidate
vaccines in vivo (Anderson & Alexander, 1983). Perhaps the most dramatic
demonstration that common antigenic determinants exist on the surface of all animal
spermatozoa has been obtained in a study in which a polyclonal antiserum raised
against sea urchin sperm plasma membranes was shown to cross-react with
spermatozoa from at least 28 species representing 7 phyla of the animal kingdom (Lopo
& Vacquier, 1980).
6.2 Materials and Methods
6.2.1 RAM APAAP Staining
A schematic diagram of this staining procedure is provided in Figure 6.1. Prepared
spermatozoa were washed and resuspended in PBS at a concentration of 20 x 106/ml.
Aliquots of this sperm suspension (5(0.1) were spotted onto each well of a 12 well
Hendley slide (CA Hendley, Essex, UK) and air dried overnight at room temperature.
The slides were then wrapped individually in aluminium foil and stored in a dessicator
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at -70°C. Immediately prior to use, the slides were defrosted for at least 30 minutes
and subsequently unwrapped. They were fixed in 1% para-formaldehyde in PBS for
30 minutes and then washed twice in TBS (0.05M Tris, 0.15M NaCl, pH7.6). Neat
antibody solution (5|il) was added to each well and the slides were incubated for 1 hour
in a humid chamber at room temperature. The slides were again washed twice in TBS
before I0|il of rabbit anti-mouse immunoglobulins (RAM; Dako, High Wycombe,
Bucks, UK) at a 1/25 dilution in TBS were added to each well and incubated for 30
minutes in a humid box. The slides were washed twice in TBS and then lOp.1 of
alkaline phosphatase/anti-alkaline phosphatase complex (APAAP; Dako) were added to
each well. After incubation for 1 hour, the slides were once again washed twice in
TBS. Two further rounds of RAM APAAP staining (15 minutes each) were performed
before the slides were developed. Alkaline phosphatase substrate (10[il; 0.5mM
napthol AS-MX phosphate, 2% dimethylformamide, 0.1M Tris, pH8.2, 0.01M
Sigma
levamisole, 3.9mM Fast Red TR sal$ was added per well and incubated for 18
minutes. The slides were first washed in TBS then in gently running tap water before
being mounted in Apathy's aqueous mounting medium (BDH, Poole, Dorset, UK).
6.2.2 Boar Spermatozoa
Boar spermatozoa were kindly provided by The Meat and Livestock Commission Pig
Breeding Centre (Selby, North Yorkshire, UK). The spermatozoa were washed three
times in PBS and resuspended at 20 x 106 cells/ml. Slides were prepared and stained
using the enhanced RAM APAAP protocol described in Section 6.2.1.
6.2.3 Marmoset Spermatozoa
Edinburgh
Marmoset spermatozoa were collected by the staff at thej^Primate Colony. After
copulation, spermatozoa were collected from ovariectomized female marmosets by
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vaginal lavage. The spermatozoa were washed twice in BWW and the concentration
adjusted to 20 x 106 cells/ml. Slides were prepared and stained using the enhanced
RAM APAAP protocol described in Section 6.2.1.
6.2.4 Leucocyte Preparation
Leucocytes were prepared from whole blood using Polyprep (Nycomed, Birmingham,
UK). Blood was collected from healthy volunteers who were all regular blood donors
and immediately placed into a 7ml polystyrene tube (Sarstedt, Leicester, UK)
containing heparinized beads (Lithium Heparin Barrier Beads; Sarstedt) to prevent
coagulation. Anticoagulated whole blood (5mls) was layered over 3.5mls of Polyprep
and centrifuged at 500 x g for 30 minutes. After centrifugation, two leucocyte bands
were visible. The top band at the sample/medium interface consisted of mononucleated
cells (lymphocytes) and the lower band of polymorphonucleated cells (neutrophils and
macrophages) while the erythrocytes were pelleted. The two leucocyte bands were
harvested using a Pasteur pipette and washed in BWW medium. The pellet was
resuspended in a known volume of BWW (normally 1ml) and the cells counted. The
percentage of white blood cells (WBC) was determined using Testsimplet slides
(Boehringer Mannheim, Lewes, East Sussex, UK). The number of WBC/ml was
calculated and the cell concentration adjusted to 1 x 106 WBC/ml PBS. Slides were
made and the leucocytes stained using the enhanced RAM APAAP protocol described
in Section 6.2.1.
6.3 Results
The regional binding of the twelve monoclonal antibodies to human spermatozoa was
investigated using enhanced RAM APAAP staining of para-formaldehyde fixed cells.
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Although all twelve monoclonals bound to the entire surface of human spermatozoa,
staining was more intense in certain regions particularly the midpiece and the acrosome.
A representative example of this staining is shown in Figure 6.2. No staining was
observed when no primary antibody was used nor when a monoclonal antibody raised
against leucocyte common antigen (CD45; Scottish Antibody Production Unit,
Carluke, Scotland, UK) was used as the primary antibody however intense red staining
of the whole sperm surface was achieved when polyclonal anti-human sperm plasma
membrane antiserum was employed (Figure 6.2).
A preliminary investigation into the species specificity of the monoclonals was
performed using spermatozoa from the common marmoset (Callithrix jacchus) and
from White Yorkshire pigs. The results are summarized in Table 6.1 and representative
photographs of the staining are shown in Figures 6.3 (marmoset) and 6.4 (boar). Four
monoclonals, namely spm 1/2, spm2/l, spm4/3 and spm 4/4, did not cross-react
with spermatozoa from either species. The other eight antibodies cross-reacted with
both marmoset and boar spermatozoa, each binding to the entire cell surface. Once
again, staining was not evenly distributed over the sperm surface. The acrosomal
region and the midpiece of some marmoset spermatozoa were more intensely stained
(Figure 6.3) and in boar samples, staining of the cytoplasmic droplet and midpiece
were particularly strong (Figure 6.4). As with human spermatozoa, no staining was
achieved using no primary antibody nor with anti-leucocyte common antigen antibody
and the entire sperm surface from both species was stained when polyclonal anti-human
sperm plasma membrane antiserum was used (Figures 6.3 and 6.4).
The ability of the antibodies to recognize somatic cells was assessed using cells
isolated from human blood by density centrifugation. The results are shown in
Table 6.2 and representative examples of this staining are provided in Figure 6.5.
Four monoclonals (spm 1/2, spm 2/1, spm 4/3 and spm 4/4) did not recognize any
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Figure 6.2 Representative RAM APAAP staining of human sperm cells— (A)
polyclonal anti-human sperm plasma membrane antiserum, (B) no first antibody, (C)
monoclonal antibody spm 4/3, (D) monoclonal antibody spm 4/6.
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Antibody Human Marmoset Boar
spm 1/1 + + +
spm 1/2 + - _
spm 2/1 + _ _
spm 2/2 + + +
spm 4/1 + + +
spm 4/2 + + +
spm 4/3 + -
spm 4/4 + _ _
spm 4/5 + + +
spm 4/6 + + +
spm 4/7 + + +
spm 4/8 + + +
Table 6.1 Summary of the results of cross reactivity tests assessed by
immunostaining of spermatozoa from different species. Positive staining is indicated,
+ and no staining,
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Figure 6.3 Representative RAM APAAP staining of marmoset spermatozoa—
(A) polyclonal anti-human sperm plasma membrane antiserum, (B) anti-leucocyte
common antigen monoclonal antibody, (C) monoclonal antibody spm 1/1, (D)
monoclonal antibody spm 1/2.





Figure 6.4 Representative RAM APAAP staining of boar spermatozoa— (A)
polyclonal anti-human sperm plasma membrane antiserum, (B) anti-leucocyte common
antigen monoclonal antibody, (C) monoclonal antibody spm 4/5, (D) monoclonal
antibody spm 4/3.
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Antibody Lymphocytes Neutrophils &
Macrophages
spm 1/1 + +
spm 1/2 _ -
spm 2/1 - -
spm 2/2 + +
spm 4/1 + +
spm 4/2 + +
spm 4/3 _ _
spm 4/4 _
spm 4/5 + +
spm 4/6 + +
spm 4/7 + +
spm 4/8 + +
Table 6.2 Results of cross-reactivity tests assessed by immunostaining of different
cells found in human blood. Positive staining is indicated, + and no staining,
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Figure 6.5 Representative RAM APAAP staining of cells isolated from human
blood by density centrifugation. Panels A-D show mononucleated cells (lymphocytes)
and panels E-H show polynucleated cells (neutrophils and macrophages)— (A) and
(E) positive staining of leucocytes with anti-leucocyte common antigen monoclonal
antibody, (B) and (F) background staining using no primary antibody, (C) monoclonal
antibody spm 4/6, (D) monoclonal antibody spm 4/4, (G) monoclonal antibody
spm 2/2, (H) monoclonal antibody spm 4/3.
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of the other cells whereas the other eight immunoglobulins cross-reacted with
lymphocytes, neutophils and macrophages. No staining was seen when no primary
antibody was used (figure 6.5) nor when control antibody (anti-growth hormone) was
used (data not shown).
6.4 Discussion
It is remarkable that the distribution of 'surface' molecules often corresponds closely to
well-defined intracellular structures such as the acrosome, equitorial segment,
post-acrosomal region, midpiece and tail. Some researchers have suggested that the
surface localization of some restricted antigens may be an artifact and that these
molecules are in fact intracellular (Hjort & Hansen, 1971; Jones et al, 1983).
Contradictory results from different assays are sometimes obtained (Boettcher et al,
1977; Hancock & Faruki, 1985; Bronson et al, 1986) but these can be attributed to
variations in the sensitivity and specificity of the method used (Smithwick & Young,
1990). Results may be markedly affected by a change in method as this often alters or
destroys sperm surface antigens (Villarroya & Scholler, 1986; Saxena et al, 1986). It
is therefore important to maintain both the morphologic and antigenic integrity of cells
in order to accurately identify the antibody binding region (Haas et al, 1988) and the
importance of standardizing the conditions of fixation and staining used in
immunocytochemical analysis has been stressed by several investigators (Hancock et
al, 1982; van Ewijk et al, 1984; Walker et al, 1984; Haas et al, 1988). Methanol
fixation permeabilizes the cells thus exposing internal antigens (Hjort & Hansen, 1971;
Haas et al, 1988). However fixation in gluteraldehyde or para-formaldehyde is much
less harsh and neither reagent appears to alter the sperm plasma membrane
morphologically, although they slightly increase the level of non-specific binding of
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immunoglobulin (Haas et al, 1988). Thus the cells used for immunocytochemical
analysis were all fixed in para-formaldehyde.
All twelve monoclonal antibodies bound to the entire human sperm plasma
membrane thus indicating that common membrane components exist throughout the
plasmalemma. However, the intensity of staining did vary over different regions of the
sperm surface and was particularly strong over the midpiece and acrosome. This
uneven distribution of staining was not peculiar to the monoclonal antibodies, as it was
also seen when polyclonal antiserum was used and may reflect the varying depth of the
sperm cell in different regions.
Antigens recognized by other antibodies have similarly been shown to be
located over the entire cell surface (Jones et al, 1983; Moore & Hartman, 1984). The
production of such a high proportion of monoclonal antibodies not localized to a
specific domain may be partly due to the immunogen used for antibody production,
which was a purified sperm plasma membrane preparation (Aitken et al, 1987a).
During the membrane preparation production process, two sorts of membrane vesicle
are made— (1) those that are electron dense and are composed of outer acrosomal
membrane and (2) those which are distended or collapsed consisting of plasma
membrane. After sucrose density centrifugation, the membrane preparation is solely
composed of the latter type of vesicle (Aitken et al, 1987a). Boar sperm plasma
membrane preparations isolated by a similar technique have also been shown to be of a
high purity (Gillis et al, 1978; Peterson et al, 1980a) and apparently free of acrosomal
membranes (Peterson et al, 1980a). Thus as no acrosomal membranes are present in
the immunogen, the monoclonal antibodies produced from this fusion would not be
expected to localize specifically to the acrosome. An ELISA was the primary screening
assay used to monitor the production of antibodies directed against spermatozoa by the
hybridomas and this may also be a contributory factor in the high incidence of
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monoclonal antibodies not localized to a specific domain. It has been previously shown
that radioligand or enzyme-linked binding assays tend to select antibodies directed
towards antigens distributed on the sperm tail or over the entire cell as this type of
localization generally produces the largest signal (Moore & Hartman, 1984; Saling et
al, 1985).
Even though post-testicular spermatozoa have little or no ability to synthesize
plasma membrane lipids or proteins (Lardy & Phillips, 1941; Scott et al, 1967; Bragg
& Handel, 1979), the lipid and protein composition of the sperm plasma membrane
changes drammatically during maturation and capacitation (Cardullo & Wolf, 1990;
Fusi & Bronson, 1990; Berger, 1990). Fusi & Bronson (1990) demonstrated that
different antibody binding patterns could be obtained using the same sera and
spermatozoa from the same donor but in different functional states (capacitated versus
uncapacitated). Using monoclonal antibodies, Myles & Primakoff (1984) showed that
guinea pig sperm surface antigens were redistributed during capacitation as did Saxena
et al (1986) for boar spermatozoa and Okabe et al (1986a&b) for mouse spermatozoa.
O'Rand (1977) demonstrated that some rabbit sperm surface antigens maintained a
certain fluidity over the sperm surface prior to exposure to capacitating conditions but
following capacitation their domain became restricted. Similar changes were shown to
occur in human spermatozoa during capacitation by Margalioth et al (1992). Thus the
ability of some monoclonal antibodies to bind to spermatozoa or the regionality of this
binding, alters with the functional state of the spermatozoon (Anderson & Alexander,
1983). The effect of capacitation state on the binding of the monoclonal antibodies
reported here was not investigated.
Eight of the antibodies cross-reacted with spermatozoa from the other two
species tested (marmoset and boar). As was found with human spermatozoa, although
the intensity of staining varied over different regions, all eight antibodies recognized
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molecules which were present over the entire cell surface. The conservation of
regionally of binding between species has been previously noted. Isahakia (1991)
reported a monoclonal raised against baboon spermatozoa which localized to the
acrosome, BSA 4. This antibody cross-reacted with human, rat and mouse
spermatozoa where it was also restricted to the acrosomal domain. Monoclonals,
however, recognize only a small region of a particular molecule and it is therefore
possible that other parts of the molecule may differ between species. Thus the structure
and function of the antigens recognized in different species by cross-reacting antibodies
may also differ (Isahakia & Alexander, 1984) and cross-reacting monoclonals which
have an effect on sperm function in one species will not necessarily have the same
effect on the function of spermatozoa from other species (Anderson & Alexander,
1983).
It is interesting to note that the same four monoclonal antibodies which did not
cross-react with either boar or marmoset spermatozoa, also did not cross-react with
leucocytes suggesting that these four monoclonals recognized molecules on human
spermatozoa which are both species- and gamete cell-specific. Although the antibodies
did not recognize any molecules on the surface of leucocytes, it does not necessarily
follow that the epitopes recognized will not be present on other cells in the body.
Similarly the antigens may be present on spermatozoa from other species which were
not tested. Testing the monoclonal antibodies against a more comprehensive panel of
cells and spermatozoa from other species would resolve this question.
6.5 Summary
All twelve monoclonal antibodies displayed no regionality of antigen localization when
assessed by enhanced RAM APAAP staining of para-formaldehyde fixed cells.
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Although they bound to the entire surface of human spermatozoa, the intensity of
staining over different regions did vary and was particularly strong over the midpiece
and acrosome. The species specificity of the monoclonals was assessed using
spermatozoa from marmoset and boar. Eight immunoglobulins (spm 1/1, spm 2/2,
spm4/l, spm 4/2, spm 4/5, spm 4/6, spm 4/7 and spm 4/8) cross-reacted with
spermatozoa from both species and the other four did not bind to spermatozoa from
either species. Cross-reactivity with somatic cells was assessed using cells isolated
from human blood by density centrifugation. Eight antibodies cross-reacted with
lymphocytes, neutrophils and macrophages whereas the other four monoclonals
(spm 1/2, spm 2/1, spm 4/3 and spm 4/4) did not elicit staining of any of the other
cells tested. These four monoclonals (spm 1/2, spm 2/1, spm 4/3 and spm 4/4) did
not recognize spermatozoa from either marmoset or boar nor did they cross-react with
leucocytes. The antigens recognized by these four antibodies may therefore be highly
specific to human spermatozoa.
7 Effect of Monoclonal Antibodies on
in vitro Tests of Sperm Function
7.1 Introduction
The prevention of gamete interaction and thus fertilization by anti-sperm antibodies can
occur directly by blocking the sperm-egg receptors, or indirectly by preventing
spermatozoa from reaching the site of fertilization by impeding sperm transport
mechanisms (Aitken, 1982; Bronson et al, 1984). The research reported here is
concerned with the former type of mechanism namely those antibodies which directly
interfere with fertilization and thus the latter type will not be considered further.
The process of fertilization is complex and involves many steps. On
copulation, spermatozoa are ejaculated into the vagina of the female and they must
undergo a long journey through the female reproductive tract to reach the ampulla of the
fallopian tube which is the site of fertilization. A series of biochemical and
morphological changes collectively known as 'capacitation' (Austin, 1952) occur in
spermatozoa during this journey. This process is known to involve alterations to the
sperm plasma membrane and the exhibition of hyperactivated motility (Alexander,
1989; Sidhu & Guraya, 1989). On reaching the site of fertilization, spermatozoa
traverse through the cumulus cells surrounding the egg and bind to the zona pellucida
where interaction with one of the zona proteins, ZP3, causes the spermatozoon to
acrosome react (Leyton & Sating, 1989). The acrosome reaction (AR) involves a series
of fusions of between the plasma and outer acrosomal membranes culminating in the
release of hydrolytic enzymes contained within the acrosome (Alexander, 1989).
Bound acrosome-reacted spermatozoa can penetrate the zona pellucida to reach the
perivitelline space where they bind to and fuse with the egg plasma membrane
(Wassarman, 1988a). Anti-sperm antibodies can block fertilization at any one of these
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points and thus there is not one single test which can measure all aspects of sperm
function and a variety of tests have been developed (Bronson et al, 1981; Katz et al,
1989a; Aitken, 1990).
7.1.1 Acrosome Reaction
The acrosome reaction does not result in any morphological changes in human
spermatozoa which are visible under the light microscope and thus tests which involve
the use of a stain to specifically label the acrosomal contents or outer acrosomal
membrane have been developed (Cross & Meizel, 1989; Aitken, 1990). Labels
conjugated to either monoclonal antibodies (Wolf et al, 1985; Aitken, 1988a) or plant
lectins (Talbot & Chacon, 1980; Mortimer et al, 1987) have been used successfully.
One of the major problems with these stains is their inability to distinguish between a
true physiological acrosome reaction and degenerative acrosomal loss (Aitken, 1989a;
Tesarik & Testart, 1989). This problem can be overcome by combining the stain
monitoring the acrosome with a vital stain to indicate the viability of the spermatozoa
such as the supravital stain Hoechst 33258. This is a fluorescent DNA-binding dye that
has limited membrane permeability and thus stains only non-viable cells (Cross et al,
1986; Mortimer et al, 1990; Holden et al, 1990). Alternatively the hypo-osmotic
swelling test (HOS) may be used. This method identifies living cells that have an intact
plasma membrane by virtue of the coiled configuration of the sperm tail which occurs
when the spermatozoa are forced to swell by immersion in a hypo-osmotic medium
(Drevius & Eriksson, 1966; Jeyendran et al, 1984; Schrader et al, 1986). A second
problem with these tests is the low level of acrosome reactions (AR) which occur
spontaneously (Mallet et al, 1985; Morales et al, 1988). Ideally AR tests should
determine the ability of capacitated spermatozoa to undergo the AR in response to its
physiological stimulus, the zona pellucida. However this is seldom possible and an
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alternative stimulus such as the divalent cation ionophore, A23187 (Wolf et al, 1985) is
used. A23187 induces an influx of exogenous calcium (Irvine & Aitken, 1986b) and a
progressive increase in intracellular pH which consequently induce a sequence of
membrane changes leading to the AR (Aitken et al, 1984). Thus the addition of
A23187 replaces the stimulus normally delivered by the zona pellucida and induces the
AR in all competent cells (Aitken et al, 1984; Tesarik & Testart, 1989).
7.1.2 Sperm-Zona Pellucida Interaction
Some sperm samples can show a normal capacity to acrosome react but their poor
motility renders the spermatozoa incapable of penetrating the zona pellucida (Tesarik &
Testart, 1989). This is the main source of the inconsistencies which exist between the
results of in vitro tests of the AR and the actual fertilizing ability of spermatozoa in
vivo. Tests have therefore been developed to evaluate the ability of human spermatozoa
to penetrate the human zona pellucida in vitro. The only technique available to study
this interaction utilizes intact or salt-stored human ova (Aitken, 1989a). The first
penetration test reported used non-living immature oocytes recovered from the ovaries
of cadavers 8-45 hours post mortem (Overstreet & Hembree, 1976) but nowadays ova
that have failed to fertilize in an IVF programme are used. They are fixed in a high salt
solution which destroys the oocyte but leaves the zona pellucida intact (Yanagimachi et
al, 1979). Once the salt-stored zonae are washed free of salt, they readily interact with
human spermatozoa and permit assessment of the capacity of the spermatozoon to bind
to and penetrate the zona pellucida (Aitken, 1989a; Tesarik & Testart, 1989). As the
oocyte is destroyed during the fixation process, many complex legal and ethical
problems are avoided. A second consequence of destroying the oocyte is that the block
to polyspermy is not produced and many spermatozoa can penetrate each zona (Tesarik
& Testart, 1989). As the ova are obtained from IVF programmes, it is possible that
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they have already been bound by spermatozoa and thus several ova must be run
with each sample tested and the appropriate controls performed (Aitken, 1989a).
Alternatively the spermatozoa being tested can be labelled (Liu et al, 1991). Recendy
the hemizona assay has been developed which involves the microsurgical bisection of
human zonae to produce matched halves which can be used for comparison of treated
and control spermatozoa (Burkman et al, 1988; Hodgen et al, 1988; Oehninger et al,
1990). The use of viable living oocytes would give a more accurate picture of the
fertilizing capacity of the spermatozoa tested although there are many ethical and
practical reasons why this is not routinely performed.
7.1.3 Sperm-Oocyte Fusion
Concomitant with the acrosome reaction, a specialized area of plasma membrane
overlying the equatorial segment acquires the ability to fuse with the vitelline membrane
of the oocyte and it is this area which initiates sperm-egg fusion (Bedford et al, 1979;
Yanagimachi et al, 1988a). Ideally this fusion process should be assessed using a
homologous IVF system with mature human ova however this has both ethical and
logistical problems (Aitken, 1989a). The alternative approach is a heterologous IVF
system employing cross-species fertilization of zona-free hamster oocytes, the hamster
egg penetration test (HEPT; Yanagimachi et al, 1976). Hamster ova are unique in that
the block to interspecies fertilization resides entirely in the zona pellucida and thus when
the zona is enzymatically removed, the naked oocyte will fuse with acrosome-reacted
spermatozoa from a wide variety of species (Yanagimachi et al, 1976; Aitken, 1989a).
Human spermatozoa are no exception and once the acrosome reaction is complete they
can fuse with the hamster vitelline membrane in a similar manner to the homologous
system where fusion is initiated by the plasma membrane overlying the equatorial
segment (Koehler et al, 1982). The HEPT therefore provides a measure of the ability
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of the human sperm plasma membrane to undergo the sequence of membrane
associated changes involved in capacitation, the completion of the acrosome reaction
and the genesis of a fusogenic equatorial segment which is capable of interacting with
the vitelline membrane of the oocyte (Aitken, 1989a) and thus gives an indication of the
fertilizing ability of spermatozoa. Although not every aspect of sperm biology involved
in the fertilization of human ova is measured, HEPT results generally reflect those
obtained using the homologous IYF system particularly when the ionophore A23187 is
used to induce the AR (Gould et al, 1983; Aitken ex al, 1984).
7.2 Materials and Methods
7.2.1 Agglutination
Percoll Section 3.2.1)
Spermatozoa from the 100%jfraction (at a concentration of 20 x 106/ml;),were mixed
with an equal volume (usually lOOpl) of the antibody solution to be tested in the wells
of a microtitre plate. The plate was covered and incubated for 20 minutes at 37°C and
then examined for agglutination.
7.2.2 Acrosome Reaction
The effect of the antibodies on the acrosome reaction (AR) was studied using
fluorescently labelled peanut agglutinin. Spermatozoa isolated from isotonic Percoll (at
a concentration of 20 x 106/ml) were diluted with an equal volume of antibody
solution. For each antibody tested, a second tube was prepared which also contained
the ionophore A23187 (free acid; Calbiochem, Nottingham, UK) at a final
concentration of 1.25|lM. After a 3 hour incubation at 37°C with 5% CO2, a small
aliquot (10|il) was removed and used to determine the motility of the spermatozoa. The
rest of the sample was centrifuged at 500 x g for 5 minutes and the pellet resuspended
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at a concentration of 20 x 106 spermatozoa/ml in medium BWW. Hypo-osmotic
swelling medium (HOS; 25mM sodium citrate, 75mM fructose) was added and the
sample incubated for a further hour at 37°C in 5% CO2. The solution was centrifuged
at 500 x g for 5 minutes and the sperm pellet resuspended in ice cold methanol at a
concentration of 20 x 106/ml. The spermatozoa were applied to each spot of a 4-well
Hendley slide (CA Hendley, Essex, UK) and air dried at 37°C. Each spot was
overlaid with 2mg lectin-fluorescein isothiocyanate/ml PBS (from Arachis hypogaea
[peanut]; Sigma, Poole, Dorset, UK) and incubated at 4°C for 15 minutes. The excess
lectin was washed off using PBS and the slides mounted in Citifluor (Citifluor Ltd,
London, UK). The slides were examined using a fluorescent microscope. Scoring
criteria were as follows. The spermatozoon was classified as acrosome reacted if only
the equatorial segment was fluorescent or no fluorescence was visible on the sperm
head. However if the equatorial segment was fluorescent and the acrosomal region had
either patchy or complete fluorescence, the spermatozoon was classified as not
acrosome reacted. Only spermatozoa with curly tails were classified (those which were
alive and therefore represented 'true' acrosome reactions). At least 200 spermatozoa
were counted and categorized for each treatment
7.2.3 Zona Binding Assay
The effect of the antibody solutions on the interaction between spermatozoa and the
zona pellucida was assessed using salt-stored human eggs (Yanagimachi et al, 1979).
The assistance of Professor John Aitken and Ms Donna Buckingham in performing this
assay is gratefully acknowledged.
Percoll Section 3.2.1)
Sperm Preparation Prepared 100%|fraction spermatozoa (at 20 x 106/ml;Jwere
diluted by adding an equal volume of antibody solution or control and incubated at
37°C with 5% CO2 for 1-2 hours. They were then washed by centrifugation at
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500 x g for 5 minutes and resuspended in BWW at a concentration of 10 x 106/ml
before being placed as discrete drops under liquid paraffin at 37°C in small petri dishes.
Oocyte Preparation Unfertilized human oocytes from in yitro fertilization (IVF)
cycles were obtained from the IVF programme at Kings College Hospital, London; the
Department of Obstetrics and Gynaecology, University of Cambridge and the Bourn
Hall Clinic, Bourn, Cambridge. They were stored in 1.5M MgCU in 0.1% dextran.
Salt stored human ova were isolated and washed thoroughly in BWW medium to
ensure that contamination with spermatozoa from the IVF procedures was minimal.
Three or four ova were added to each drop of antibody/spermatozoa mixture and
incubated at 37°C for 2-3 hours. The eggs were washed thoroughly in BWW to
remove any spermatozoa not bound to the zona pellucida before being fixed and stained
in 0.2mg/ml H33258,0.5% gluteraldehyde for 15 minutes. After washing the oocytes
in BWW, they were mounted on a slide under a coverslip supported at the corners by a
(1:10:0.5)
mixture of paraffin, vaseline and beeswax,j^and examined under ultraviolet light. The
number of spermatozoa bound to the zona pellucida were counted using a
Hamilton-Thorn Motility Analyzer (Hamilton-Thorn Research, Danvers, MA, USA).
7.2.4 Hamster Egg Penetration Test
The effect of the antibody solutions on the interaction between spermatozoa and the
oolemma was assessed using the hamster egg penetration test (HEPT; Yanagimachi et
al, 1976). The assistance of Professor John Aitken and Ms Donna Buckingham in
performing this test is gratefully acknowledged.
Percoll (Section 3.2.1)
Sperm Preparation Spermatozoa from the 100%jfractionjwere used and for each
antibody solution or control, two tubes were prepared. Both contained a 1:1 dilution of
spermatozoa and antibody but only one contained the ionophore A23187 (free acid;
Calbiochem) at a final concentration of 1.25pM. The tubes were incubated at 37°C
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with 5% CO2 for 3 hours. A small aliquot was removed and used to assess the state of
the acrosome reaction (Section 7.2.2) and the motility of the sperm population. The
remaining spermatozoa were washed by centrifugation at 500 x g for 5 minutes and
resuspended in BWW at a concentration of 10 x 106/ml. The sperm suspension was
placed in discrete 50(0.1 droplets under liquid paraffin ready for the addition of zona free
hamster oocytes.
Egg Preparation Zona free hamster oocytes were prepared using conventional
procedures as described by Yanagimachi et al (1976) and Aitken et al (1982a). Female
Syrian hamsters (Mesocricetus auratus) were injected in the morning of day one of the
oestrous cycle with 80 International Units (IU) pregnant mare's serum (PMS;
Folligon; Intervet Laboratories, Cambridge, UK), in the evening of day three (56 hours
later) with 80IU of human chorionic gonadotrophs (hCG; Gonoadotrophon LH;
Paines and Byrne Ltd, Greenford, UK) and the eggs recovered the following day in the
early afternoon. The hamsters were sacrificed, the fallopian tubes were dissected out
and the cumulus mass containing ova was freed into BWW. Cumulus cells were
removed by incubation in hyaluronidase (0.1% in BWW) for 5 minutes. The eggs
were washed three times in BWW and then transferred to trypsin (0.1% in BWW) for
1-2 minutes to remove the zona pellucida. The oocytes were washed three times in
BWW to ensure efficient removal of the granulosa cells, then placed in the droplets of
spermatozoa under liquid paraffin. The dishes containing the zona free hamster eggs
and the human spermatozoa were incubated at 37°C in 5% CO2 for 3 hours. The eggs
were washed free of any loosely attached spermatozoa and then compressed gently on
slides to a depth of about 30(im under 22 x 22mm coverslips supported at the corners
by a paraffin, vaseline and beeswax mixture. The slides were examined by phase
contrast microscopy for the presence of any decondensed sperm heads with adjacent or
closely associated sperm tails. The percentage of eggs which had spermatozoa within
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their cytoplasm and the mean number of incorporated spermatozoa per oocyte were
calculated.
7.2.5 Data Analysis
The percentage of cells acrosome reacted in each treated population as compared to the
control was analysed using the chi-square test (Lewis & Burke, 1949; Cochran, 1952,
1954). The percentage of eggs penetrated in the HEPT was also analysed using the
chi-square test whereas the actual number of spermatozoa penetrating each egg was
analysed using the Mann-Whitney U test (Mann & Whitney, 1947). The number of
spermatozoa bound per mm2 of zona pellucida was also analysed using the
Mann-Whitney U test The significance level was set at p < 0.05 (Siegel, 1956).
7.3 Results
7.3.1 Agglutination
The ability of the purified monoclonal antibody solutions to cause sperm samples to
agglutinate was assessed and the results are presented in Table 7.1. All twelve
antibodies caused some degree of mixed agglutination causing spermatozoa to clump
together via their heads and tails. Five antibodies in particular (spm 4/2, spm 4/4,
spm 4/6, spm 4/7 and spm 4/8) were strong agglutinators.
7.3.2 Acrosome Reaction
The effect of the monoclonal antibodies on the acrosome reaction was tested on three
separate occasions in a blind manner and the results from all three experiments pooled
before data analysis was performed. The results of the tests performed without
ionophore are shown in Figure 7.1a and those performed in the presence of ionophore














Table 7.1 Summary of effect of monoclonal antibodies on the agglutination of
spermatozoa. Different degrees of agglutination are indicated (+), weak agglutination;
+, agglutination; ++, strong agglutination.






































1/1 1/2 2/1 2/2 4/1 4/2 4/3 4/4 4/5 4/6 4/7 4/8
Antibody
C 1/1 1/2 2/1 2/2 4/1 4/2 4/3 4/4 4/5 4/6 4/7 4/8
Antibody
Figure 7.1 Effect of monoclonal antibodies on the percentage of acrosome reacted
spermatozoa in a population (± standard error). The test was performed in the absence
(a) or presence (b) of the ionophore A23187. Significance levels were determined by
chi-square analysis — *, p < 0.05; **, p < 0.01; ***, p < 0.001.
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are shown in Figure 7.1b. Two of the antibodies, namely spm 1/1 and spm 1/2,
caused significant decreases in the number of acrosome-reacted spermatozoa both in the
absence and presence of A23187. Four further antibodies caused significant decreases
in the number of spermatozoa acrosome reacted only in the absence (spm 2/2 and
spm 4/3) or presence (spm 2/1 and spm 4/5) of ionophore.
7.3.3 Zona Binding Assay
The influence of the monoclonal antibodies on the interaction between spermatozoa and
the zona pellucida was assessed using salt-stored human oocytes. The results are
detailed in Table 7.2 and depicted graphically in Figure 7.2. Two of the antibodies,
spm 1/2 and spm 4/6, caused significant decreases in the mean number of spermatozoa
binding per mm2 of zona resulting in binding of only 35-40% of the number of
spermatozoa bound to control zonae. The other ten antibodies had no effect on the
sperm-zona interaction.
7.3.4 Hamster Egg Penetration Test
The effect of the different monoclonal antibodies on the sperm-oocyte interaction was
assessed using the hamster egg penetration test (HEPT) and the results are summarized
in Tables 7.3 (percentage of eggs penetrated) and 7.4 (mean number of spermatozoa
penetrating each egg). The tests were carried out in the presence and absence of the
ionophore A23187 in order to provide conditions under which both inhibitory and
stimulatory antibodies could be identified.
Antibody spm 4/4 caused a marked decrease in the number of spermatozoa
penetrating each egg in the presence of A23187 but a corresponding decrease in the
penetration rate was not seen. This is indicative of the fact that only one spermatozoon
is required to penetrate each egg for a maximal penetration rate of 100% to be achieved.
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Antibody Control Treated
spm 1/1 29.7+3.4 (10) 23.2±5.8 (7)
spm 1/2 26.8±3.9 (11) 10.9±3.7 (8)a
spm 2/1 29.7±3.4 (10) 28.9+1.3 (8)
spm 2/2 29.7±3.4 (10) 28.7±3.2 (9)
spm 4/1 29.7±3.4 (10) 31.4±1.8 (9)
spm 4/2 29.7±3.4 (10) 28.5±2.5 (8)
spm 4/3 11.6±5.4 (8) 19.4±3.2 (8)
spm 4/4 11.6±5.4 (8) 13.1±5.1 (7)
spm 4/5 11.6±5.4 (8) 16.6+5.7 (9)
spm 4/6 26.8±3.9 (11) 9.4+3.4 (7)a
spm 4/7 11.6+5.4 (8) 8.6+3.9 (8)
spm 4/8 11.6±5.4 (8) 8.9±3.1 (8)
Table 7.2 Pooled results of the effect of monoclonal antibodies on the interaction
between spermatozoa and the zona pellucida. Values are expressed as the mean number
of spermatozoa bound x 103 per mm2 of zona ± standard deviation and the number of
zonae tested is shown in brackets. Significance levels were determined using the
Mann-Whitney U test and indicated a, p < 0.001.
The area of the zona pelludica shown on the screen of the Hamilton Thorn Motility
Analyser (HTMA) was estimated using the formula for the area of a circle, 7tr2. The
microscope diaphragm was reduced to produce a circle which had a diameter of
80mm on the HTMA screen. Using a micrometer, it was found that lOOjim on the
microscope stage corresponded to 65mm on the screen of the HTMA. Thus the zona
pellucida viewed down the microscope corresponded to a circle of diameter 80 x
0.1/65 = 0.12mm with an area of 0.011mm2. The number of spermatozoa counted by
the HTMA was therefore equivalent to the number bound per 0.011mm2 of zona
pellucida. The results were expressed as the number of spermatozoa bound x 103 per
mm2 of zona pellucida.
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Figure 7.2 Pooled results of the effect of monoclonal antibodies on the mean
number of spermatozoa bound to the zona pellucida. Values are expressed as a
percentage of the control value (± standard deviation). Significance levels were
determined using the Mann-Whitney U test and indicated ***, p < 0.001.
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- A23187 + A23187
Control Treated Control Treated
spm 1/1 17.9% (28) 69.2% (13)b 100.0% (8) 100.0% (8)
spm 1/2 20.7% (116) 30.4% (69) 100.0% (63) 41.0% (83)c
spm 2/1 0.0% (26) 5.6% (18) 100.0% (6) 100.0% (6)
spm 2/2 0.0% (26) 13.3% (15) 100.0% (6) 100.0% (6)
spm 4/1 0.0% (26) 0.0% (22) 100.0% (6) 100.0% (6)
spm 4/2 42.1% (19) 38.9% (18) 100.0% (6) 100.0% (6)
spm 4/3 42.1% (19) 35.0% (20) 100.0% (6) 100.0% (6)
spm 4/4 0.0% (24) 7.1% (14) 100.0% (6) 100.0% (6)
spm 4/5 0.0% (24) 4.8% (21) 100.0% (6) 100.0% (4)
spm 4/6 9.8% (82) 17.6% (51) 100.0% (59) 36.1% (72)c
spm 4/7 14.0% (50) 33.3% (51)a 100.0% (35) 100.0% (32)
spm 4/8 14.0% (50) 34.4% (32) 100.0% (35) 91.2% (34)
Table 73 Pooled data for the percentage of eggs penetrated in HEPT. The number
of eggs analysed for each antibody is shown in brackets. Significance levels were
determined by chi-square analysis — a, p < 0.05; b, p < 0.01; c, p < 0.001.
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- A23187 + A23187
Control Treated Control Treated
spm
1/1 0.21±0.50 (28) 1.31±1.44 (13)a 12.5012.56 (8) 9.5011.31 (8)b
spm
1/2 0.47±1.29 (116) 0.9911.98 (69) 19.3217.49 (63) 5.7319.73 (83)c
spm
2/1 0.00+0.00 (26) 0.0610.24 (18) 16.6713.44 (6) 19.1714.31 (6)
spm
2/2 0.00+0.00 (26) 0.1310.35 (15) 16.6713.44 (6) 16.5011.87 (6)
spm
4/1 O.OOiO.OO (26) O.OOiO.OO (22) 16.67+3.44 (6) 14.3312.88 (6)
spm
4/2 0.53±0.70 (19) 0.3910.50 (18) 23.5015.21 (6) 21.3312.16 (6)
spm
4/3 0.53±0.70 (19) 0.4010.60 (20) 23.5015.21 (6) 23.3316.98 (6)
spm
4/4 0.00±0.00 (24) 0.0710.27 (14) 15.5011.38 (6) 9.5012.88 (6)b
spm
4/5 0.00+0.00 (24) 0.0510.22 (21) 15.5011.38 (6) 16.0014.55 (4)
spm
4/6 0.12±0.40 (82) 0.4511.53 (51) 15.2719.94 (59) 0.9611.57 (72)c
spm
4/7 0.18±0.48 (50) 0.4110.64 (51)a 15.00111.70 (35) 21.31112.91 (32)b
spm
4/8 0.18±0.48 (50) 0.4110.62 (32) 15.00111.70 (35) 8.9415.95 (34)
Table 7.4 Pooled data for the mean number (± standard deviation) of spermatozoa
penetrating per egg in HEPT. The number of eggs used to test each antibody is shown
in brackets. Levels of significance were tested using the Mann-Whitney U Test and
indicated a, p < 0.05; b, p < 0.01; c, p < 0.001.
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Antibody spm 4/7 had a stimulatory effect on the percentage of eggs penetrated and the
mean number of spermatozoa/egg when the test was performed without A23187 and
the increase in the number of spermatozoa/egg was also seen when A23187 was
present. No increase in the penetration rate was seen in the presence of ionophore as
the control rate was already 100%. Interestingly one antibody, spm 1/1, showed a
stimulatory effect on both penetration and the number of spermatozoa/egg in the
absence of A23187 but an inhibitory effect in the presence of A23187. Two of the
antibodies, spm 1/2 and spm 4/6, caused highly significant decreases in both the
penetration rate and mean number of spermatozoa/egg when the test was performed in
the presence of A23187. The ability of these two antibodies to block the sperm-oocyte
interaction as assessed by HEPT with A23187, was investigated at decreasing sperm
concentrations of 10 x 106/ml, 5 x 106/ml and 1 x 106/ml. The results of these
experiments, expressed as the percentage of eggs penetrated and the mean number of
spermatozoa penetrating each egg respectively, are shown in Table 7.5 and Figure 7.3
for spermatozoa treated with spm 1/2 and in Table 7.6 and Figure 7.4 for spm 4/6
treated spermatozoa. Both antibodies caused significant decreases in the number of
spermatozoa penetrating each egg and concomitant dose-dependent decreases in the
penetration rate. The other seven antibodies, namely spm 2/1, spm 2/2, spm 4/1,
spm 4/2, spm 4/3, spm 4/5 and spm 4/8, exhibited no effect on the HEPT.
A summary of the effects of the monoclonal antibodies on the biological assays
is provided in Table 7.8.
7.4 Discussion
The importance of the acrosome for several steps in the fertilization process is
highlighted by the occurrence of infertile men whose spermatozoa have no acrosome, a
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Sperm Concentration Control Treated
10 x 106 100% (33) 36.4% (45)a
5x 106 100% (27) 11.4% (44)a
lx 106 100% (25) 0.0% (41)3
Table 7.5 Pooled data for the percentage of eggs penetrated in HEPT at various
sperm concentrations for control and spm 1/2 treated spermatozoa performed in the
presence ofA23187. The number of eggs analysed is shown in brackets. Significance





















Sperm Concentration (x 106)
Figure 7.3 Pooled data for the mean number of spermatozoa penetrating each egg
in HEPT performed with ionophore at various sperm concentrations in the presence or
absence of monoclonal antibody spm 1/2. Significance levels were determined using
the Mann-Whitney U test and are indicated ***, p < 0.001. Control spermatozoa are
shown, 11 and spm 1/2 treated spermatozoa, D . The number of eggs analysed is
shown in brackets.
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Sperm Concentration Control Treated
10 x 106 100% (24) 21.2% (33)a
5x 106 100% (25) 0.0% (28)a
lx 106 100% (24) 0.0% (26)a
Table 7.6 Pooled data for the percentage of eggs penetrated in HEPT at various
sperm concentrations for control and spm 4/6 treated spermatozoa both carried out in
the presence of A23187. The number of eggs analysed is shown in brackets.






































Sperm Concentration (x 106)
Figure 7.4 Pooled data for the mean number of spermatozoa penetrating each egg
in HEPT performed with ionophore at various sperm concentrations in the presence or
absence of monoclonal antibody spm 4/6. Significance levels were determined using
the Mann-Whitney U test and are indicated ***, p < 0.001. Control spermatozoa are
shown, □ and spm 4/6 treated spermatozoa, EH . The number of eggs analysed is
shown in brackets.
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pen sp/egg pen sp/egg
spm 1/1 ♦ II II lit . ft
spm 1/2 ♦ Hi
spm 2/1 II .
spm 2/2 . . . . _
spm 4/1 . _ _ . _ _ _
spm 4/2 . . _ . _ _
spm 4/3 . . . . _
spm 4/4 . . . . . . ft
spm 4/5 . . . til .
spm 4/6 . . . w w iff
spm 4/7 . ♦ ♦ .
spm 4/8 _ _ _ _ _
Table 7.7 Summary of results of biological assays. An increase is denoted by T ,
a decrease by ^ and no significant change from control values by One arrow
indicates a significant result of p < 0.05; two arrows, p < 0.01; three arrows,
p < 0.001.
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condition known as globozoospermia (Jeyendran et al, 1985; Aitken et al, 1990). The
lack of an acrosome is incompatible with the participation of spermatozoa in the whole
process of fertilization because a normal acrosome reaction has been shown to be a
prerequisite for sperm penetration of the egg investments (Moore & Bedford, 1983;
Katz et al, 1989a; von Bernhardi et al, 1990). Spermatozoa from globozoospermic
men are therefore incapable of binding to the zona pellucida or fusing with the oolemma
(Weissenberg et al, 1983; Syms et al, 1984; Lalonde et al, 1988; Aitken et al, 1990).
The original definition of capacitation included all maturational changes which occurred
in spermatozoa after they left the male reproductive tract and rendered them capable of
penetrating eggs (Austin, 1952; Chang, 1984; Boatman & Robbins, 1991). This has
gradually evolved and now capacitation is more commonly defined as the physiological
changes which occur in spermatozoa and are prerequisites for the acrosome reaction
(Yanagimachi, 1988b; Zinaman et al, 1989). However, with the possible exception of
hyperactivated motility, no criteria for analysing capacitation and the acrosome reaction
independently have been identified (Sidhu & Guraya, 1989) and the ability of
spermatozoa to undergo the acrosome reaction is indicative of the fact that capacitation
is complete.
Treatment of the spermatozoa with six of the monoclonal antibodies caused
significant decreases in the percentage of spermatozoa which acrosome reacted. These
six antibodies may therefore interfere with some process occurring either during the
maturational changes that comprise capacitation or during the acrosome reaction itself.
The fact that four of the antibodies affected the acrosome reaction under either
spontaneous or inducing conditions but not both, highlights the differences between
these two reactions. The use of A23187 leads to a progressive increase in cytoplasmic
calcium and intracellular pH and a consequential increase in the proportion of cells
undergoing the acrosome reaction (Aitken et al, 1984; Irvine & Aitken, 1986b).
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Although the end result is the same, the mechanism of spontaneous and induced
acrosome reactions may be different and differences have been identified in the
acrosome reaction when induced naturally using follicular fluid or artificially using
A23187 (Tesarik et al, 1990; Mahony et al, 1991b). Furthermore Leyton et al (1989)
produced a monoclonal antibody, M42, raised against mouse spermatozoa which
blocks the zona- and ZP3-induced acrosome reactions but not the ionophore induced
reaction.
It is now thought that appropriate timing and location of the acrosome reaction
is a requirement for successful fertilization (Wolf, 1989; Schill et al, 1988; Tesarik et
al, 1990). Human spermatozoa can initiate binding to the zona pellucida after acrosome
reacting (Morales et al, 1989) but only those which undergo this reaction at the zona
pellucida seem to be capable of penetration (Tesarik et al, 1988; Tesarik, 1989). The
human zona pellucida thus plays a significant role in the induction of the acrosome
reaction (Cross et al, 1988; Aitken, 1989b). In the mouse, crosslinking of receptors
on the sperm surface by one of the zona proteins, ZP3, has been shown to induce the
acrosome reaction (Leyton & Sating, 1989). However the A23187- and zona
pellucida-induced acrosome reaction are different in that the latter is induced on the zona
pellucida and not in spermatozoa swimming free in medium (Liu & Baker, 1990) and
thus a more physiological test of the ability of spermatozoa to acrosome react is by their
ability to bind to and penetrate the zona pellucida.
The number of spermatozoa bound to the zona pellucida in vitro has been
shown to correlate with the fertilization rate in IVF programmes (Kruger et al, 1986,
1988; Liu et al, 1988; Liu & Baker, 1988) and as such the number of spermatozoa
bound to the zona is an important indicator of the fertilizing ability of spermatozoa (Liu
et al, 1991). Two of the monoclonal antibodies, spm 1/2 and spm4/6, caused
significant decreases in the number of spermatozoa bound per mm2 of zona surface
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resulting in a level of binding that amounted to only 40% (spm 1/2) or 35% (spm 4/6)
of the number bound to control zonae. This is similar to the degree of inhibition
exhibited by another whole-sperm specific monoclonal antibody reported by Mahony et
al (1991a) which inhibited zona binding by 70%. The mechanism by which the
sperm-zona interaction was inhibited may have involved antigens that become
expressed during sperm maturation, prior to this interaction (Trimmer et al, 1985;
Saling, 1986). This may be the case for antibody spm 1/2 which also caused an
inhibition of the acrosome reaction.
Although spermatozoa from proven fertile donors (men who have fathered a
child within the last two years) were used for all the biological assays, there was still a
degree of variation in the number of spermatozoa bound to the zonae on different test
days. This was probably related to the different sperm samples used for the tests, as
other workers have also identified the presence of significant inter-ejaculate variability
in the functional competence of spermatozoa (Rogers et al, 1983; Irvine & Aitken,
1986a; Katz et al, 1989a). Oocyte quality may also influence the number of
spermatozoa bound to the zona pellucida (Chen & Sathanathan, 1986; Mahadevan et
al, 1987) but as pooled stored oocytes were used for each test and randomly assigned
to control or antibody-treated sperm droplets, this variable should not have contributed
to any significant differences found between the two sperm populations.
The influence of the monoclonal antibodies on sperm-oocyte fusion was
assessed using the HEPT. The use of the calcium ionophore A23187 in this assay
overcomes one of the major defects in this system in that it lacks the stimulus for the
acrosome reaction which is normally delivered to the spermatozoon by the zona
pellucida (Aitken et al, 1987b). Induction of the acrosome reaction using A23187
maximizes the number of spermatozoa fusing with the vitelline membrane often
resulting in high penetration rates of 100% (Liu & Baker, 1990) and provides optimal
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conditions under which antibodies exerting an inhibitory effect can be identified. Three
of the antibodies exhibited significant inhibitions of HEPT only when the test was
performed in the presence of A23187. Antibodies spm 1/2 and spm 4/6 caused
decreases in both the penetration rate and the mean number of spermatozoa penetrating
each egg whereas antibody spm 4/4 only caused a decrease in the number of
spermatozoa/egg without a corresponding decrease in the penetration rate. This is
consistent with the findings of Aitken & Elton (1984) who demonstrated that when
penetration levels were high, the mean number of spermatozoa per egg rather than the
penetration rate was a more sensitive measure of the fertilizing potential of sperm
populations.
When the HEPT is performed in the absence of A23187, it relys on
spontaneous acrosome reactions occurring in the sperm population to produce a
fusogenic equatorial segment capable of initiating the sperm-oolemma interaction.
Spontaneous acrosome reactions do not occur frequently (Mallet et al, 1985; Morales et
al, 1988) and thus the penetration rate and mean number of spermatozoa penetrating
each egg are low. This provides suitable conditions under which antibodies exerting a
stimulatory effect can be identified. One such antibody is spm 4/7 which caused a
significant increase in the penetration rate and mean number of spermatozoa/egg when
the test was performed in the absence of A23187. This antibody also stimulated
sperm-oocyte fusion in the presence of A23187 although a corresponding increase in
the penetration rate was not seen as this was at its maximal 100% level. Spm 4/7 had
no effect on the number of spermatozoa bound to the zona pellucida. However the
sperm-zona binding assays were performed using spermatozoa from proven fertile men
and therefore the number of spermatozoa attached to the zona would be nearly maximal.
Although the zona bioassay provided a suitable test system for the presence of
inhibitory antibodies, stimulatory antibodies would not be identified under such
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conditions. This stimulatory effect of some antbodies on the HEPT has been reported
previously. Bronson et al (1981) and Aitken et al (1987a) identified some sperm
specific antibodies found in the sera of infertile people which stimulated sperm
penetration of zona-free hamster oocytes. Subsequent publications from the former
group have suggested that this increase in penetration is primarily exerted through the
ability of the antibodies to increase the number of adherent spermatozoa via specific
IgG Fc receptors (Fey receptors) on the vitelline membrane of zona-free hamster eggs
or by immunoglobulin bridging if the antibody recognizes shared or cross-reacting
epitopes on the plasma membranes of the gametes (Bronson et al, 1990a&b). It is
interesting to note that spm 4/7 belongs to the IgM class of antibodies (Chapter 5) and
would therefore not be expected to bind to IgG Fc receptors. Furthermore Fusi et al
(1991) showed that control murine IgM did not interact with the Fey receptor on the
hamster oolemma. An alternative mechanism of action for stimulatory antibodies was
suggested by Aitken et al (1987a). This involved the stimulatory antibodies
crosslinking receptor sites on the sperm surface thus activating the cell and initiating the
biochemical events normally involved in the induction of membrane fusion. The ability
of anti-receptor antibodies to mimic the action of the ligand upon binding subsequently
leading to the activation of the cell, is well established (Schechter et al, 1979; Zick et
al, 1984; Detmers etal, 1987; Ledbetter etal, 1987; O'Brien etal, 1987; Ikari et al,
1988). The recent discovery that aggregation of sperm receptors for the zona pellucida
by one of the zona proteins, ZP3, is involved in the induction of the mouse sperm
acrosome reaction (Leyton & Saling, 1989; Macek et al, 1991) coupled with the
knowledge that as an IgM antibody, spm 4/7 is capable of receptor crosslinking,
makes this an exciting possibility.
Although millions of spermatozoa are present in a normal ejaculate, only tens to
hundreds can be found at any one time within the fallopian tube (Hafez, 1978;
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Bronson et al, 1984; Chretien, 1989; Barratt & Cooke, 1991) and thus assessing the
ability of the antibodies to block sperm-oocyte fusion in the presence of 10 x 106
spermatozoa/ml (equivalent to 1 x 106 spermatozoa in the test droplet) is rather an
unnatural situation. It has been shown that the amount of antigen represented as the
number of spermatozoa present in an assay, is highly critical in producing a positive or
negative result (Dor et al, 1981) and there is a tendency for decreased penetration rates
to result when decreased sperm densities are used (Overstreet et al, 1980; Tyler et al,
1981; Aitken, 1989a). However the densities used in the HEPT droplets are still in
excess of those found at the natural site of fertilization in the ampulla of the fallopian
tube (Hafez, 1978). Therefore the effect of the two antibodies spm 1/2 and spm 4/6,
which showed the most marked inhibition of penetration and decrease in the number of
penetrating spermatozoa per egg in the HEPT performed in the presence of A23187,
were further analysed for their ability to exert this effect at decreasing sperm
concentrations of 10 x 106/ml, 5 x 106/ml and 1 x 106/ml. Results of HEPT tests
are often expressed in terms of the percentage of eggs penetrated and as such are
correlated to the fertilizing potential of spermatozoa in vitro but the results can also be
expressed in terms of the mean number of spermatozoa penetrating each oocyte and this
is an even better predictor of fertility (Irvine & Aitken, 1986a). When penetration rates
are high, the mean number of spermatozoa/egg rather than the penetration rate yields
more information on the fertilizing ability of sperm populations (Aitken & Elton, 1984,
1986) and is demonstrated by the data presented here in that the value obtained for the
number of spermatozoa penetrating each egg is more sensitive than the penetration rate
to variations in the concentration of spermatozoa No difference in the penetration rate
was seen for untreated control spermatozoa at all three concentrations as this was at its
maximal 100% level but the mean number of spermatozoa penetrating each egg did
vary. It was similar for sperm concentrations of 10 x 106/ml and 5 x 106/ml but was
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reduced at 1 x 106 spermatozoa/ml (Figures 7.3 & 7.4). This is consistent with
previous data published by Tyler et al (1981) who also found that the results of HEPT
varied with sperm concentration and that there was a marked decline in the penetration
rate if the density of spermatozoa in the test droplet fell below 1 x 106/ml. This is
because as the number of spermatozoa present in the assay droplet decreases, the
frequency of sperm-oocyte collisions also decreases (Aitken, 1989a) and consequently
the mean number of spermatozoa penetrating each egg and penetration rate also fall. At
all three concentrations, antibody-treated spermatozoa showed both a significant
inhibition of penetration and a marked decrease in the number of spermatozoa
penetrating each egg. This may be due to there being less antigen present for the
antibody to bind to at decreasing sperm concentrations and therefore a higher
percentage of spermatozoa would be bound by antibody. Thus more spermatozoa are
prevented from binding to and fusing with the vitelline membrane by either a direct or
indirect block of the sperm component which binds to the oolemma. Alternatively at
decreased sperm concentrations more of the spermatozoa may be agglutinated and less
are therefore free to interact with the egg plasma membrane. It has previously been
shown that it is the concentration of motile spermatozoa which is most important in
determining HEPT results and below a concentration of 0.4 x 106 motile
spermatozoa/ml, the penetration rate is greatly reduced (Aitken et al, 1982a; Barros et
al, 1988). Thus ifmore spermatozoa are agglutinated, less are free and able to bind to
and penetrate the oocyte. Both spm 1/2 and spm 4/6 caused some degree of sperm
agglutination but the fact that other monoclonal antibodies tested also caused a similar
degree of agglutination without a corresponding decrease in penetration or number of
spermatozoa/egg (eg spm 2/1 and spm 4/2), indicates that the inhibitory effects of
these antibodies cannot be due to their agglutinating activity alone.
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Some monoclonal antibodies do not cause agglutination and this is thought to be
due to a relatively low density of the antigen on the surface of the spermatozoa (Riedel
et al, 1990). As all twelve of the monoclonal antibodies recognized components of the
sperm surface which covered the whole surface and were not restricted to any particular
domain (Chapter 6), it is not surprising that they all caused some degree of sperm
agglutination. It has previously been shown that sperm agglutinating antibodies can
result in a decrease in fertilization by interfering with a number of reproductive
functions (Alexander, 1984; Menge et al, 1984) and thus any inhibition of sperm-zona
pellucida or sperm-oolemma binding could be an indirect result of the agglutinating
property of the antibody rather than a direct effect on the sperm surface molecule
involved in that process (Moore & Hartmann, 1984; Mahony et al, 1991a).
Furthermore Dor et al (1981) showed that the presence of sperm agglutinating
antibodies in serum correlated with the interference of sperm fertilizing ability as
assessed by the HEPT although they did not determine whether this effect was
primarily due to the agglutinating properties of the antibody or the masking (directly or
indirectly) of important sperm components. Thus as multivalent antibodies can exhibit
non-specific actions due to their agglutination properties (Metz, 1972), care must be
taken in the interpretation of inhibitory results of tests which assess the effect of these
antibodies. The production of univalent Fab fragments by papain digestion and their
subsequent use in the assays would resolve this problem allowing determination of
whether agglutination and/or steric hindrance were factors which played a role in the
inhibition (Menge & Black, 1979; Tzartos, 1979; Moore, 1981; Huang et al, 1981b;
Mahony et al, 1991a). Although Fab preparations of the antibodies reported here were
not made, this would be the next logical step to further characterize the antibodies
showing inhibition of sperm-zona and sperm-oolemma binding, particularly spm 1/2
and spm 4/6.
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The results of many sperm function tests often correlate because similar
functions are measured by these tests (Liu et al, 1988). Sperm capacitation and a
subsequent acrosome reaction are thought to be required for successful results in both
the zona-binding assay and the HEPT (Overstreet et al, 1980; Yanagimachi, 1981) and
thus antibodies interfering with these processes should be detected by both systems.
However the zona-binding assay and HEPT do not measure exactly the same events
occurring prior to fertilization and Bronson et al (1982) reported that antibodies
previously shown to promote penetration of zona-free hamster eggs, blocked sperm-
zona interaction indicating that antibodies can have differing effects on these two
systems. Four monoclonals caused decreases in the percentage of spermatozoa
acrosome reacted without exhibiting biological activity in any of the other tests. This
may reflect the stringent conditions under which the sperm-zona binding assays and
HEPT were performed as the number of spermatozoa used for each assay was in vast
excess with respect to the natural situation. Also several workers have now suggested
that spermatozoa displaying spontaneous acrosomal loss are inherently inferior
defective spermatozoa whereas fertile spermatozoa are included in the unreacted
population which respond to A23187 (Fukunda et al, 1989; Stock & Fraser, 1989;
White et al, 1990; Fenichel et al, 1991; Cummins et al, 1991). Furthermore proven
fertile donors have been shown to display a low spontaneous (5-10%) and a high
inducible (15-70%) acrosomal loss (Tesarik, 1989; Stock & Fraser, 1989; Cummins
et al, 1991; Fenichel et al, 1991; Ford et al, 1991) although a high degree of donor to
donor variation in the number of spermatozoa exhibiting spontaneous or
A23187-induced acrosome loss has been identified (Tesarik, 1985; Kallajoki et al,
1986b; Stock & Fraser, 1989). However spontaneously acrosome-reacted
spermatozoa are still functionally competent and can fertilize zona-free eggs and
produce healthy young when transferred to pseudopregnant mothers (Naito et al,
Chapter 7 Biological Assays 146
1992). Topfer-Petersen et al (1985) reported that infertile men with polyzoospermia
(an increased number of spermatozoa in their ejaculate, usually >350 x 106/ml) have
an abnormally high rate of spontaneous acrosome reactions and suggested that this
contributed to their infertility. Thus the significance of the acrosome reaction measured
in vitro in predicting the fertilizing ability of spermatozoa is still in dispute and has not
clearly been demonstrated (Braun et al, 1991). Therefore antibodies affecting the
number of spontaneously occuring acrosome reactions would not neccessarily be
expected to show biological activity in the other tests of sperm function.
Intriguingly one antibody, spm 1/1, inhibited both spontaneous and A23187-
induced acrosome reactions and the HEPT when performed in the presence of
ionophore, but appeared to have a slight stimulatory effect on the HEPT in the absence
of A23187. This stimulation of the HEPT is thought to be spurious as the non-specific
stimulation of sperm-egg fusion by antibody coated spermatozoa has been previously
reported (Aitken et al, 1987a; Bronson et al, 1990b). Thus this antibody is thought to
be essentially an inhibitory antibody.
Although human sperm fusion to zona-free hamster oocytes occurs in a similar
fashion to fusion with human oocytes in that it is initiated by the plasma membrane
overlying the equatorial region (Koehler et al, 1982), it is still a heterologous system.
Thus antibodies inhibiting sperm-oocyte fusion in the HEPT may not necessarily inhibit
this interaction in the homologous situation. Although many antibodies which have
been reported to inhibit the heterologous system have subsequently been shown to
inhibit the homologous situation, occasionally this has not been so. Primakoff & Hyatt
(1986) reported on a monoclonal antibody which was raised against guinea pig
spermatozoa which inhibited the fusion of guinea pig spermatozoa to zona-free hamster
oocytes in the HEPT. However this antibody did not block sperm-oocyte fusion when
it was tested in the homologous situation using zona-free guinea pig eggs. This
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indicates that some aspect of the fusion mechanism is different in the two systems and
care should be taken not to extrapolate HEPT results to include the homologous
system. Testing the homologous situation for the monoclonal antibodies reported here
would require the use of mature living human ova with all the ethical and legal
problems that this would entail. Such experiments have not been carried out but would
be a necessary progression of the work once agglutination and steric hindrance factors
had been eliminated.
7.5 Summary
Several in vitro tests of sperm function were used to assess the effects of the
monoclonal antibodies on various processes involved in fertilization and a summary of
the results is presented in Table 7.8. Antibodies spm 1/2, spm 4/6 and to a lesser
extent spm 4/4 had inhibitory effects on the HEPT and the first two also inhibited
sperm-zona pellucida binding. Monoclonal antibody spm 1/2 also decreased the
number of spermatozoa in a population undergoing the acrosome reaction. Four further
antibodies inhibited the acrosome reaction— antibodies spm 2/1 and spm 4/5 inhibited
the A23187-induced acrosome reaction whilst antibodies spm 2/2 and spm 4/3
inhibited only the spontaneous acrosome reaction— but did not display any biological
activity in the other tests of sperm function. One monoclonal antibody, spm 4/7, had a
stimulatory effect on the HEPT.
8 Molecular Characterization of Sperm
Antigen Recognized by Monoclonal
Antibody spm 1/2
8.1 Introduction
The study of fertilization played a part in the discovery of chromosomes and DNA as
the genetic material. In the 1850's, Rudolf Virchow recognized that the fertilized egg
was the 'mother cell' of all the cells that make up an organism (Stent & Callendar,
1978). This led to the anomaly that although both spermatozoon and egg made equal
hereditary contributions to the conceptus, their sizes were very disparate. It was noted
that the egg contained an enormous amount of cytoplasm yet the spermatozoon was
almost devoid of it and this led to the inference that the nucleus which was
approximately the same size in both cells, was the component that contained the factors
responsible for cellular heredity. Subsequently by the 1880's it had been discovered
that the nuclei of the spermatozoon and egg contained an equal number of
chromosomes which conferred hereditary material. Soon after this, Weissmann
proposed a theory of heredity and development including the concept of a linear
arrangement of hereditary units (genes) along the chromosomal threads (Weissmann,
1891-1892). The rediscovery of Mendel's classic genetics paper (Mendel, 1866) by
Correns in 1900, led to intensive study of heredity and the birth of genetics as a
discipline. It was not until 1944 that Avery, MacLeod and McCarty (1944) discovered
that genes are embodied in deoxyribonucleic acid (DNA) and not until the 1950's was
this generally accepted (Stent & Callender, 1978). The era of molecular genetics in
which the DNA nucleotide was studied as the fundamental unit, had dawned. The
elucidation of the double helix structure of DNA by Watson and Crick (1953) was
quickly followed by the formulation of the hypothesis that the DNA nucleotide base
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sequences specify the amino acid sequence in the corresponding peptide and that some
sort of genetic code must exist (1953 Cold Spring Harbor Symposium; Stent &
Callendar, 1978). In 1961, Crick et al provided evidence for a non-overlapping triplet
code and it was finally broken by Nirenberg & Matthaei (1961) and Lengyel et al
(1961).
Since then progress has been rapid and a range of powerful techniques have
been developed. Using these techniques, genes for all types of proteins can be
purified, sequenced, changed at will, reintroduced into individual cells of all kinds and
expressed there as proteins (Darnell et al, 1990). Recombinant DNA technology has
become an invaluable tool for research workers in a wide variety of disciplines. This is
particularly true in fields such as reproductive biology where starting materials for
identification and purification are limited. Indeed the techniques available are so
efficient and relatively simple to perform that it is often easier (and quicker) to clone the
gene for a protein, sequence it and predict the amino acid sequence of the
corresponding protein than to purify the protein and sequence it directly.
The discovery by Campbell in 1971 that the central third of the bacteriophage
lambda (k) genome is not essential for lytic growth led to its development as a cloning
vector and a large number of k vectors have since been developed (Williams &
Blattner, 1980; Sambrook et al, 1989). Vectors that have a single target site for
insertion of foreign DNA are known as 'insertion' vectors and those that contain two
sites flanking a segment of non-essential DNA that can be replaced by foreign DNA are
known as 'replacement' vectors (Sambrook et al, 1989). One such insertion vector is
A.gtll (Huynh et al, 1985) which carries a portion of the E. coll (3-galactosidase gene
which includes the upstream elements essential for its expression. Within the
carboxy-terminal coding region of this gene is a single £coRl site into which foreign
DNA can be inserted. In appropriate host cells, expression of the chimeric gene can be
induced using isopropyl-l-thio-(3-D-galactoside (IPTG) and a fusion protein
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synthesized (Young & Davis, 1983a). Expression of the intact (3-galactosidase gene
results in dark blue plaques when the phage are plated in the presence of the
chromogenic substrate 5-bromo-4-chloro-3-indolyl-p-D-galactoside (X-gal). When
this gene is disrupted by the insertion of foreign DNA, the recombinant phage form
colourless plaques in the presence of X-gal and thus can be easily identified (Miller,
1972; Sambrook et al, 1989). The fusion protein consists of the amino-terminal
portion of (3-galactosidase fused to the sequence encoded by the downstream open
reading frame. Thus cDNA libraries constructed in the expression vector A,gtl 1 may be
screened immunologically for expression of specific antigens in E. coli (Young &
Davis, 1983b). This technique was utilized to isolate the gene encoding the antigen
recognized by monoclonal antibody spm 1/2.
8.2 Materials and Methods
8.2.1 Screening of Library
A commercially available human testicular cDNA library cloned into the expression
vector, lambda gtll (Xgtll; Clontech, Cambridge, UK) was screened using the
anti-human sperm plasma membrane monoclonal antibody spm 1/2 described
previously in this thesis. A diagrammatic overview of the screening protocol is
provided in Figure 8.1.
A single white colony of streaked out E. coli Y1090 from an LB plate (12.5g
Luria broth base and 7.5g agar, both Gibco, Paisley, Scotland, UK; in 500mls water)
containing 50|ig/ml ampicillin (Penbritin; Beecham Research Laboratories, Bradford,
UK), 30p.g/ml 5-bromo-4-chloro-3-indolyl-6-D-galactoside (X-gal; Gibco) and
30(1g/ml isopropyl-l-thio-B-D-galactoside (IPTG; Gibco), was grown up overnight in
LB broth (12.5g Luria broth base in 500mls water) containing 0.2% maltose at 37°C
with good aeration. For each 82mm plate, a 0.2ml aliquot of the Y1090 overnight







Figure 8.1 Diagrammatic representation of Agtl 1 cDNA library screening method.
See text for details.
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culture was mixed with 0.1ml of lambda diluent (lOmM tris-HCl, pH7.5, lOmM
MgCl2, O.lmM EDTA) containing 3 x 104 plaque forming units (pfu)/ml. The phage
were allowed to adsorb to the cells at 37°C for 15 minutes. The cells were then plated
onto an LB plate using 2.5mls LB top agar (12.5g Luria broth base and 3.6g agar in
500mls water) containing 560|ig/ml X-gal. The plates were incubated at 42°C for 3.5
hours and then overlaid with a dry nitrocellulose filter (Hybond C-super; Amersham,
Aylesbury, Bucks, UK) which had previously been saturated in lOmM IPTG. This
induced expression of the P-galactosidase gene. After incubating the plates for a
further 3.5 hours at 37°C, the first filter was removed and replaced with a second filter.
The plates were again incubated for 3.5 hours at 37°C after which the second filter was
removed. Phage plaques producing recombinant protein recognized by antibody
spm 1/2 were identified as follows. The filters were blocked in 5% (w/v) dried milk
(Marvel; Premier Brands, Knighton, Adbaston, Stafford, UK) in Tris buffered saline
(TBS; 20mM Tris, 150mM NaCl) containing 0.05% (v/v) tween-20 for 1 hour. The
filters were washed three times for 10 minutes in TBS-tween and incubated with the
first antibody (diluted in TBS-tween) overnight at 4°C. Once again the filters were
washed three times in TBS-tween and then incubated for 2-3 hours at room temperature
with the second antibody, sheep anti-mouse immunoglobulin conjugated to horseradish
peroxidase (Amersham) diluted 1/1000 in 5% (w/v) dried milk in TBS-tween. After
the filters were washed three times in TBS-tween, positive plaques were identified
using an enhanced chemiluminescence (ECL) detection system (Amersham).
8.2.2 Preparation of Lambda Lysates
In order to purify phage DNA, a phage lysate was prepared using a liquid culture
method. A single well-isolated phage plaque was picked from an agar plate and placed
in 100(11 of phage buffer (20mM Tris-HCl, pH7.4, lOOmM NaCl, lOmM MgS04).
This was left overnight at 4°C for the phage to elute. A fresh culture of E. Coli strain
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Y1090 was started by innoculating a single colony into 5mls of LB medium
supplemented with 50|il of 1M MgS04 and 50|il of 20% (w/v) maltose and shaken
(2 400 rpm) overnight at 37°C. The next day, 500|il of the overnight culture was
added to the phage elution and incubated at 37°C for 20 minutes to allow the phage to
adsorb to the bacteria. This was then used to innoculate lOOmls of prewarmed LB
medium (37°C) which was supplemented with 1ml of 1M MgSC>4. This was shaken
(2 400 rpm) at 37°C until lysis occurred. If cell lysis had not occurred after 7 hours
of incubation, 500|il of chloroform was added and the solution shaken for a further 15
minutes. The cellular debris was spun down at 8 000 x g for 10 minutes. The
supernatant was transferred to a sterile container and stored at 4°C.
8.2.3 Isolation of Phage DNA
Phage DNA was isolated from the lysate medium using LambdaSorb phage adsorbent
(Promega, Southampton, UK) according to the manufacturer's instructions. Briefly,
100p.l of LambdaSorb was used for each lOmls of lysate. This solution was mixed for
30 minutes and then centrifuged at 10 000 x g for 15 minutes. The pellet was
resuspended in 1ml of phage buffer (20mM Tris-HCl, pH7.4, lOOmM NaCl, lOmM
MgS04) per lOmls of initial phage lysate and transferred to a microcentrifuge tube.
This was spun for 5 minutes at 12 000 x g in a microcentrifuge and the supernatant
discarded. The pellet was once again resuspended in 1ml of phage buffer and spun at
12 000 x g for 5 minutes. The pellet was resuspended in 0.5mls release buffer
(lOmM Tris-HCl, pH 7.4, lOmM EDTA) per lOmls initial lysate. This solution was
heated at 67°C for 5 minutes and spun again at 12 000 x g for 5 minutes. The
supernatant was transferred to another tube and 5pl of 5M NaCl added per 0.5mls of
supernatant. This was mixed and the DNA extracted with one volume of 1:1
phenol/chloroform (1 part TEN buffer-saturated phenol, pH7-8; 1 part chloroform).
The solution was vortexed for 1 minute and then centrifuged at 12 000 x g for 5
Chapter 8 MolecularBiology 154
minutes. The upper aqueous phase was transferred to a fresh tube and 1 volume of
chloroform was added. This was also vortexed for 1 minute and centrifuged as above.
The upper aqueous phase was again transferred to another tube and 2 volumes of 100%
ethanol were added. This was placed at -20°C for at least 30 minutes. After
centrifuging at 12 000 x g for 5 minutes, the supernatant was carefully removed and
the pellet resuspended in 1ml of 70% ethanol. This was spun again, the supernatant
carefully aspirated and the DNA pellet dried under vacuum. The pellet was
resuspended in an appropriate volume (usually 50|il) of TE buffer (lOmM Tris-HCl,
pH7.8, ImM EDTA). Before use, the isolated lambda DNA was treated with RNase A
as detailed in Section 8.2.4.
8.2.4 RNase A treatment
Contaminating RNA in the isolated phage DNA, was removed by treatment with
RNase A. DNase-free RNase A was added to the DNA solution to a final
concentration of 100|ig/ml and incubated at 37°C for 30 minutes. Sodium chloride was
added to a final concentration of 50mM and the DNA extracted using 1 volume of 1:1
phenol chloroform (1 part TEN buffer-saturated phenol, pH7-8; 1 part chloroform).
The solution was vortexed for 1 minute and then microcentrifuged at 12 000 x g for 5
minutes. The upper aqueous phase was transferred to a fresh tube and 1 volume of
chloroform added. After vortexing for 1 minute, this was spun at 12 000 x g for 5
minutes. The upper aqueous phase was again transferred to a new tube and 2 volumes
of 100% ethanol added. This was placed at -20°C for at least 30 minutes and then
centrifuged at 12 000 x g for 10 minutes. The supernatant was carefully removed and
the pellet resuspended in 1ml of 70% ethanol. The tube was centrifuged at
12 000 x g for 5 minutes and the DNA pellet dried under vacuum. The pellet was
resuspended in an appropriate volume ofTE buffer (typically 50pl).
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8.2.5 EcoRl Digestion
The restriction enzyme £coRl was purchased from Promega and used in conjunction
with the restriction enzyme buffer supplied with it. Digests were prepared in
1.5 x restriction buffer and incubated overnight at 37°C.
8.2.6 Agarose Gel Electrophoresis
All agarose gels were ran using a Minnie submarine agarose gel unit (model HE33;
Hoefer Scientific Instruments, Newcastle, Staffs, UK). 0.8% agarose gels (SeaKem
GTG Agarose; FMC Bioproducts, High Wycombe, Bucks, UK) in 0.5 x TBE
containing 0.3(1g/ml ethidium bromide (EtBr; Sigma, Poole, Dorset, UK) were run at a
constant voltage of 80V for 1-2 hours using 0.5 x TBE as the running buffer. Low
melting point agarose gels (typically 2%; Nusieve GTG agarose; FMC Bioproducts)
in 0.5 x TAE containing 0.3(tg/ml EtBr were run at a constant voltage of 45V for 2
hours at 4°C using 0.5 x TAE as the running buffer.
8.2.7 Primer Synthesis
Primers were made using an oligonucleotide synthesizer (Applied Biosystems,
Warrington, Cheshire, UK). The primers were removed from the column using ice
cold ammonia and deprotected by incubating overnight in a 55°C water bath. The
deprotected primers were stored at -20°C and aliquots prepared by ethanol precipitation
as required.
8.2.8 Polymerase Chain Reaction
The DNA insert of the positive phage was amplified using the polymerase chain
reaction (PCR; Saikiera/, 1985, 1988; Mullis etal, 1986; Mullis &Faloona, 1987).
PCR was performed using a GeneAmp PCR Reagent kit with AmpliTaq DNA
Polymerase (Perkin Elmer Cetus, Norwalk, CT, USA) using two primers synthesized
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as described in Section 8.2.7 and a programmable heating block (Hybaid, Teddington,
Middlesex, UK). The forward primer was a 22-mer located 16 to 37 base pairs (bp)
upstream of the EcoRl site of X. gt 11 and had the sequence
5'-GGTGGCGACGACTCCTGGAGCC-3'. The reverse primer was also a 22-mer,
located 23 to 44 bp downstream of the EcoRl site of Xgtl 1 and had the sequence
5'-GACACCAGACCAACTGGTAATG-3'. The final concentrations of the
components in the 100|il reaction mixture were AmpliTaq DNA Polymerase, 2.5 Units;
dNTPs, each 200pM; 1 x reaction buffer (lOmM Tris-HCl pH8.3, 50mM KC1,
1.5mM MgCl2, 0.001% (w/v) gelatin); forward primer, 0.5fiM; reverse primer,
0.5|lM. DNA from the phage lysate preparation was used as the DNA template. Prior
to use 10[il lysate + 60[il water were mixed and heated to 70°C for 5 minutes then kept
on ice until they were added to the other PCR components. The PCR reaction had an
initial melt temperature of 94°C for 5 minutes and was followed by 30 cycles of
annealing (1 minute at 50°C), extension (1 minute at 72°C) and melting (1 minute at
94°C). The final extension was carried out at 72°C for 7 minutes. The reaction
products were checked by electrophoresis in a submerged 0.8% agarose gel in 0.5 x
TBE buffer run at a constant voltage of 80V for 1 hour. The PCR fragment was then
subcloned into a plasmid vector as described in Section 8.2.9.
8.2.9 Subcloning into pBluescript SK-
To enable sequencing, the PCR fragment was cloned into a phagemid vector,
pBluescript SK- (Stratagene, Cambridge, UK) using a method involving proteinase K
as described by Crowe et al (1991). The PCR product was phenol/chloroform
extracted and then adjusted to 5mM EDTA, lOmM Tris (pH8), 0.5% SDS. Proteinase
K (Promega) was added to a final concentration of 50pg/ml and the mixture incubated
at 37°C for 30 minutes. The enzyme was denatured by heating to 68°C for 10 minutes.
Phenol/chloroform extraction was followed by chloroform extraction and the DNA
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precipitated using ethanol. The DNA was digested with the restriction enzyme fcoRl
as described in Section 8.2.5 and the products run on a 2% low melting point agarose
gel in 0.5 x TAE buffer (Nusieve; FMC Bioproducts). The band composed of the
£c<?Rl -digested PCR fragment was cut out of the gel and ligated to dephosphorylated
ZscoRl-cut pBluescript SK- overnight. The following day, XL1-B competent cells
(Section 8.2.10) were electrotransformed with this ligation mixture using a Gene Pulser
(BioRad, Hemel Hempstead, Hertfordshire, UK) as follows. Aliquots of competent
cells (40|il) were thawed at room temperature and then immediately placed on ice.
Between lpl and 2(il of ligation mix was added to each cell suspension, mixed well and
incubated on ice for 0.5-1 minute. The DNA-cell mixture was transferred to a cold
0.2cm sterile electroporation cuvette and pulsed for 15 seconds. The Gene Pulser
apparatus was set at 25|iF and 2.5kV and the Pulse Controller at 200 ohms. The cells
were immediately resuspended in prewarmed (37°C) SOC medium (2% Bacto
tryptone, 0.5% Bacto yeast extract, lOmM NaCl, 2.5mM KC1, lOmM MgCl2, lOmM
MgSC>4, 20mM glucose; 1ml) and the cells incubated at 37°C for 1 hour with shaking
in 17 x 100mm polypropylene tubes. The cells were then plated on LB plates
containing 50|ig/ml ampicillin, 40|ig/ml X-gal and 0.5mM IPTG (LAX plates) and
grown overnight at 37°C. Cells transformed by wild type pBluescript SK- grow as
blue colonies on these plates whereas those transformed with recombinant phagemid
result in white colonies. Cells which contain no phagemid are sensitive to ampicillin
selection and therefore die. Several white (putative positive) colonies were grown up
and phagemidDNA purified using Magic Mini-Prep columns (Promega). To identify
positive clones, the DNA was digested with £c<?Rl (Section 8.2.5) to release the
subcloned fragment and electrophoresed in a 0.8% agarose gel (Section 8.2.6).
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8.2.10 Preparation of Competent Cells
E. coli XL1-Blue competent cells were prepared as follows. One litre of L broth was
innoculated with 1/100 volume of a fresh overnight culture ofXL1-B cells. The cells
were grown at 37°C with vigorous shaking till the absorbance at 600nm was between
0.5 and 0.8. At this point the cells were harvested by chilling the flask on ice for 15-30
minutes followed by centrifugation in a cold rotor at 4 000 x g for 15 minutes. The
supernatant was removed and the pellet resuspended in 1 litre of ice cold water. The
suspension was then centrifuged as before and the pellet resuspended in 0.5 litres of ice
cold water. After a third centrifugation, the pellet was resuspended in approximately
20mls of ice cold 10% glycerol. A final centrifugation step was performed and the cells
resuspended in 2-3mls of ice cold 10% glycerol so that the final cell concentration was
approximately 1-3 x 106 cells/ml. This suspension was frozen in aliquots (40|il) on
dry ice and stored at -70°C until required.
8.2.11 Alkaline Denaturation of DNA
Prior to sequencing, phagemidDNA was denatured using alkaline treatment The DNA
was denatured in 0.2M NaOH, 0.2mM EDTA for 30 minutes at 37°C when it was
neutralized by adding 0.1 volumes of 3M sodium acetate (pH4.5-5.5). The DNA was
precipitated with 2-4 volumes of ethanol for 15 minutes at -70°C and then pelleted by
centrifugation at 14 000 x g for 10 minutes. The pelleted DNA was washed with
70% ethanol and after a second centrifugation, the pellet was dried under vacuum. The
DNA was then redisolved in water to be used for sequencing analysis (Section 8.2.12).
8.2.12 Sequencing
The nucleotide sequence of the subcloned PCR-amplified insert was determined
according to the dideoxynucleotide chain termination method of Sanger et al (1977)
using a commercially available sequencing kit (Sequenase; United States Biochemical
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Corporation, Cambridge, UK) and 35S-dATP (Amersham). The annealing reaction
comprised 7pl DNA (or DNA plus water), 2|il Sequenase 5 x reaction buffer and l|il
primer (approximately 300ng). The tubes were warmed to 65°C for two minutes then
allowed to cool slowly to <30°C (approximately 1 hour). The labelling reaction was
carried out by adding l|il dithiothreitol (DTT, 0.1M), 2pi diluted labelling mix (1:4),
0.5|il 35S-dATP and 2p.l diluted Sequenase enzyme (1:8) to the annealed
template-primer mix and this was incubated at room temperature for 5 minutes. The
reactions were terminated by adding 3.5|il of the sequencing reaction to each of the
prewarmed (37°C) termination mixes containing a dideoxynucleotide (ddA, ddC, ddG
and ddT; 2.5|il) and incubated for 5 minutes at 37°C. The reactions were finally
stopped by adding 4}il of formamide stop dye to each termination mix and the tubes
stored on ice until the gel was prepared. The sequencing reaction products were run on
a Hydrolink Long Ranger sequencing gel (AT Biochem, Newcastle, Staffs, UK)
prepared according to the manufacturer's instructions. Gels were run using an LKB
power supply at 35W constant power for either 2.5 hours (for sequence close to
primer) or 5.5 hours (for sequence distant form the primer). The gel was transferred to
Whatman 3MM filter paper and carefully covered with cling film. The gel was dried
under vacuum at 80°C for 30 minutes (Slab Gel Dryer, Hoefer Scientific Instruments,
Newcastle, Staffs, UK) after which the cling film was removed and the gel exposed to
X-ray film (Kodak X-OMAT AR; Kodak, Liverpool, UK) overnight.
8.2.13 Homology Analysis
Homology searches of the Genbank and Owl databases were kindly performed by Dr
Philippa Saunders and Dr Phil Taylor.
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8.3 Results
One million plaques were screened in duplicate and three putative positive clones were
identified. After further rounds of screening only one proved to be a true positive and it
was plaque purified. A lambda lysate was produced and the phage DNA purified using
LambdaSorb. This DNA was digested with the restriction enzyme EcoRl, to release
the insert and then electrophoresed on a 0.8% agarose gel (Figure 8.2) indicating that
the insert was approximately 1.9kb in size and contained no internal EcoRl sites. In
order to obtain sufficient material for subcloning and subsequent sequencing, the DNA
insert was amplified by the polymerase chain reaction (PCR) using a forward primer
situated 16-37bp upstream and a reverse primer situated 23-44bp downstream from the
FcoRl site of Xgtll. The sequence of these primers and their relative positions on
A,gtll are depicted in Figure 8.3. The PCR products were electrophoresed on a 0.8%
agarose gel (Figure 8.4) which indicated that the PCR product was approximately
1.9kb in size. This PCR product was subcloned into the phagemid vector pBluescript
SK- (Figure 8.5) and this construct used for sequence analysis. As the sequence was
elucidated, further primers were synthesized in order to obtain the nucleotide sequence
of the whole insert (Figure 8.6). The insert comprized 1997 nucleotides and contained
an open reading frame (ORF) from nucleotide 1 to nucleotide 660 coding for the
carboxy-terminal 219 amino acids of the antigen recognized by spm 1/2 (Figure 8.7).
The amino acid sequence Asn-X-[Ser or Thr] (where X is any other amino acid other
than Pro) has been proposed as a possible consensus sequence for N-linked
glycosylation (Kasahara etal, 1989; Wright et al, 1990; Schwoebel etal, 1991). The
predicted amino acid sequence includes three of these possible sites for N-linked
glycosylation at amino acid numbers 51, 81 and 145. The sequence Ser-[Asp or
Glu]-X-X-Pro has likewise been suggested as a possible target site for O-linked
glycosylation (Wright et al, 1990) and one possible site is present at amino acid number









Figure 8.2 Electrophoresis in 0.8% agarose gel showing size of cloned insert.
Lane 1, size markers, an EcoRl and HindUL digest of lambdaDNA producing bands of
sizes 21 227b, 5 148b, 4 973b, 4 268b, 3 530b, 2 027b, 1 904b, 1 584b,
1 375b, 975b, 831b, 564b and 125b; Lane 2, undigested positive clone; Lane 3,
positive clone digested with EcoRl showing release of an insert of approximately
1.9kb; Lane 4, undigested cloning vector, Xgtl 1; Lane 5, Xgtl 1 digested with EcoRl.
The gel was run at 80V for 1 hour in 0.5 x TBE.
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Forward Primer i
I I J.
5 • -GGTGGCGACGACTCCTGGAGCCCGTCAGTATCGGCG SAATTC :AGCTGAGCGCCGGTCGCTACCATTACCAGTTGGTCTGGTGTC-3 1
3 '-CCACCGCTGCTGAGGACCTCGGGCAGTCATAGCCGC GTTAAG STCGACTCGCGGCCAGCGATGGTAATGGTCAACCAGACCACAG-5 1
EcoRl Site
Reverse Primer
Figure 8.3 DNA sequence of ^gtll around the FcoRl restriction site showing the
sequence and position of the primers used during PCR amplification of the insert DNA














Figure 8.4 Electrophoresis of PCR products in 0.8% agarose gel. Lane 1, pGEM
DNA size markers (Promega) producing bands of sizes 2 645b, 1 605b, 1 198b,
675b, 517b, 460b, 369b, 350b, 222b, 179b, 126b, 75b, 65b, 51b and 36b; Lane 2,
PCR products from amplification of A,gtl 1 positive clone; Lane 3, same as lane 2 but
no template was added; Lane 4, size markers, an EcoRl and HindUl digest of lambda
DNA producing bands of sizes 21 227b, 5 148b, 4 973b, 4 268b, 3 530b, 2 027b,
1 904, 1 584b, 1 375b, 975b, 831b, 564b and 125b. The gel was run at 80V for 1
hour in 0.5 x TBE.






Figure 8.5 Electrophoresis of subcloned PCR fragment in pBluescript SK- in an
0.8% agarose gel. Lane 1, DNA size markers, an ZscoRl and Hindlll digest of
lambda DNA producing bands of sizes 21 227b, 5 148b, 4 973b, 4 268b, 3 530b,
2 027b, 1 904b, 1 584b, 1 375b, 975b, 831b, 564b and 125b; Lane 2, uncut
cloning vector pBluescript SK-; Lane 3, cloning vector pBluescript SK- digested with
EcoRl; Lane 4, uncut positive subclone; Lane 5, positive subclone digested with
EcoRl producing vector band at 3kb and release of insert of 1.9kb; Lane 6, PCR
fragment. The gel was run at 80V for 1 hour in 0.5 x TBE.
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1 GAATTCGGGA AGTGTGTCCG TGATTGTGAA AAGTACAAGC CTGGCGTGTT
51 GCTGGGGTTT AACATGAAAG AATTAAATAA AGTCAAGCAT GAGATGGATT
101 TTGATGCTGA GTGGCTATTT GAAAATCATG ATGAGAAGGA TTCCAGAGljc)
151 lAATGCTAGTA AGACTGCTGh CAAAAAGCTC AACCTTGGGA AGGAAGATGA
201 CAGTTCCTCA GACAGTTTTG AAAATTTGGA AGAAGAATCC AATGAAAGTG
251 GTAGCCCTTT TGACCCTGTT TTTGAAGTTG AACCTAAAAT CTCTAACGAT
301 AACCCAGAGG AACATGTACT GAAGGTAATT CCTGAGGATG CTTCAGAATC
351 TGAGGAGAAG CTAGACCAAA AAGAGGATGG TTCAAAATAC GAAACTATTC
401 ATTTGACTGA GGAACCAACC AAACTAAlfeC ACAATGCATC TGATAGTGAGl
451 GTTGACCAAG ACGATGTTGT TGAGTGGAAA GACGGTGCTT CTCCATCTGA
501 GAGTGGGCCT GGATCCCAAC AAGTGTCAGA CTTTGAGGAC AATACCTGCG
551 AAATGAAACC AGGAACCTGT CTGACGAGTC TTCCCAAAGC GAAGATGCAA
601 GGAGCAGTAA GCCAGCTGCC AAAAAAAAGG CTACCATGCA AGGTGACAGA
651 GAGCAGTTGA AATGGAAGAA TAGTTCCTAT GGAAAAGTTG AAGGGTTTTG
701 GTCTAAGGAC CAGTCACAGT GGAAGAA1GC ATCTGAGAAT GATGAGCGCTl
751 TATCTAACCC CCAGATTGAG TGGCAGAATA GCACAATTGA CAGTGAGGAT
801 GGGGAACAGT TTGACAACAT GACTGATGGA GTAGCTGAGC CCATGCATGG
851 CAGCTTAGCC GGAGTTAAAC TGAGCAGCCA ACAGCGCTAA GTGCAGGTTC
901 CCTGTTGGTG ACATGCTGCA GCCTGGAACT CTGATCTCCA GTGTGACTGC
951 AAAGCTGTCT TCTCACTGGT ACTGCCTTGT GAGTACTGGT TGGACTGTGG
1001 GGCATGTGGC GCTGCAGTTC CAGTGGTTAT TTCTAAGTCT ATGACAGGAC
1051 AGGCTGTTCT TGCTTCAGAA CCTTCTCTGA CAGACACGGT AACTAAATGT
1101 GAAAAACCAA TAAGCTGGTG ACTCATGAAT ACACACGAGG AAAAGCAGAG
1151 GTTTATTTTA TCTGCCTTTT CAACATTTCT TTCCCTCTGT GAAATGATTG
1201 GTCAGATGTC TTTGAGAAGT GTTAAACTAA TTCACATGGT AGTGTAGGGC
1251 CAACATACAA GCTACCAGTC TAATGTGTAT AGTAGACTTT GGGAAAAGCG
1301 attttttttc ATGTATTCAT TCTGATAGTT GAAATGTATA TTTGTACAGT
1351 CTTTTAGACC TATTCAAGTG ATGCTCATGA TCCTGCTACT GTGTGCCCAT
1401 CATAGATTTC tttttttagt GTTGCCCTTG CTGTGTAATA AACGCTCTAT
1451 CTAGTTTACC TAGCAAApIgC TCAAAACTGC GCTAGTATGG ACtrTTTTGGA
1501 CAGACTTAGT TTTTGCACAT AACCTTGTAC AATCTTGCAA CAGAGGCCAG
1551 CCACGTAAGA TATATATCTG GACTCTCTTG TATTATAGGA TTTTTCTTGT
1601 TCTGAATATC CTTGACATTA CAGCTGTCAA AAACAAAAAC TGGTATTTCA
1651 GATCTGTTTT CTGAAATCTT TTAAGCTAAA ATCACATGCA AGAATTGACT
1701 TTGCAGCTAC TAATTTTGAC ACCTTTCAGA TCTGTATAAA AGTGTGTTGT
1751 GTTGAAGCAG CAAACCAATG AGTGCTGCAT TTTGGATATT TAGTTTTATC
1801 TTTAGTTCAA CACCATCATG GTGGATTCAT TTATACCATC taataJtatgaJ
1851 iCACACTGTTG TAGTATGtTAT AATTTTGTGA TCTTTATTTT CCCTTTGTAT
1901 TCATTTTAAG CATCTAAATA AATTGCTGTA TTGTGCTTAA aaaaaaaaaa
1951 aaaaaaaaaa aaaaaaaaaa AAAAAAAGAA AAAAAAAACC CGAATTC
Figure 8.6 Nucleotide sequence of cloned cDNA showing position and sequence
of primers used for sequencing. The nucleotides are numbered on the left and arrows
indicate the direction of the primer.



























































































Glu Lys Asp Ser Arg Val |[ Asn Ala Ser | Lys Thr Ala Asp Lys Lys Leu Asn Leu Gly Lys Glu Asp
134 GAG AAG GAT TCC AGA GTC AAT GCT AGT AAG ACT GCT GAC AAA AAG CTC AAC CTT GGG AAG GAA GAT
Asp Ser Ser Ser Asp Ser Phe Glu Asn Leu Glu Glu Glu Ser|| Asn Glu Ser |Gly Ser Pro Phe Asp

















































































































































































































































































Figure 8.7 Nucleotide sequence of cloned cDNA and deduced C-terminal amino
acid sequence of the antigen recognized by spm 1/2. The deduced amino acid
sequence is shown above the nucleotide sequence. The nucleotides are numbered on
the left and amino acids are numbered on the right. The open reading frame contains
three potential N-linked glycosylation sites which are shown in solid boxes, and one
potential O-linked glycosylation site shown in a broken box. The 3' untranslated
region contains two polyadenlation siganls (AATAAA) which are underscored with the
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166. A triple serine residue sequence which occurs at positions 68-70 has also been
suggested as a potential phosphorylation site (Yan et al, 1990). The insert has a long 3'
untranslated region of 1357 nucleotides which contains a putative mRNA degradation
signal (ATTTA; Caput etal, 1986; Shaw &Kamen, 1986) at nucleotides 1830-1834.
Two polyadenylation signals (AATAAA; Berget, 1984; Joshi, 1987) are also present
at positions 1438-1443 and 1918-1923. A poly-A tail begins at nucleotide 1940, 17bp
downstream from the second polyadenylation signal. A hydrophobicity plot (Kyte &
Doolittle, 1982) of the predicted amino acid sequence was generated, averaging six
amino acids for each point (Figure 8.8). This indicated that the carboxyl terminus of
spm 1/2 antigen is mainly hydrophilic. The DNA and amino acid sequences were
checked for homology by carrying out searches of the Genbank and Owl databases
respectively. Neither the nucleic acid nor amino acid sequences showed any significant
homology with the sequences contained in the banks.
8.4 Discussion
One positive clone was identified after screening the human testicular cDNA library and
the insert was amplified using the polymerase chain reaction. Direct sequencing of
PCR products is possible (Wrischnik et al, 1987; Innis et al, 1988; Winship, 1989)
although often some difficulty is encountered. It was therefore decided to subclone the
PCR-amplified insert before sequence analysis was undertaken. Subcloning of PCR
products is relatively inefficient even when restriction sites have been incorporated into
the PCR primers (Lew, 1991). This may be due to inefficient cleavage of restriction
sites at or near termini and one method used to overcome this problem utilizes long
oligonucleotide primers that contain sequences complementary to the vector (Shuldiner
et al, 1990). An alternative theory as to why PCR products are often difficult to
subclone was proposed by Crowe et al (1991) who suggested that the Taq polymerase
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Figure 8.8 Hydrophobicity plot generated from the deduced amino acid sequence
of the C-terminus of the antigen recognized by spm 1/2.
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used during the PCR remains bound to the DNA and inhibits restriction endonuclease
activity. Thus increased cloning efficiency was achieved after incorporating a
proteinase K digestion step into the cloning protocol prior to endonuclease digestion
and this method was therefore followed to subclone the PCR-amplified insert reported
here.
DNA fragments up to 7.2kb can be cloned into the .EcoRl site of A.gtl 1 (Huynh
et al, 1985; Sambrook et al, 1989) as to be packaged efficiently, the length of the
phage genome must be between 78% and 105% of that of wild-type bacteriophage
lambda (Kaiser & Murray, 1985; Sambrook etal, 1989). The insert of 1.9kb isolated
here falls well within this range. The sequence contains an open reading frame from
nucleotide 1 to nucleotide 660 which encodes the C-terminal 219 amino acids of
spm 1/2 antigen. The long 3' untranslated region contains a putative mRNA
degradation signal and two polyadenylation signals. Only one polyadenylation signal
appears to function in the testis as only one poly-A tail is found, 17bp downstream
from the second signal. Welch et al (1990) also discovered two polyadenylation
signals in the cDNA encoding a sperm-specific antigen although, as reported here, only
one of these appeared to function.
Analysis of the deduced amino acid sequence revealed three possible N-linked
and one possible O-linked glycosylation sites. It is quite probable that carbohydrates
are added to the protein at these positions as many sperm proteins are glycosylated and
carbohydrates have been shown to be important in mammalian fertilization (Ahuja,
1982; Lambert, 1984; Boldt, 1989; Shur, 1989; Wassarman, 1989; Kimber, 1990;
Miller & Ax, 1990). The predicted amino acid sequence has a molecular weight of
24.5kD and this is less than the estimated molecular weight of 36kD obtained from gel
electrophoresis and blotting studies (Chapter 5). When a full length sequence is
obtained, the molecular weight calculated from the predicted sequence is often less than
that estimated on gels due to glycosylation of the protein (Adham et al, 1989; Baba et
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al, 1989; Wright etal, 1990). However the discrepency found here is mainly because
only the carboxy-terminal region of the protein has been cloned. In order to obtain
clones which contain the amino terminus and 5' untranslated region sequences, the
library must be rescreened using the cDNA sequence as a probe.
8.5 Summary
The gene encoding the antigen recognized by antibody spm 1/2 was isolated from a
human testicular cDNA library cloned into the expression vector A,gtll. The insert
DNA was amplified using the polymerase chain reaction and then subcloned into the
phagemid pBluescript SK- for sequence analysis. The whole insert was sequenced and
found to be 1997 nucleotides in length. It contains an open reading frame from
nucleotide 1 to nucleotide 660 which encodes the carboxy-terminal 219 amino acids of
the antigen recognized by spm 1/2. The predicted amino acid sequence contains three
possible sites for N-linked glycosylation and one possible site for O-linked
glycosylation. The insert has a long 3' untranslated region of 1337 nucleotides which
contains a mRNA degradation signal, two polyadenylation signals and a poly-A tail
which starts 17 nucleotides downstream from the second polyadenylation signal. The
hydrophobicity plot generated from the predicted amino acid sequence indicated that the
C-terminus of spm 1/2 antigen was mainly hydrophilic. Screening of the Genebank
and Owl databases for homologous sequences, indicated that the protein recognized by
spm 1/2 has not previously been described.
9 General Discussion
This thesis describes the production and characterization of twelve monoclonal
antibodies raised against the human sperm plasma membrane. It is thought that most
sperm antigens are not directly involved in the fertilization process (Mahony &
Alexander, 1991) as only a small proportion of antibodies which react with the sperm
surface affect fertility as assessed using a variety of in vitro tests of sperm function
(Anderson et al, 1987). Similarly only three of the twelve antibodies described here
were shown to be strongly biologically active. Two of these antibodies, spm 1/2 and
spm 4/6, caused a significant inhibition of fertilization and are thus of interest in the
development of a contraceptive vaccine. The other antibody, spm 4/7, stimulated
fertilization and may have a clinical application in the treatment of subfertile men.
Any animal used for a fusion must contain cells expressing antibodies directed
against the desired molecule otherwise it is impossible to successfully produce
monoclonal antibodies against this molecule (Milstein, 1982). Thus the animal requires
to be primed with the desired antigen prior to the fusion. Although the immunogen
does not have to be pure, numerous hybrids have to be screened in order to identify
those which are positive if it is not. This is often a time-consuming and labour-
intensive procedure. The probability of obtaining biologically active monoclonal
antibodies may be increased by partially purifying the immunogen so that it contains a
relatively higher amount of active antigen. Thus a purifed sperm plasma membrane
preparation was used as the immunogen in the production of the antibodies reported
here (Chapter 4).
Since this work was initiated, alternative methods to increase the proportion of
positive clones have been developed. One such method utilizes biotin-streptavidin-
mediated electrofusion (Lo et al, 1984; Wojchowski & Sytkowski, 1986; Hewish &
Werkmeister, 1989). This protocol involves biotinylating the desired antigen (against
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which the monoclonal antibodies are to be directed) and mixing this with B-
lymphocytes from a preimmunized animal. B-lymphocytes which produce antibody
against the desired antigen will then bind to the labelled antigen. This B-lymphocyte-
antigen-biotin complex is then brought into close proximity with biotinylated myeloma
cells using a streptavidin bridge. The cells are then fused using electrical pulses and
cultured as per the classical monoclonal antibody production technique (Chapter 4).
The vast majority of the resulting hybrids secrete antibodies against the desired antigen.
There are two main reasons for this. Firstly the streptavidin bridge ensures that the two
cells which require to be fused to produce the specific monoclonal antibodies, are
closely linked when the electric current is passed. Only a relatively small number of
other cells are close enough to each other, by chance, when the pulse is applied, to fuse
and therefore the background rate of negative fusions is low. Secondly, Chang (1989)
reported that electrofusions are more effective when they involve cells of a similar size
and non-activated spleen cells are generally smaller than myeloma cells whereas
activated B-lymphocytes are approximately the same size as myeloma cells. Thus most
of the hybrids produced using this method produce antibodies directed against the
desired antigen. Modifications of the basic hybridoma technique such as this one,
make the process more efficient and less demanding. A larger panel of antisperm
antibodies can then be produced from which biologically active ones can be identified.
Although whole spermatozoa can produce antibodies that induce infertility,
there are many sperm antigens which have been shown to be shared with other somatic
tissues and cells in the body (Freund et al, 1955; Kerek, 1974; Jacob, 1977; Chaffee
& Schachner, 1978; Menge & Fleming, 1978; Mathur et al, 1981; Jorgensen &
Moller, 1983). Therefore sperm-based contraceptive vaccines must utilize sperm-
specific antigens as cross-reactivity with somatic cells could interfere with other cellular
processes leading to serious side effects. While spm 4/6 cross-reacted with various
leucocyte subsets tested, spm 1/2 did not (Chapter 6). Although these preliminary
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results suggest that spm 1/2 is tissue specific, further investigation using a more
extensive panel of somatic tissues is required to establish this unequivocally. On
Western blots, spm 4/6 stained a large smear and is thus thought to recognize a
commonly occurring epitope such a carbohydrate (Chapter 5). Carbohydrates have
been shown to be important in fertilization (Shur, 1989; Wassarman, 1989; Miller &
Ax, 1990) and recently Phillips (1991) suggested that sperm-zona pellucida binding
may involve a simple relatively non-specific binding mechanism utilizing sugars. It is
unlikely that this is the only mechanism for sperm-zona pellucida binding but such an
interaction may be involved in the maintenance of sperm binding to the zona pellucida
after the aerosome reaction has occurred.
Multivalent antibodies can exert non-specific actions due to their agglutinating
ability (Metz, 1972; Moore & Hartmann, 1984). Antibodies can prevent the interaction
between spermatozoa and eggs by agglutinating most of the spermatozoa and leaving
few free in solution to interact with the oocyte. Such antibodies have an inhibitory
effect on the sperm-zona binding assay and HEPT but represent 'false positives'
because the antibody does not recognize a biologically active protein. Antibodies can
mask receptors in the sperm surface by steric hindrance as immunoglobulin molecules
are relatively large and this also gives a false positive result in these in vitro tests of
sperm function (Moore & Hartmann, 1984). Any role of agglutination and steric
hindrance in the inhibition of the sperm-zona pellucida and sperm-oolemma interactions
by monoclonal antibodies spm 1/2 and spm 4/6 was not directly assessed (Chapter 7).
However none of the antibodies were tested at very high concentrations and other
antibodies caused a similar degree of agglutination but had no affect on fertilization
(Chapter 7). Spm 1/2 also inhibited the acrosome reaction indicating that the antigen
recognized by this antibody may be involved in events during capacitation and/or the
acrosome reaction. This suggests that neither steric hindrance nor agglutination played
a role in the spm 1/2 block of fertilization. On the other hand, monoclonal antibody
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spm 4/6 did not have any effect on the acrosome reaction although it inhibited both
sperm-zona pellucida binding and sperm-oolemma fusion. Although spm 4/6 belongs
to the IgG2a subclass and is therefore smaller than the pentameric IgM antibodies, it
recognizes a commonly occurring epitope which is thought to be a carbohydrate
(Chapter 5) and thus the spm 4/6 block to fertilization may be partly attributable to
steric hindrance. These problems can be overcome by digesting the antibody molecules
with papain to produce Fab fragments. These Fab fragments only contain one antigen
binding domain and are therefore unable to crosslink. They are also much smaller than
whole immunoglobulins and thus lose their ability to mask other molecules.
Preparation of Fab fragments would be the next logical step to determine the potential
of these antibodies and their corresponding antigens for contraceptive vaccine
development
Passive immunization with antibodies raised against sperm-specific antigens is a
feasible approach to the development of contraceptive vaccines as it has been shown
that monoclonal antibodies passively administered to female mice have an antifertility
effect (Saling & Waibel, 1985; Saling et al, 1986; Sating, 1990). Similar studies in
males have also reduced fertility although the effect was less dramatic in males than
females (Lee et al, 1987). This is probably due to the action of the blood-testis barrier
which sequesters much of the male reproductive tract from the immune system. Most
monoclonal antibodies raised against human sperm antigens have been produced in
mice and these murine antibodies have limited potential for transfer to humans because
of their xenogeneic status. Although human monoclonal antibodies have been made,
many problems have been encountered and frequently the resulting human antibodies
are not of the appropriate isotype or do not possess the desired specificity (James &
Bell, 1987; Winter & Milstein, 1991). Transforming murine antibodies into chimeric
antibodies by combining the variable domain of the murine antibody with constant
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domains from human antibodies is not sufficient to overcome this problem (Morrison et
al, 1984; Boulianne et al, 1984; Bruggemann et al, 1989). In order to reveal the full
potential of such antibodies, they must be fully humanized. This involves reshaping
both the variable and constant domains of the antibody to make them 'human-like'.
This was first successfully achieved by Reichmann et al (1988) and a few humanized
antibodies have since been produced (Queen et al, 1989; Brown et al, 1991; Co et al,
1991). Generation of humanized antibodies has proved difficult (Co et al, 1991;
Winter & Milstein, 1991) although this technique is still in its infancy and has yet to
realize its potential.
Until recently, the production of monoclonal antibodies has required
preimmunization of animals (usually rodents). However towards the end of last year, a
new technique for monoclonal antibody production which bypassed the need for both
immunization and classic hybridoma technology, was published (Marks et al, 1991).
This involved amplification of antibody genes from human B-lymphocytes using PCR
and cloning the DNA fragments into phage DNA. This was done in such a way that
when the phage infected a bacterium, Fab fragments were made and displayed on the
phage surface. A 'phage display library' was thus created where every phage carried a
different antibody on its surface. Marks and colleagues were than able to select and
culture phage that bound a particular antigen and so produce human monoclonal
antibodies of defined specificity without the need for immunization. The development
of techniques such as these hold great promise for the future and is essential if the
production of a contraceptive vaccine by passive immunization is to become a reality.
The alternative to passive immunization is to administer a contraceptive vaccine
using active immunization with purified protein. Preliminary investigations with
sperm-specific antigens have been performed and indicate that a long lasting but
reversible contraceptive effect can be obtained in both males and females although this
effect is titre dependent and varies from one animal to the next (Naz, 1987b; Primakoff
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et al, 1988b; Liu et al, 1989c; Shaha et al, 1990). In order to purify bulk quantities of
a sperm antigen, vast amounts of spermatozoa would be required and this is
impractical. The impact of molecular techniques on this problem has been profound.
Once the gene encoding the desired sperm antigen has been cloned, unlimited supplies
of recombinant protein can be produced thus alleviating the need for large quantities of
starting material. Recombinant proteins have been used in several small scale active
immunization trials. Although they are less effective than the native protein in
stimulating an immune response, an antifertility effect was still seen (Liu et al, 1990;
Wright et al, 1990). This indicates that it is plausible to induce infertility using
recombinant proteins.
A partial clone of the gene encoding the antigen recognized by monoclonal
antibody spm 1/2 has been identified and the sequence elucidated (Chapter 8). In order
to carry out further studies to evaluate the contraceptive potential of the spm 1/2
antigen, this sequence may be used to isolate a full-length clone from a human testicular
cDNA library. Recombinant spm 1/2 protein could then be produced and preliminary
trials conducted to identify if it can induce infertility.
Synthetic peptides can also be used as the basis of vaccines and they may help
reduce side effects by increasing specificity (Arnon, 1986). Suitable peptide sequences
can be identified by epitope mapping studies. This method involves systematically
synthesizing all the overlapping short peptides (of say 7 or 8 amino acids in length) in
the entire protein sequence and measuring their reactivity with antibodies raised against
the native protein (Geysen et al, 1984). A monoclonal antibody can also be used to
identify the short peptide which has greatest binding and this is called a 'mimetope'
(Geysen et al, 1985). The protein recognized by spm 1/2 can be epitope and mimetope
mapped and the short peptides thus identified can then be chemically synthesized and
used as the basis for a contraceptive vaccine (Vanage et al, 1992).
Chapter 9 General Discussion 111
From the original twelve antibodies raised against the human sperm surface one
antibody, spm 4/7, had a stimulatory effect on fertilization (Chapter 7). This antibody
had no effect on the acrosome reaction nor on the interaction between spermatozoa and
the zona pellucida but significantly stimulated sperm-oolemma fusion. It has
previously been suggested that such antibodies exert their stimulatory effect by
increasing the number of spermatozoa adherent to the oolemma via specific Fey
receptors which are present on the vitelline membrane of hamster oocytes (Bronson et
al, 1981, 1990a&b). However spm 4/7 is an IgM antibody (Chapter 5) and therefore
does not bind to Fey receptors (Fusi et al, 1991). Alternatively spm 4/7 may recognize
an epitope which is common to both spermatozoon and egg and function by antibody
bridging (Bronson et al, 1990b). This may fortuitously increase sperm-egg fusion by
simply increasing the number of sperm adherent to the oolemma. It is not known
whether spm 4/7 recognizes any molecules on the hamster oolemma but this would be
a relatively simple experiment to perform in order to provide evidence for or against this
mechanism of action. A third possible mechanism by which spm 4/7 may exert its
stimulatory effect is by crosslinking receptors and activating the sperm cell thereby
initiating the normal biochemical events which occur upon sperm contact with the
oolemma (Aitken et al, 1987a). This mechanism requires that spm 4/7 is a multivalent
antibody and could be tested by preparing Fab fragments. If this antibody works by
receptor clustering, these Fab fragments alone should not be able to activate
spermatozoa but the addition of a second antibody to crosslink the first antibody should
and this would provide substanciating evidence for this mechanism. This is an exciting
possibility and would provide a tool with which the biochemical events occurring in the
spermatozoon upon contact with the oolemma could be probed and investigated.
The use ofmonoclonal antibody technology has permitted the identification of
molecules important in the fertilization process and in conjunction with molecular
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studies, it has allowed a more detailed insight into the intricacies of the sperm-egg
interaction. This has important implications for both the treatment of infertile couples
and the development of novel forms of contraception.
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